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Alcohol use disorder is a global health issue that affects a significant portion of 
the population, with affects including both negative mental and physical consequences.  
Currently, there are few treatment options available to those who suffer from alcohol 
use disorder, alcohol abuse, or alcohol dependence. Identifying candidate genes or 
environmental influences would therefore improve the means for possible treatments or 
identification of those people at risk for alcohol use disorder. Previous studies in 
humans have demonstrated an inverse association between initial sensitivity and risk 
for alcohol abuse. This connection allows investigators, and our laboratory, to 
investigate genetic and environmental factors that may influence initial ethanol sedation. 
Our laboratory utilizes Drosophila melanogaster (flies) as a model organism to identify 
these such factors influencing acute behavioral responses to alcohol. Our lab has found 
 
 
evidence for both environmental and genetic factors that influence initial alcohol 
sensitivity in flies. In one study, flies that are fed increased amounts of dietary yeast are 
resistant to ethanol. We have found that this ethanol resistance is related to the amount 
of nutrients that is consumed, which then affects alcohol uptake/metabolism, to 
influence initial alcohol sensitivity. Importantly, we found that serotonergic neuron 
function is essential for regulating the consumption of high dietary yeast media for the 
increased nutrient intake to occur. In two separate projects, we identified a role for 
myocyte enhancer factor 2 (Mef2) and nitric oxide synthase (Nos) in initial alcohol 
sensitivity. Mef2 was obtained via a GWAS study identifying genes with an association 
with initial sensitivity in humans. We found that decreasing or altering Mef2 expression, 
using mutants or Mef2 RNAi, resulted in flies having decreased sensitivity to alcohol. 
The gene Nos, came out of a previous genetic interaction screen in the laboratory. 
Multiple reagents to assess Nos’s role in alcohol behavior were obtained and consistent 
evidence from three piggyBac transposon insertion flies and, importantly, a Nos null fly, 
demonstrate that decreased Nos expression results in increased ethanol sensitivity. 
Other preliminary results suggest that Nos expression during adulthood, as well as the 
mechanism of S-nitrosation, may be important for ethanol sedation in Drosophila.
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Chapter 1 – Introduction 
 
 
 
1. Overview of problematic alcohol consumption in humans  
1.1.  Alcohol use disorder, alcohol abuse, and alcohol dependence 
Alcohol use disorder (AUD) can broadly be described as the harmful use of 
alcohol. AUD is a significant global health problem1. There was an estimated 283 million 
adults (5.1%, aged 15+ years) anticipated to suffer from AUD in 2016, while in the 
United States alone there was an estimated 15.1 million adults (6.2%, aged 18+) in 
20151. A substantial portion of global deaths (5.3%) in 2016, approximating 3 million, 
resulted from the contribution of alcohol1. Some of the categories for the cause of 
alcohol related deaths include: 21.3% digestive diseases, 20.9% unintentional injuries, 
19% cardiovascular diseases and diabetes, 12.9% infectious diseases, and 12.6% 
malignant neoplasms1. Globally, cardiovascular disease is the top cause of mortality 
and 3.3% of these deaths are attributed to alcohol1. Irregular heavy drinking, or high 
volume consumption, of alcohol leads to an increased risk for cardiomyopathy, 
rapid/irregular heart rate, and brain bleeds1. Additionally, it has been found that a 
person can develop asymptomatic alcoholic cardiomyopathy when large amounts of 
alcohol are consumed over multiple years and there is an ~50% 4 year mortality rate2. 
Furthermore, it is thought that acetaldehyde (first metabolite in alcohol metabolism) may 
also contribute to the development of alcohol cardiomyopathy3.  
2 
 
Research has linked alcohol consumption to the development of numerous 
cancer types in humans and rodent models. The risk to develop cancer caused by 
alcohol is typically higher for women than men, and can be caused by damage to DNA 
or by inhibition of the DNA repair process1. Alcohol exposure in rats led to increased cell 
death (as seen by expression of cleaved caspase 3), increased levels of double 
stranded DNA breaks (as indicated by increased H2AX), decreased DNA repair 
pathway genes, and increased oxidative stress in the hippocampus4. These different 
measures, taken together, demonstrate the toxicity of alcohol and its negative impact on 
regions of the brain4. Of the 9 million deaths in 2016 caused by cancer, alcohol 
attributed to 4.2% of them1. In addition to cancer, high mortality has been commonly 
associated with alcoholic hepatitis and liver cirrhosis.  
The widespread range of negative effects of alcohol also extends to negative 
mental health aspects5. This can include different types of mood or anxiety disorders, 
dementia6, Alzheimer’s7, or even increased suicidalidy8 1. Moreover, infectious disease 
account for almost 13% of all alcohol related deaths1. Alcohol consumption has been 
shown to lead to an increased risk for transmission of sexually transmitted diseases, by 
increasing the probability of risky sexual behavior1, 9. This includes having unprotected 
sex or having multiple sexual partners, which subsequently increases the likelihood of 
transmission and infection of sexually transmitted diseases. A second way alcohol can 
influence the risk for infections and transmission, is by the suppression of the immune 
system, which allows for easier infection by a disease1, 10. In fact, it has been shown 
there is a threefold increase in the risk for tuberculosis in the population of people who 
are diagnosed with AUD1, 11. As a disease that has far reaching effects, any treatment 
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or diagnostic tools to combat problem alcohol drinking would be beneficial to the world 
population. 
 
1.2. Diagnostic criteria for alcohol use disorder 
The diagnostic criteria for AUD is outlined by the 2013 version of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM), fifth addition. To qualify as having 
AUD, someone must have experienced 2 of the 11 symptoms listed in the past twelve 
months12. Also, a person can be categorized as having mild (2-3 criteria), moderate (4-5 
criteria), or severe (6+ criteria) AUD12. Previously, the fourth addition of the DSM broke 
the diagnosis into two categories, alcohol abuse and dependence. Abuse was 
diagnosed when one of four criteria were present in the last 12 months, whereas alcohol 
dependence would be diagnosed with three of seven criteria if present in the last 12 
months12. The current criteria is considerably different from the DSM-IV criteria, 
released in 1994 and then the revision, DSM-IV-TR, in 200012. The DSM-IV included 
legal issues as a potential criterion, which is not part of the DSM-V. Importantly, the 
DSM-V added alcohol cravings as a possible symptom, which was missing from the 
DSM-IV12. Some of the themes that have stayed the same between the two sets of 
diagnostic criteria include consuming more alcohol than wanted, alcohol affecting 
everyday life or causing issues with friends/family, gaining tolerance to the effects of 
alcohol, and not being able to stop use or having alcohol withdrawal symptoms12.   
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1.3. Alcohol use disorder, alcohol abuse, and alcohol dependence as a complex 
disorder 
The cause of alcohol use disorder, alcohol abuse, and alcohol dependence is of 
interest to help combat the negative mental/physical consequences it poses on society. 
Twin studies have been used to identify the main components involved in the risk for 
alcohol abuse. Kendler et. al. found via a female twin study that genetics and individual 
environment are the main factors leading to risk of alcohol abuse13. In this study 2,060 
female twins were interviewed and, based on DSM-III-R criteria, 185 had alcohol 
dependence and 357 met the broad criteria for alcoholism13. It was found that of the 
ACE (additive genetics, common environment, and unique environment) model, AE fit 
best across all definitions of alcoholism used13. This suggests common environment 
does not play a significant role in the risk for alcoholism, whereas genetic and unique 
environmental factors do. The authors also found that, no matter the definition of 
alcoholism, the amount of variance genetic factors were estimated as contributing 
towards alcoholism was  ~50-61% and unique environment contributing ~39-50%13. 
Other studies have found similar results for both, or either, males and females14-16. 
Therefore, it is widely accepted that the risk for alcohol abuse is ~50% based on 
genetics and the other ~50% is based on unique environmental factors.  
One important finding is that initial sensitivity of alcohol is associated with the risk 
for alcohol abuse. If a person is more tolerant, or resistant, to the effects of alcohol, they 
have an increased associated risk for abusing alcohol; whereas those that have a larger 
response, or are sensitive to alcohol, have a decreased associated risk for alcohol 
abuse17. In addition, there is a numeric score that rates a person’s initial sensitivity to 
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alcohol, called the Self-Rating of the Effects of Alcohol (SRE)18. This score is compiled 
from the answer to four questions about the first five times they consumed alcohol. 
Participants relayed the number of drinks it took to start feeling the following: i) different, 
ii) dizzy/slurred speech, iii) uncoordinated movements, and iv) sleep or pass out18. 
Furthermore, this SRE score is also associated with the outcome of alcoholism18. 
 
1.4. Current methodology used to identify genetic factors influencing alcohol use 
disorders, alcohol abuse, and alcohol dependence 
Different methods have been used to identify genes that may be contributing to 
the risk for alcoholism. Some of the earliest studies began using linkage studies which 
principally used large families that have affected and unaffected individuals. It is 
determined whether any markers, or single nucleotide polymorphisms (SNPs), that have 
known locations, segregate with the affected individuals more than expected. 
Importantly, this method is helpful for when there is not prior knowledge about what the 
genetic contributions/mechanisms are because it is an unbiased approach and takes 
the whole genome into consideration19. As an example, from the COGA samples, strong 
linkage was found between alcohol dependence and a region on chromosome 420. 
Chromosome 4q contains the cluster of alcohol dehydrogenase (ADH) genes and has 
been replicated in other studies21. A major limitation to this method is that the 
chromosomal locations identified are typically large (>10 megabases)22 and can contain 
dozens to multiple dozens/hundreds of candidate genes due to the marker likely being 
in linkage disequilibrium with the potential influencing gene23. Therefore this method 
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requires follow up work that is necessary to investigate the region to find the gene that 
may be influencing the association with the phenotype of interest. 
A second method that has been used to identify genes involved in a phenotype 
of interest is the candidate gene approach. A hypothesis can be made, and tested, 
about whether a gene/allele may be seen more commonly in an affected population 
compared to a control population. This process allows for the initial genome wide 
approach of investigation to be skipped because the investigator is able to test a 
specific question24. On the other hand, a significant limitation to this approach is that it is 
only useful when there is previous knowledge of the genes/mechanisms involved in a 
phenotype24. 
Association studies have made it to the forefront of investigation into genetic 
factors influencing a phenotype. This method looks across hundreds of thousands of 
SNPs/alleles to determine if any appear more often than expected in an affected sample 
compared to control23. One major advantage of using genome wide association studies 
(GWAS) is that that common variants that may influence a phenotype can be identified, 
so finding multiple common variants can be used to explain a portion of risk for a 
disease25. On the other hand, finding numerous common variants could lead to 
frustration due to the fact that very little of the variance for a phenotype can be 
accounted for (i.e., height26). A major downfall of this approach is that there is little 
statistical power to detect the variants that may be contributing to a phenotype of 
interest. Large sample sizes are typically necessary to increase the power of the 
analysis to find meaningful associations worth further investigation23. Additionally there 
is a lot of heterogeneity in alcohol phenotype. This can be seen in the criteria that used 
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to diagnose an individual with AUD, possibly making it harder to replicate findings 
across studies.  
 
1.5. Known genetic contributions influencing risk for alcohol use disorder, alcohol 
abuse, and alcohol dependence 
Genes that have been found to be involved in the risk for AUD, alcohol abuse, 
and alcohol dependence are very limited. There is, however, consistent evidence for the 
genes involved in alcohol metabolism – alcohol dehydrogenase (ADH) and aldehyde 
dehydrogenase (ALDH). For both ADH and ALDH, there are multiple family members or 
classes of genes. There are 7 ADH genes that are classed into 5 categories and class I 
ADHs, specifically ADH1A, ADH1B, and ADH1C, can act as heterodimers and typically 
are the most involved in the first oxidation step of alcohol to acetaldehyde27. ADH1B is 
more highly expressed than all other ADH genes in the liver and is thought to contribute 
the most out of the class I ADH genes to the oxidation of alcohol27. There are three 
isoforms of ADH1B and each have a different rate of alcohol metabolism as well as 
having altered allele frequencies depending on the population. ADH1B*1 has the lowest 
rate of alcohol metabolism and, when compared to a second allele, ADH1B*2, it is 
associated with an ~3 fold increase in risk for alcohol dependence28. ADH1B*2 is highly 
prevalent in American and Asian populations, with lower frequencies in European and 
south Asian groups, and is a protective allele against alcoholism and is associated with 
decreased alcohol consumption27. The third isoform, ADH1B*3, also has a higher rate of 
metabolism for alcohol over that of ADH1B*127. The ADH1B*3, though, is almost 
exclusively found in populations of African descent and is protective against alcoholism. 
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ADH1C has two isoforms. ADH1C*1 is associated with protective effects against alcohol 
dependence, has high allele frequencies in most population groups, and is more active 
at metabolizing alcohol than ADH1C*227. A smaller, potential significant role in ethanol 
metabolism is the class II ADH, ADH427.  
ALDHs have 19 genes in a total of 9 major family groups, but only three genes 
from 2 classes, I and II (ALDH1A1, ALDH1B1, and ALDH2) are typically found to be 
important for oxidation of acetaldehyde to acetate. The reaction of acetaldehyde to 
acetate is the second step of alcohol metabolism and is largely carried out in the 
mitochondria27. ALDH2 has two main isoforms (ALDH2*1 and ALDH2*2) and depending 
on which version a person has, can substantially change the effects of alcohol on them. 
Specifically, ALDH2*2 has been found to be protective against alcohol dependence and 
is mainly found in East Asian populations, with a very low frequency in African and 
American populations, and essentially causes the enzyme to be inactive27. This 
subsequently results in buildup of acetaldehyde which can have toxic side effects such 
as nausea, flushing, and headaches27. These side effects are typically unpleasant and 
people who carry this isoform typically tend to consume less alcohol. Compared to 
ALDH2, ALDH1A1 and ALDH1B1 are thought to contribute minorly to acetaldehyde 
oxidation, but play a bigger role if ALDH2 is nonfunctioning27.  
Other genes that have been shown to be associated with some aspect of alcohol 
use disorder, alcohol abuse, or alcohol dependence include genes encoding -
Aminobutyric Acid (GABA) receptors, dopamine receptors, the serotonin transport gene, 
and neuropeptide Y (NPY)28. Briefly, the GABAA receptor is made up of multiple 
subunits, one specific subunit of this receptor has fairly consistent evidence suggesting 
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a role in alcohol dependence or alcoholism susceptibility and is encoded by the 1 
GABA receptor (GABRB1) gene28. Some examples include linkage studies that found 
there was a nominal association (p=0.0002) with chromosome 4q, near GABRB1, and 
alcohol dependence29 and family based association study using the COGA sample30. 
DRD2, or the dopamine D2 receptor gene, is one of five dopamine receptors and is the 
most widely agreed upon dopamine receptor for a potential role in alcoholism. Even as 
it is the most agreed upon dopamine receptor of influence, there is a wide range of 
evidence for31, 32 and against33, 34 DRD2 association with alcohol dependence. Another 
gene with data suggesting association with aspects of alcohol dependence is the gene 
encoding the serotonin transporter protein (5-HTT). In the promoter of the 5-HTT gene, 
there can be an inclusion of a repeated sequence that classifies the gene as being the 
long or short allele35. The short and long allele have been shown to have different 
abilities in basal transcription activity with the long version being ~3 fold higher35. There 
are both positive and negative reports for its involvement in alcohol dependence28. Even 
with the contradictory findings with the studies on the serotonin reuptake transporter, 
subsequently serotonin signaling, it demonstrates the potential link between serotonin 
and alcohol responses in humans. This further supplies the necessity for further 
identification of factors (either genetic or environmental) that may be modifying the 
effects of the L and S alleles on alcohol responses in humans. Additionally, 
neuropeptide Y (NPY), has been associated with consumption of alcohol, but the 
direction of the specific variants influence is mixed. One study found that a specific 
variant, a leucine to proline substitution, caused a 34% increase in alcohol 
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consumption36 while others have seen this specific variant appear more often in non-
alcoholics37. 
The genes above, besides ADH and ALDH, have pretty controversial findings 
regarding associations with alcohol dependence or symptoms of AD. There are many 
factors that may be contributing to this ambiguous data such as the large heterogeneity 
of alcohol abuse, dependence, and AUD. This suggests there needs to be some 
refining of linkage and association studies to better improve the capability of confidently 
identifying genes with potential roles in any of these phenotypes.  
 
1.6. Known environmental influences contributing to risk for alcohol use disorder, 
alcohol abuse, and alcohol dependence 
 There is a wide variety of factors outside genetics that can influence the risk for 
AUD, especially for young children and adolescents. Environmental factors can 
influence risk for alcohol dependence at ~50%. A large contributor to the risk for alcohol 
abuse as an adult is different adverse childhood experiences (ACE). ACEs include 
different categories such as sexual, mental, and physical abuse, and parental 
separation/divorce or mental illness. Multiple studies have been able to find 
associations between ACEs and alcohol misuse38, 39. In addition to ACEs, there are also 
other factors including type of friends an adolescent has, parental monitoring, and 
availability of alcohol. Dick, et.al found that the highest environmental risk factors for 
increasing alcohol consumption in children ages 12-14 and 15-17 are i) peer group 
deviance, ii) low parental monitoring, and iii) alcohol availability, while for young adults 
18-21, the top factors are the same except low parental monitoring drops out40. Another 
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group found adolescent girls have an increased risk for alcohol abuse when there is low 
supervision by parents as well as having older aged friends41.   
Another environmental factor, which is largely unstudied, includes diet and how it 
affects alcohol behaviors in human. In humans, there is some evidence implicating 
direct, as well as indirect, connections between diet and alcohol behaviors. Evidence 
includes multiple studies that have found an association between body mass index 
(BMI) and alcohol abuse. Specifically in a study with participants from Finland, it was 
found males have a positive association of consuming larger amounts of alcohol (ten or 
more drinks a week) and obesity; whereas women had the opposite, where lower 
alcohol consumption associated with obesity42. A second study found similar results 
where males who were overweight/obese, or had a BMI score of greater than 25, had 
increased lifetime odds to suffer from alcohol abuse or dependence43. Consistently, 
obese women, those with a BMI score of greater than 30, had a decrease in odds for 
alcohol abuse in the last year43. Lichenstein and colleagues similarly found that teenage 
males who had high BMI values were at an increased risk for development of alcohol 
dependence44. This group was also able to find that CHRM2, a gene previously 
associated with alcohol dependence 45, is associated with increased BMI in the teenage 
male population44, potentially making a connecting link between BMI and alcohol 
dependence.  
Furthermore, a gene associated with BMI was also found to be associated with 
alcohol dependence, was further explored by Wang and colleagues46, 47. Initially, the A 
allele of the FTO gene was found to increase the likelihood of a person being 
overweight by 1.31 fold or for being obese at 1.18 fold48. Wang and colleagues found 
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that 16 SNPs in FTO were associated with alcohol dependence46. Still, another study 
determined that CPNE5 also had significant associations with obesity and alcohol 
dependence47. The group used the SAGE (the study of addiction – genetics and 
environment) to determine whether any number of the 77 SNPs located in CPNE5, in 
which 17, were associated with obesity and 10 with AD47. Together, these studies 
implicate that the same genetic factors can influence both obesity and alcohol 
dependence, suggesting the possibility of there being a further connection between 
them.  
There is little evidence surrounding serotonin, its precursor tryptophan (which is 
largely acquired via diet), and its effects on alcohol behavior. Nesic et. al., found that 
non-binge drinkers given a tryptophan rich diet had an increase in desire for alcohol 
consumption after being through a stressful event, whereas there was an increase in 
desire for alcohol in binge drinkers when given a tryptophan low diet49.  
 
2. Drosophila melanogaster – a way to investigate and model human disease 
2.1. Conservation between humans and flies 
 An important key factor of Drosophila melanogaster is that they contain orthologs 
for 62% of human genes that cause disease50. This has allowed flies to be used as a 
tool to understand molecular mechanisms or to identify therapeutic options of diseases 
when the task, if using other model organisms, would be much more challenging or time 
consuming. As an example, Fragile X can be modeled in flies to help identify the 
mechanisms underlying its development. In the human population, Fragile X has a 
prevalence of ~1/3500 boys and is characterized by developmental delay, intellectual 
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disability, and autistic-like behavior51. Loss of function mutations in the FMR1 gene, 
which encodes the protein FMRP, results in the development of Fragile X. Drosophila 
have an orthologous gene, dfxr, that is expressed in neurons like the FMR1 gene 
expression in humans and mutations in dfxr lead to failure of axon extension51. This 
phenotype in flies is important because it is anticipated that FMR1 in humans regulates 
morphology of cell body projections51, allowing for mechanistic inquires to be 
investigated into this process.  
As a second example of the utility of Drosophila as a model of human disease, 
Alexander Disease is based on astrocyte dysfunction and leads to neurodegeneration 
and eventual loss of life52. The dominant mutations in GFAP, accounting for >95% of 
patients with this disease, result in protein aggregates formed in astrocytes called 
Rosenthal fibers, defects in the myelin sheath, seizures, and neurodegeneration52. 
Although the causative gene for Alexander Disease is known, there are no further 
mechanistic aspects known as to how the GFAP mutations lead to disease 
progression52. Expression of mutated human GFAP in flies causes recapitulation of 
symptoms seen in humans: seizures, cell death, and Rosenthal-like fibers53. The 
authors utilized this model in flies to identify that nitric oxide (NO) is released from glia 
and is important for mediating neuronal cell death54. These studies demonstrate the 
utility of the fly in identify mechanisms that may be influencing human disease. 
Importantly, in relation to investigating alcohol-related behaviors in flies, there are 
conserved neurotransmitter systems, synaptic machinery, secondary messengers, and 
channels55. Conserved behavioral responses between flies and mammals, even 
humans, to alcohol start at the initial level of hyperactivity when exposed to low doses of 
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ethanol, and sedative effects when exposed to higher doses of alcohol. To identify this 
phenomenon, one group of authors used an acrylic chamber to determine locomotion of 
flies exposed to ethanol vapor. In this study, the wings of flies were clipped and placed 
in the acrylic chamber, where once exposed to ethanol vapor, the path and amount of 
lines travelled by the fly were recorded56. They found that flies had peak locomotor 
activity at ~10 minutes after the initial ethanol exposure start and that sedation occurred 
at ~25 minutes56. Other techniques have been developed to measure the sedative 
effects of alcohol such as the inebriometer. In the inebriometer flies are exposed to 
alcohol and the length of time required for them to elute from a tube with spaced slats is 
recorded57. In addition, other methods measure ethanol sedation via some 
measurement of, or loss of, a flies natural tendency to demonstrate negative geotaxis: 
such as counting the amount of flies that become sedated or lose postural control 
overtime when exposed to ethanol vapor58, 59, alcohol sedation recovery60, loss of 
righting reflex61, the eRING assay62, and calculating the speed at which the flies move 
when exposed to alcohol63.  
Rapid tolerance is another form of alcohol behavior that mammals, and flies56, 
develop. Tolerance is developed when there is a first exposure alcohol, a recovery 
period, and then a second exposure to alcohol. In the second exposure, the amount of 
time it takes for a similar response as seen in the first exposure, takes longer56. Genetic 
manipulations have been able to influence the development of both ethanol sedation 
and rapid tolerance, such as a mutation in the gene homer which results in initial 
ethanol sensitivity and decreased development of rapid tolerance64. On the other hand, 
some genetic manipulations affect either ethanol sedation or rapid tolerance, but not 
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both. Such was found when RNAi against Akap200 was expressed in glia had normal 
ethanol sedation but decreased development of rapid tolerance65. 
Flies, like humans and rodents, can also develop withdrawal symptoms. Flies 
going through withdrawal have increased susceptibility to seizures, seen as a lower 
stimulus voltage needed for induction of seizures66. This method is performed by 
applying a shock to the fly brain via electrodes and the induced seizure response is 
recorded66. When slo, a BK channel, is overexpressed in the fly, there is a decrease in 
the voltage stimulus that is needed to induce seizures, similar to the levels seen when 
flies are going through withdrawal66 , suggesting a role for this gene in the development 
of ethanol withdrawal.  
Additionally, flies will also prefer to consume liquid food that contains ethanol 
over a non-ethanol containing choice. One study found that the flies having access to 
liquid food with or without ethanol, measured via CAFÉ67, had a significant preference 
for alcohol containing food and the preference increased over time68. Even in conditions 
where quinine, an aversive substance to flies, was added to the liquid food containing 
ethanol, flies were willing to intake the aversive substance as long as the ethanol was 
present68.  
 
2.2. Current approaches used to investigate genetic contributions in flies 
 One prominent genetic manipulation tool that is used commonly throughout 
Drosophila studies, is the UAS-Gal4 system69. This system allows for tissue specific 
expression of Gal4, a protein that binds to an upstream activating sequence (UAS), and 
activate transcription of a specific transgene of interest69. This system allows for tissue 
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specific genetic manipulations throughout the life span of Drosophila. A second method 
that is also commonly used is the GeneSwitch system70. GeneSwitch is very similar to 
the UAS-Gal4 system, except in order for transcriptional activation to occur, a steroid 
must be present to allow for binding of Gal4-like protein to the UAS sequence70. This 
system allows for temporal and tissue specific control of transgene expression. It can be 
used to determine what stage, development or adulthood, the gene is required for a 
phenotype or used to surpass developmental lethality issues.  
 
2.3. Known genetic contributions influencing alcohol-related behaviors in Drosophila 
 Ethanol metabolism occurs in a similar manner as in vertebrates. Flies contain 
ADH and ALDH that are involved in alcohol metabolism71. Interestingly, similar to 
humans, natural variation in fly Adh can influencing alcohol metabolism71. Two alleles, 
AdhF and AdhS have differences in enzymatic activity, where AdhF is higher and causes 
flies to be resistant to alcohol71. By 2015, ~95 genes were published and found to affect 
aspects of alcohol responses in flies72. More importantly, there are genes that have 
been found to play a role in different aspects or symptoms of alcohol use disorder, 
alcohol abuse, or alcohol dependence in humans (mentioned in section 1.5) that have 
altered behavioral responses to alcohol in flies72. Dzitoyeva, et. Al (2003) used two 
approaches, RNAi targeting of the GABABR1 subunit of the GABAB receptor in flies as 
well as treatment with an antagonist of the GABAB receptor, to demonstrate the role of 
GABA receptors in alcohol behavior in flies73. The authors found that there was effects 
on sedation recovery with both the RNAi and antagonist approach73. This relates to the 
fact that GABA has been implicated in human alcohol dependence28-30. 
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When considering dopamine and its response in flies, a few studies have shown 
its importance in ethanol related behaviors, just as has been found in humans31, 32. 
Bainton et. al, found that treatment of flies with 3IY, a competitive inhibitor for the rate 
limiting enzyme in dopamine synthesis, significantly reduced the amount of time of 
ethanol induced hyperactivity61. Furthermore, serotonin has also been suggested as 
playing a role in fly alcohol sedation, whereas the serotonin reuptake transporter has 
been more studied for associations with alcohol dependence in humans28. Chen et. al, 
found that when flies have a subtype of protein kinase C (PKC) knocked down in Ddc 
positive neurons, but not Th positive neurons, flies are resistant to alcohol74. This would 
suggest that expression of this specific PKC isoform in serotonergic neurons is 
important for ethanol sedation. Additionally, treatment of these flies with two different 
serotonin reuptake inhibitors (citalopram and Prozac), the ethanol resistance phenotype 
of the PKC knockdown flies was rescued back to control levels74.  
Furthermore, just as the mammalian gene NPY has been shown to alter 
consumption and sedation in mice when knocked down, the fly ortholog NPF plays a 
role in fly alcohol behavior75. One study ablated NPF neurons in flies by expressing DTI 
(a diphtheria toxin that inhibits protein synthesis76) and resulted in flies being resistant to 
alcohol sedation compared to controls75.  
Some studies have even combined human GWAS studies and utilized 
Drosophila to further investigate their candidate genes. In one study, authors used the 
Irish Affected Sib Pair Study of Alcohol Dependence (IASPSAD) and participants had to 
have been diagnosed with AD by the criteria in the DSM-IV to be included in the study77. 
They found a significant association with a SNP in the ryanodine receptor 3 (RYR3) 
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gene and AD in this sample, p=1.47x10-7 77. The fly orthologous gene to human Ryr3 is 
RyR and two loss of function mutations cause a decrease in the development of rapid 
tolerance77. A second study performed a GWAS for genes that are associated with 
alcohol consumption, and identified the autism susceptibility candidate 2 (AUTS2) 
gene78. The Drosophila ortholog of human AUTS2 is called tay and the authors found 
that mutations in tay, or pan-neuronal expression of tay RNAi, resulted in flies being 
resistant to alcohol78. A third study found that Ras suppressor 1 (RSU1) was associated 
with AD in adults as well as for an association with lifetime frequency of drinking in a 
younger population sample79. The fly ortholog is icarus (ics) which encodes Rsu1, 
causes ethanol resistance when the gene interrupted by a P element and expression of 
UAS-Rsu1 was able to rescue the phenotype79.  
In a more recent article, Arf6 and Efa6 loss of function mutant flies demonstrated 
a higher preference for alcohol when having not been previously exposed to the drug 
compared to control fly preference80. Additionally, Efa6 mutants are sensitive to the 
effects of alcohol compared to controls80. The human ortholog of Efa6 includes genes 
PSD1-4, and specifically PSD3, had an association with the amount of alcohol 
consumed by a human within the last 30 days80. These examples show the importance 
of the conserved biology and behavioral responses to alcohol between flies and 
humans. This allows for identification, or follow-up studies from GWAS investigations, of 
genes that may be involved in the risk for alcohol dependence, abuse, or AUD in 
humans. Using flies allows for specific questions to be asked and mechanisms to be 
probed that would otherwise be harder to perform in humans or other vertebrate 
models.  
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2.4. Known environmental influences contributing to alcohol-related behaviors in 
Drosophila and other model organisms 
Altering environmental conditions, such as rearing conditions, is an easier task to 
accomplish in flies compared to other types of model organisms. Studies have used 
hypoxia or hypercapnia to investigate genetic contributions in flies that can alter the 
development of seizure-like activity81. Other studies have used alterations in the fly diet 
to study how a high fat diet influences responses to stress82.  
Sekhon and colleagues set out to address the specific questions whether there is 
an overlap between genes influencing food intake and alcohol intake in flies. The 
authors used recombinant inbred fly lines and assessed food intake, ethanol intake, and 
preference of these different lines. Through correlations of the various measures, the 
authors identified that factors influencing consumption of food or ethanol, from capillary 
tubes specifically, are positively correlated83. This suggests that there may be some 
overlap specifically in genes responsible for consumption of food and alcohol, relating 
the two processes.  
Looking further into the connection of diet and alcohol behaviors, minimal work 
has been previously done in other model organisms. The few studies, which 
demonstrate there is a relationship between diet and alcohol, are very important for 
supporting the idea that human risk for alcohol use disorder, alcohol abuse, and alcohol 
dependence may be in part affected by diet. One study investigated whether six 
different mouse “standard” chows could alter alcohol-related behaviors across two 
different laboratory tests, drinking in the dark (DID) and continuous 2-bottle choice 
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(C2B2), in C57BL/6J (BL6) mice84. The authors found that the DID mice had altered 
ethanol consumption and C2B2 mice had changes in ethanol preference as well as 
consumption when given access to these six different diets84. A second study in mice 
investigated how different genetic backgrounds, BL6 or DBA/2J (D2), responded 
differently in alcohol behavioral tests when subjected to food with altered concentrations 
of long-chain -3 fatty acid (LCO3)85. They found that a diet with low LCO3 levels 
resulted in altered alcohol induced locomotor activation in BL6 and D2 mice, and with 
higher levels of LCO3 in D2 mice85. Their study also demonstrated a difference in 
ethanol preference in BL6 mice when fed low or high levels of LCO3, but no changes in 
the D2 mice ethanol preference85. Furthermore, D2 mice had a significant increase in 
the duration of the loss of righting reflex (LORR) test when given high LCO3 diets 
compared to low LCO3 diets, but BL6 mice demonstrated no difference in effects in 
LORR85. These data, demonstrate that diet can play an important role on alcohol-
related behaviors in mice, and that genetic background can alter diet induced responses 
to alcohol85. An additional rodent study probed whether calorie restriction influences 
responses to alcohol in rats. The investigators were able to identify that a 25% calorie 
restricted diet in rats lead to a decrease in the self-administrative setting in an ethanol 
reward challenge as well as having a decrease in relapse behavior compared to control 
animals86. Together, these studies suggest that altering dietary components influence 
alcohol responses in mammals. 
A study using C. elegans also demonstrates the role diet can play on alcohol-
related behaviors. C. elegans develop acute functional tolerance (AFT), which means 
they develop tolerance to ethanol while they are being exposed to the drug, allowing the 
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animal to recover from the effects of alcohol resulting in decreased speed87. A fat-3 
mutant strain, fat-3 is necessary for the synthesis of long-chain polyunsaturated fatty 
acids, does not develop acute functional tolerance as seen by no increase in speed 
after 30 minutes of ethanol exposure compared to the 10 minute time point87. Using 
mutant strains of other enzymes needed for the metabolism of other long-chain 
polyunsaturated fatty acids, the investigators found that eicosapentaenoic acid (EPA) is 
necessary for C. elegans to develop acute functional tolerance and supplementation 
with EPA is sufficient to rescue fat-3 mutant strains lack of development of acute 
functional tolerance87. These data, in combination with the rodent data above, highly 
suggest a role for diet in alcohol related behaviors spanning across both invertebrates 
and vertebrates.  
 
3. Myocyte enhancer factor 2 (Mef2) in mammals and flies 
 The family of human myocyte enhancer factor 2 (MEF2) is an important family of 
transcription factors that is expressed in most tissues at both adult and embryonic time 
points88. In mammals there are four MEF2 genes, A-D, all with highly conserved MADS 
and Mef2 domains, which are important for MEF2’s ability to bind target DNA88. 
Drosophila have one orthologous gene, Mef2, which is orthologous to human 
(highest>lowest) MEF2A>MEF2C> MEF2D>BORCS8-MEF2B>MEF2B89 . Mef2 has 
been mainly studied for its role in muscle development in the fly88. Not only is Mef2 
important in myogenesis in flies, but the MEF2 family in mammals is important for 
muscle differentiation 90, 91, human disease/cancer 92, 93, and neuronal differentiation 94-
96. As MEF2 is a versatile transcription factor, it is opens the gateway to investigation of 
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mechanisms that could be important in ethanol-related behaviors in flies, and in a 
translatable manner to mammals. Identification of these processes could open the 
avenue for development of new drug therapies for treatment of alcohol use disorder, or 
identification of people who may be at an increased risk for abusing the drug. 
 
4. Nitric oxide synthase (Nos) in mammals and flies 
Nitric oxide synthase (Nos) is an enzyme that converts L-Arginine to Citrulline 
and NO. This reaction is, in most cases, calcium and calmodulin dependent and 
requires numerous cofactors including FAD, FMN, BH4, and NADP97. Vertebrates have 
three genes that encode NOS: neuronal NOS (nNOS or NOS1), inducible NOS (iNOS 
or NOS2), and endothelial NOS (eNOS or NOS3). NOS1 and NOS3 are considered the 
constitutive forms of NOS and are dependent on calcium whereas NOS2 is inducible 
and not dependent on calcium97. In vertebrates NO has many functions, some including 
acting as a neurotransmitter, being involved in blood vessel regulation97, and is involved 
in the development of many human disease states such as Parkinson’s disease, and 
Alzheimer’s98.  
Drosophila melanogaster has a single ortholog and is most highly conserved with 
NOS1 (DIOPT score 1389), with the other two vertebrate forms of Nos falling after, 
NOS3 (DIOPT score 1289) and NOS2 (DIOPT score 1089). RNA-Seq expression data 
has fly Nos primarily located in the head, which is consistent with high levels of protein 
expression of NOS1 in human neurons and oligodendrocytes99. Fly Nos has been 
shown to be involved in numerous processes in the fly, such as imaginal disc 
regeneration100, axon pruning and regrowth101, and immune responses102. Very little 
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evidence has previously supported a role for NO signaling in ethanol-related behaviors, 
although, there have been a few studies in rodents103-105. Therefore this gap in 
knowledge of how NO signaling may play in ethanol-related behaviors is understudied.  
 
5. Relevance 
 As mentioned in Section 1.1, alcohol use disorder has many negative influences 
on people that spans across the globe - from premature and/or preventable deaths, to a 
loss of productivity, mental health effects, or development of disease states1. Currently, 
there are not many treatment options available and those that are available are not 
always effective106. These treatment options include prescription drug treatment or 
individual/group therapy. One study found that when a person chose to undergo any 
treatment (either going to Alcoholics Anonymous (AA) or getting professional help) at a 
three year follow-up, had ~38% rate of relapse, whereas those that did not get any help 
had a relapse rate of ~57%107. This suggests that treatment, when options are available, 
are possible for decreasing the rate of relapse. It is this gap in knowledge of the 
mechanisms/factors influencing alcohol abuse, dependence, and alcohol use disorder 
that needs to be filled to allow for more effective treatment options to help, or help 
prevent, the development of the disease. 
Studies utilizing model organisms, such as Drosophila melanogaster, are 
imperative for identification of gene/mechanism/environmental factors that could be 
translated to influencing the risk for humans to develop alcohol use disorder. 
Importantly, if flies could help us to understand the different genetic and environmental 
factors influencing alcohol-related behaviors, it could potentially lead to the ability of 
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multi therapeutic action in humans (treatment with both drugs and diet). This could 
potentially allow for more successful outcomes for those who suffer from alcohol use 
disorder, alcohol abuse, or alcohol dependence.  
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Chapter 2: Materials & Methods 
 
 
 
Drosophila materials 
Table sugar (sucrose; multiple brands from Richmond Restaurant Service, 
Richmond, VA), yellow cornmeal (enriched degerminated, 62-101, Genesee Scientific, 
San Diego, CA), saf-instant yeast (Lesaffre Yeast Corp., Milwaukee, WI), Drosophila 
agar type II (66-104, Apex BioResearch Products, Genesee Scientific, San Diego, CA) 
were used to make fly media along with ampicillin sodium salt (A9518), chloramphenicol 
(C0378), methyl 4-hydroxybenzoate (tegosept, H5501), and tetracycline (T3383) from 
Sigma-Aldrich, St. Louis, MO. For studies involving different yeast brands, MP Bakers 
(101400) and MP Brewers (903312) yeast, MP Biomedicals (Solon, OH) were used. 
Polypropylene fly culture bottles (AS-335) and cotton plugs (22-456-882) were from 
Fisher Scientific, Waltham, MA; polystyrene narrow fly vials (89092-722) were from 
VWR International, Radnor, PA; fly vial cotton plugs (51-101) were from Genesee 
Scientific, San Diego, CA. Flugs (49-102) were from Genesee Scientific, San Diego, 
CA. RU486 (M8046) was from Sigma Aldrich, St. Louis, MO; Ethanol (200 proof, 89125-
172) was from VWR International, Radnor, PA.Gas drying tube caps (199610000), Bel-
Art Products (Wanye, NJ); feeder caps for Con-Ex studies (FCS13/16NA1), MOCAP 
(Park Hills, MO); 200 (41-6304) and 400 (41-6140) μm mesh, Ted Pella, Inc. (Redding, 
CA); methyl 4-hydroxybenzoate, chloramphenicol, tetracycline, ampicillin and xylene 
cyanol, Sigma-Aldrich, St. Louis, MO; FD and C Blue No. 1, Blue No. 2, Red No. 40, 
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Green No. 5, Red No. 4, Red No. 6 and Yellow No. 5, Spectrum Chemical 
Manufacturing Corp., Gardena, CA were used for investigation of consumption-
excretion and media physical interaction. For quantifying knockdown of Mef2 in adult fly 
brains, the following was used: Calbiochem normal goat serum (80000-994) was from 
VWR International, Radnor, PA; rabbit-anti Mef2 was from Dr. Bruce M. Paterson, NIH; 
chicken anti-rabbit Alexa 647 (A-21443) was from Thermo Fisher, Waltham, MA; 
Invitrogen Molecular Probes SlowFade Gold Antifade Mountant (S36936) and 
Fisherbrand Premium Superfrost Microscope Slides (12-544-7) were from Fisher 
Scientific, Waltham, MA; paraformaldehyde powder, 95% (158127), sodium chloride 
(S7653), and Triton X-100 (T8787) were from Sigma Aldrich, St. Louis, MO; and cover 
glass no.1 (89239-692) was from VWR International, Radnor, PA. Sodium phosphate, 
dibasic, 7-hydrate, crystal (3824-01), potassium chloride, crystal (3040-01), and 
potassium phosphate, monobasic, crystal (3246-01) were all J.T.Baker brand from 
Avantor, Center Valley, PA. For sequencing of Mef2 point mutations the following was 
used: Proteinase K (P2308) was from Sigma-Aldrich, St. Louis, MO; DreamTaq Green 
DNA Polymerase (EP0712) was from Thermo Scientific, Waltham, MA; ExoSAP-IT 
(782000) Affymetrix, Santa Clara, CA. Plastics for molecular biology and other liquid 
handling were from Genesee Scientific, San Diego, CA and USA Scientific, Ocala, FL. 
Oligonucleotides were from Fisher Scientific, Waltham, MA. For sequencing of nitric 
oxide synthase point mutations, the following was used: Taq DNA polymerase 
(M0273S) was from New England Biolabs, Ipswich, MA; dNTP set (BIO-39025) was 
from Bioline, Memphis, TN; ExoSAP-IT (782000) Affymetrix, place. 
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Fly husbandry and stocks 
 The w1118 (w[A]), Laussane-S (LS), Oregon-R (OR) and Samarkand (Sam) 
strains (stock numbers 5905, 4268, 25211 and 4270, respectively), UAS-Tetanus Toxin 
Light Chain (stock number 28837), two Trh-Gal4s (stock numbers 38388 and 38389), 
elavc155 (elav-Gal4), and the Mef2 RNAi line, JF03115, were obtained from the 
Bloomington Drosophila stock center (BDSC, Bloomington, IN). The r[A] strain was 
generated by backcrossing the w+ allele in Canton-S (supplied by Ron Davis, Scripts, 
Florida) into w[A] for 7 generations. The w1118 (w[VDRC]) strain and two Mef2 RNAi 
stocks v15540 and v15550 (construct ID 5039) were was obtained from the Vienna 
Drosophila RNAi Center (VDRC, Vienna, Austria). UAS-Kir2.1 was backcrossed to w1118 
for 5 generations. UAS-Kir2.1 and genetic background controls were from Dr. Scott 
Pletcher. Con-Ex ExVial and INT volumes were not different when feeding studies were 
initiated with anesthetized versus awake flies (data not shown). All studies used age-
matched flies reared, collected and tested side-by-side. 
All RNAi lines for candidate genes in follow up from human SRE GWAS are in 
table 4.2, and were obtained from BDSC. Mef265, Mef230-5 (from Richard Cripps, The 
University of New Mexico) and Mef225-34 (from BDSC, stock #9861) were backcrossed 
for seven generations to Mef2EP-321 (Mef2EP-321, BDSC, stock #43412, an insertion 
marked with mini-w in the first intron of Mef2) that we previously backcrossed for seven 
generations to w[A]. The Mef2EP-321 insertion did not alter ethanol sedation (not shown). 
The Mef265, Mef230-5 and Mef225-34 alleles were confirmed by PCR/sequencing using 
standard methods before and after being backcrossed to Mef2EP-321. Primers for PCR 
(forward/reverse) and sequencing were as follows: Mef265, 5’-
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AGATGCTGAATGTCCGAGTGT-3’/5’-GTGATGTGGCTTGTAGTGGC-3’ and 5’-
CCTTAATGCAGGTGCGCC-3’; Mef230-5, 5’-CAGTCAGCAGGAATCAGCCA-3’/5’-
TTGTTGGTGAGGGACTCGTG-3’ and5’-TGAGCATGAGCAGTAATTGAAC-3’); Mef225-
34, 5’-CAGTCAGCAGGAATCAGCCA-3’/5’-TTGTTGGTGAGGGACTCGTG-3’ and 5’-
CCACCATCTCCGTTTCCATC-3’.  
All stocks that were used in the investigation of nitric oxide synthase (NOS) and 
its effect on ethanol sedation is listed in Table 5.1 (labels, stock numbers, genotypes, 
chromosomal insertion location, where acquired, and any notes). Primers for Nos1 PCR 
and sequencing (5’-AGAATGCCCAAACCAGTCTAAATCG-3’/5’-
GGTAGCACCACCAAAGGTCGC-3’) and sequencing -5’-
ACATCGCTTGCCGTTGCTGAAATC-3’. Sequencing for was performed via Eurofins. 
Flies were grown to adulthood at 25°C/65% relative humidity with a 12-hour 
light/dark cycle on standard food medium (2Y10S3C: 2% saf-instant yeast, 10% sugar, 
3.3% cornmeal, 1% agar, 2 g/L Tegosept, 0.125 g/L chloramphenicol, 0.02 g/L 
tetracycline and 0.1 g/L ampicillin) supplemented with live yeast. Flies (3 to 5 d-old) 
were collected under light CO2 anesthesia, sex separated, and placed in fresh food vials 
containing the media indicated in the main text prior to the described studies. 
In studies using yeast paste (live or heat-killed saf-instant yeast (35% w/v) in 
water), flies were collected and placed into fresh food vials (containing 2Y10S3C as 
described above) and provided yeast paste (1 g/vial) via inverted caps from 50 mL 
conical tubes placed in the open ends of the vials. For studies using nylon mesh 
barriers, caps from gas drying tubes were bored out, circular pieces of nylon mesh were 
29 
 
melted into the caps, and the cap-nylon mesh inserts were placed in the vials to provide 
an ~2 cm gap between the flies and the yeast paste. 
The media in vials were 2Y10S3C (described above); 2Y10S3C missing 
antimicrobials, missing one or two nutrient components, or with all components diluted 
as described in the main text; 2Y10S3C supplemented with additional yeast, sugar or 
cornmeal as described in the main text; or 2Y, 10Y, 20Y or 30Y (2, 10, 20 or 30% yeast 
w/v in 1% agar). Unless otherwise noted, yeast indicates saf-instant bakers yeast.  
 
Ethanol sedation, locomotor behavior, and ethanol rapid tolerance 
Flies were collected, stored, and tested for ethanol sedation and rapid tolerance 
essentially as described 58, 108. Sedation time 50 (ST50) values (i.e. the time required for 
50% of flies in individual vials to become sedated) were determined by exposing flies to 
vapor from 85% ethanol in our standard protocol or from other ethanol concentrations 
mentioned in the figure legends. Locomotor behavior was assessed with this same 
process, without the addition of alcohol. For rapid tolerance, flies were sedated during 
an initial exposure to ethanol, allowed to recover for 4 hours at 25C/65% relative 
humidity, and then sedated during a second exposure to ethanol 108. Development of 
rapid tolerance was quantitated as fold increase in ST50 (i.e. ST50 from sedation 2 ÷ 
ST50 from sedation 1) or change in ST50 (i.e. ST50 from sedation 2 - ST50 from 
sedation 1). 
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Drosophila GeneSwitch  
Flies harboring neuronal synaptobrevin-GeneSwitch (nsyb-GS) along with UAS-
Mef2 RNAi transgenes or controls with either transgene alone were fed food topped 
with 100 l of 100 µM RU486 or vehicle (ethanol) for 6 days and used to determine 
alcohol sedation or β-galactosidase activity. Flies that contained Tubulin-GeneSwitch 
(tub-GS) and a transgene, or both controls, were fed 1 mM RU486 or vehicle (ethanol) 
food topped with 100 l solution, for 6 days, unless specified otherwise in legend, and 
alcohol sedation was determined.  
 
Internal Ethanol Measurement 
Frozen flies were homogenized in 200 µl of distilled H2O and centrifuged for 20 
minutes at 4°C 58, 108. Ethanol content in the supernatants was determined as previously 
described via a spectrophotometric method 58, 59 (all panels except internal ethanol 
experiments in Chapter 4 – Mef2) or by individual 20 µl supernatant sample aliquots 
were pipetted into 20 ml headspace gas chromatography (internal ethanol in Chapter 4 
– Mef2) vials containing 960 µl deionized water, 500 mg NaCl and 20 µl of 5 mM 1-
propanol internal standard. Samples were tested for ethanol concentration using an 
Agilent model 6890 gas chromatograph (GC) equipped with a flame ionization detector 
(FID), 0.53 mm ID Rtx BAC-1 capillary column (Restek, Bellefonte, PA) and CTC 
CombiPal headspace autosampler (Leap Technologies, Carrboro, NC). Samples were 
incubated and agitated for 10 min at 70C prior to automated injection. The GC 
parameters were as follows: 1.5 mL headspace injection volume, 5/1 split ratio, 3 min 
sample run time, injector temp 200C, oven temp isothermal 150C, detector temp 
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200C, helium carrier gas flow rate 40 mL/min, nitrogen makeup gas flow rate 18 
mL/min, hydrogen flame flow rate 25 mL/min and FID air flow rate 300 mL/min. Data 
were collected and analyzed by Clarity GC software (Apex Data Systems, Prague, CZ) 
using a linear regression analysis with no weighting. Ethanol concentrations were 
calculated by the internal standard method. A seven point calibration curve preceded 
the analysis of supernatant ethanol concentrations. Quality control ethanol standards at 
concentrations similar to those found in the test samples were interspersed at regular 
intervals with test samples (Fig 4.3 E & F). 
 
Total, dry and water weight 
Adult flies were reared and collected as above and weighed to determine total 
weight in groups of 11 while anesthetized in tared 1.5 ml snap-cap tubes with perforated 
lids. Tubes of flies were incubated at 50˚C (ambient humidity) for 24 or more h to 
volatilize water content and weighed to obtain dry weight. Water weight was determined 
as the difference between total and dry weight. Total, dry and water weights for each 
tube were expressed as mg/fly. Each tube of 11 flies generated a single datum 
 
Media and nutrient consumption 
Intake of food medium was measured using consumption-excretion of 1% FD&C 
Blue 1 in the indicated media using the sum of the dye excreted in the vial (ExVial) and 
the internal dye (INT) to reflect the volume of media consumption as described 109. Flies 
were reared and collected as described above, placed on the indicated food medium 
containing 1% FD&C Blue 1 for 24 h, and then ExVial and INT were determined. 
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Nutrient consumption (fold of 2Y) was estimated as ([ExVial+INT] x [yeast 
concentration]) ÷ ([mean 2Y ExVial+INT] x [yeast concentration]).  
 
Brain 5-HT levels 
r[A] females, reared and collected as described above, were fed 2Y or 30Y 
media for 2 days. Brains were dissected from flies and 5-HT was measured essentially 
as previously described 110-112. In brief,  single fly brains were dissected, homogenized, 
diluted with 10 µL 20 µM perchloric acid (to prevent transmitter degradation) and then 
tissue content determined with capillary electrophoresis with fast scan cyclic 
voltammetry detection. 
 
Consumption-excretion studies overview 
Agar-based food medium containing dye (dissolved in media prior to solidifying) 
was poured into plastic feeder caps (Fig. 1A) and allowed to cool at room temperature 
to solidify, placed in a humidified plastic box, and stored at 4°C overnight. The following 
day, feeder caps containing media were warmed to room temperature for 1 h, inverted 
and placed in the open end of vials containing adult flies (Fig. 1B). The feeder caps 
used in these studies hold ~4.5 mL of medium (many-fold more than flies consume), 
have flanges that prevent them from falling into the vials and fit in the vials used so that 
condensation does not build-up, yet flies cannot escape. Adult flies (typically 15/vial, but 
see Fig. 6) in the vials consumed medium from the feeder caps (the only food source) 
and then excreted waste over time (Fig. 1C). A single feeder cap was used in each vial 
over the duration of each experiment. Feeder caps were discarded at the conclusion of 
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feeding (Fig. 1D). The dye inside the flies (internal dye, INT) was collected via 
homogenization of animals in 1.5 ml of water followed by centrifugation to pellet debris. 
The dye excreted by flies on the walls of the vials (excreted vial dye, ExVial) was 
collected by addition of 3 ml of water to vials followed by vortexing (Fig. 1D). Definitions 
of abbreviations for all Con-Ex measures are provided in Table S1. Absorbance of the 
INT and ExVial dye in water extracts was determined in a spectrophotometer 
(Pharmacia Biotech Ultraspec 2000) (Fig. 1E) at wavelengths appropriate for each dye 
(Blue 1, 630 nm; xylene cyanol, 615 nm; Red 40, 504 nm; Green 5, 608 nm; Blue 2, 608 
nm; Red 4, 500 nm; Red 6, 442 nm; Yellow 5, 425 nm). Absorbance values were 
converted to volumes of medium consumed by interpolation from standard curves of 
pure dyes (Fig. 1F). Extracts of flies fed medium without dye controlled for background 
absorbance. The standard amount of time flies were allowed to consume-excrete in the 
vials was 24 h, but the consumption-excretion time was varied in some studies as 
described. When used, starvation of flies was achieved by housing them in empty vials 
for 17 h. In studies that assessed mating status on Con-Ex, virgin flies were collected 
under brief CO2 and then housed at 15 flies per bottle in the presence of 15 males 
(mated) or in the absence of males (virgin) for 2 d prior to the initiation of Con-Ex. Flies 
in all studies had a single water/food source (the feeder cap) and were housed 
undisturbed at 25°C and 65% relative humidity under a 12-hour light/dark cycle while 
consuming media from feeder caps. 
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Excretion on food medium 
Flies (20/vial) consumed standard medium containing 3% w/v Blue 1 from a 
feeder cap for 4 h (to accumulate INT dye). Flies were transferred into a new, second 
vial. A feeder cap containing the same medium, but no dye, was placed in the second 
vial and flies were allowed to excrete the previously consumed dye for 24 h (at which 
time all or virtually all INT dye has been excreted). The concentration of Blue 1 was 
increased to 3% for adequate dye signal. ExVial in the second vial was collected by 
adding 3 ml of water to the vials followed by vortexing. Excreted dye on the medium 
(ExMedium) was captured by melting the medium in each feeder cap in 25 ml of water 
in a microwave followed by centrifugation to pellet debris. Absorbance values of the 
ExVial and ExMedium dye were measured as described above. Extracts of food 
medium without dye were used to control for background absorbance. Absorbance 
values for dye collected from the vial walls and from the food medium were converted to 
volumes via interpolation from standard curves of pure dye dissolved in food medium. 
Due to low dye signal from groups with low dye concentrations, lower number of flies 
and after shorter periods of feeding, determining ExMedium in these studies was not 
possible. 
 
CAFE-excretion studies 
Studies on CAFE-excretion of liquid medium were performed as described 67 with 
modifications to capture excretion products. Adult flies (10/vial) were placed into empty 
food vials and prevented from escaping by foam plugs. One capillary feeding tube per 
vial was held in place by a plastic pipette tip placed in the foam plug such that the 
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capillary tube extended beyond the bottom of the plug by 3-5 mm. Flies were allowed to 
consume-excrete liquid medium (5% sucrose and 1% Blue 1 in water) from the capillary 
feeding tubes for 8 hours. The original capillary tubes containing sucrose and dye were 
removed, the amount of liquid medium consumed from each tube was recorded, and 
flies were then provided with fresh capillary feeding tubes containing 5% sucrose 
medium without Blue 1 for 18 h. Flies were housed in the same vials while consuming 
medium from both the first (containing Blue 1) and second (without Blue 1) capillary 
tubes, thereby allowing the excreted waste from each group of animals to accumulate in 
the vials and on the plugs. Excreted Blue 1 on the interior surface of vials (ExVial) was 
collected by adding 3 ml of water to each vial followed by vortexing. Excreted Blue 1 on 
foam plugs (ExPlug) was collected in 3 ml of water. Absorbance of Blue 1 was 
measured in a UV-vis spectrophotometer at 630 nm and absorbance values were 
converted to volumes by interpolation from standard curves of Blue 1. Flies were either 
fully fed or starved for 17 h by housing them in vials with 1% agar (wet starvation) or 
empty vials (starvation). Starvation with either protocol led to comparable amounts of 
medium consumption and excretion (not shown). Flies were housed undisturbed 
(except for replacing capillary tubes) in an opaque polycarbonate box at 25°C and 65% 
relative humidity under a 12-hour light/dark cycle throughout CAFE-excretion studies. 
Vials without flies were used to control for evaporation of liquid medium from capillary 
tubes. 
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Pletcher laboratory methods 
For the studies reported, an equal amount of Canton-S embryos were dispensed 
and reared on conventional sugar, yeast, cornmeal, and agar medium (CT) to control for 
density of developing larvae/pupae and synchronize the emergence of adults. Newly 
emerged adults were placed on fresh CT diet to allow for fly mating. 8-9 day old mated 
female and male flies were sorted under light CO2 anesthetization into groups of 15 
same-sex flies and transferred onto SY10 dietary medium containing 10% (w/v) 
sucrose, 10% (w/v) yeast, 2% (w/v) agar, 0.3% (w/v) tegosept, 0.3% (v/v) propionic 
acid, 0.002% (w/v) tetracycline, and 0.005% (w/v) kanamycin. Eight replicate vials were 
created for each sex and time point. After keeping flies on SY10 medium for three days, 
flies were then transferred onto SY10 diet containing 1% FD&C Blue No. 1 dispensed 
into the Con-Ex MoCaps for the interval specified in the figures. Time course 
measurement studies were started 2 hours after lights-on. All larvae/pupae/adults were 
maintained at 25°C, 12-hour light/dark, and 50-60% humidity throughout the 
experiment. Processing of flies/vials, absorbance measurements, and data analysis 
were performed as described in the Grotewiel laboratory methods. 
 
Human sample and phenotype 
The Avon Longitudinal Study of Parents and Children (ALSPAC) initially recruited 
14,541 pregnant women residing in Avon, UK, with expected dates of delivery April 1, 
1991, to December 31, 1992; 15,247 is the initial number of pregnancies for which the 
mothers enrolled in the ALSPAC study and had either returned at least 1 questionnaire 
or attended a “Children in Focus” clinic by July 19, 1999. Of these initial pregnancies, 
37 
 
there was a total of 14,973 live births and 14,899 children who were alive at 1 year of 
age. Subsequent phases of enrollment increased the sample size over time. The 
phases of enrollment are described in more detail elsewhere 113, 114. For the current 
analyses, full or partial phenotypic data were available for 5,626 offspring participants, 
in part reflecting the need for a subject to have had experience with alcohol to complete 
items related to alcohol sensitivity. The study website contains details of all the data that 
is available through a fully searchable data dictionary 
(http://www.bristol.ac.uk/alspac/researchers/our-data/). Ethical approval for the study 
was obtained from the ALSPAC Ethics and Law Committee and the Local Research 
Ethics Committees. 
Initial alcohol sensitivity in ALSPAC was assessed using the Self-Rating of the 
Effects of Alcohol scale (SRE) 18. Participants, aged 15.5, 16.5, and 17.5, were asked to 
consider the first five or so times they consumed alcohol and to report the number of 
standard drinks (defined in the questionnaire/interview) they consumed before they 
experienced signs of intoxication. As described previously 115, responses were 
winsorized to account for outliers and total scores were derived according to 
recommendations by Schuckit and colleagues 116. The total score was used as a 
continuous outcome in subsequent GWAS. See Edwards, Deak (115) for additional 
details.  
 
Human genetic analyses 
We used summary statistics from the SRE GWAS in ALSPAC, which contributed 
to our prior meta-analysis 115 but have not been independently reported, to identify 
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candidate genes of interest for potential follow-up. Summary statistics were uploaded to 
FUMA 117, which utilizes MAGMA 118 to conduct gene-based analyses. We selected the 
1000 Genomes EUR subset to adjust for linkage disequilibrium [described in 119].  
 
Identification of Drosophila orthologues of candidate SRE genes 
Of the human genes that were nominally implicated (pgene<0.001) in SRE 
variation, we identified genes for investigation in Drosophila based on several criteria: (i) 
prior evidence of involvement in phenotypes of potential relevance to alcohol response 
(e.g. substance use, psychopathology, or fatty liver disease) as suggested by searches 
of the Public Health Genomics Knowledge Base and PubMed; (ii) human-Drosophila 
orthology as determined using DIOPT 78, an online tool available via the DRSC/TRiP 
Functional Genomics Resources at Harvard University; and (iii) public availability of 
Drosophila RNAi reagents for manipulating expression of genes in flies. 
 
Drosophila immunohistochemistry 
Whole brains from adult female flies were dissected in PBT (100 mM Phosphate 
buffer, pH 7.2, with 0.03% (v/v) Triton X-100) under a dissecting microscope and fixed 
in 0.5 mL snap cap tubes containing 4% paraformaldehyde for 20 minutes at room 
temperature on a tube rotator. Fixed brains were washed with PBT, blocked with 5% 
normal goat serum (NGS), and incubated in primary antiserum (anti-Mef2, diluted 
1:5000 in NGS) on a tube rotator at 4°C for 48 hrs. Brains were washed with 0.3% PBT 
and exposed to the secondary antibody (chicken anti-rabbit Alexa 647, diluted 1:1000 in 
NGS) at 4°C for 48 hrs. Brains were then washed with PBT and mounted onto glass 
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slides in SlowFade mounting medium. Images were collected using a Zeiss LSM 700 
confocal microscope (Carl Zeiss Microscopy, LLC, Thornwood, NY) housed in the VCU 
Department of Anatomy and Neurobiology Microscope Facility. Confocal z-stack images 
using a pin hole of 1 Airy disc unit and Nyquist sampling were collected from each adult 
brain. Images were captured with a 10X objective using a numerical aperture of 0.3. 
The microscopy settings were optimized for the mushroom body regions of the brains 
from RNAi transgene control flies to (i) avoid oversaturation of images and (ii) allow 
comparisons in pixel intensity between brains expressing the Mef2 RNAi in neurons and 
controls. The same settings (gain, offset, power) and z-stack slice thickness were used 
in all images. All images were processed using Image J (National Institutes of Health 
120). A threshold value was individually set for each z-stack so only pixels in the brains 
were analyzed. Mef2 detection was determined as the mean pixel intensity for each 
brain 121. 
 
Statistical analysis of Drosophila results 
Statistical analyses (student’s t-test, one- and two-way ANOVAs, Bonferroni’s 
multiple comparisons (BMC), and normality tests) were performed using Prism 6.07 
(GraphPad Software Inc., San Diego, CA). P values, reported in the legend, < 0.05 were 
considered statistically significant. All numerical data are reported as mean ± SEM. 
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Chapter 3: Dietary yeast influences ethanol sedation in Drosophila via serotonergic 
neuron function 
 
 
 
A. Introduction 
 
Consumption of alcohol (ethanol) has a wide range of pleasurable effects 
including psychomotor stimulation122, 123, general improvement in mood and relief of 
stress124. Additionally, however, abuse of alcohol has far-reaching, negative health 
consequences125, 126. Alcohol abuse contributes to 3-4% of all preventable deaths 
worldwide, increases the risk for specific forms of cancer, and is responsible for 
hundreds of billions of dollars in costs annually within the United States alone125. Both 
environmental and heritable genetic factors contribute to the risk for abusing alcohol14-16, 
127. A better understanding of these environmental and genetic risk factors could 
ultimately facilitate prevention and treatment of alcohol abuse. 
Drosophila melanogaster (fruit fly or fly) is a leading invertebrate model for 
investigating molecular-genetic mechanisms that influence alcohol-related behaviors71, 
72, 128, 129. Behavioral responses of flies to alcohol include locomotor stimulation at low 
doses63, 130, sedation at higher doses58, 59, 62, 77, 131-133, development of seizures upon 
withdrawal of alcohol66, and development of tolerance after prior exposure to the drug56, 
60, 134. Additionally, flies will voluntarily consume alcohol67 and they develop exposure-
dependent alcohol preference135-138. All of the behavioral responses to ethanol in flies 
are also found in other species including humans71, strongly suggesting that alcohol 
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likely has conserved effects on nervous system function. Consistent with this possibility, 
many genes or genetic pathways that influence behavioral responses to alcohol in flies 
have also been implicated in various aspects of alcohol-related behaviors in other 
model organisms (e.g. Clic 132, GABA signaling73, 139, slo potassium channels140 and 
NPF/NPY signaling75, 141) as well as various aspects of alcohol consumption and abuse 
in humans (e.g. Adh138, 142-144, Rsu179, AUTS278, Ryr77). Thus, at least some of the 
mechanisms underlying alcohol-related behavior in model organisms might also impact 
alcohol abuse in humans. 
In addition to genetic factors, ~50% of the risk for abusing alcohol is influenced 
by environment14-16, 127. Diet is possibly one of the key—but largely underappreciated—
environmental factors that influences alcohol phenotypes in humans. Supplementation 
of the diet with tryptophan decreases alcohol craving in human binge drinkers exposed 
to stress49. Additionally, patients with higher body mass indexes (BMI) are at an 
increased risk for heavy alcohol intake42, development of alcohol dependence44 and 
alcohol abuse43. Diet also influences multiple alcohol-related behaviors in rodents84-86, 
145 and C. elegans 87. Furthermore, variants in the genes FTO and CPNE5 are 
associated with both obesity and multiple alcohol phenotypes in humans46, 47, 146 and 
several genes in flies might regulate both food intake and behavioral responses to 
alcohol83. These studies collectively suggest that diet and diet × genotype interactions 
might play important roles in multiple aspects of alcohol-related behavior in animals and 
impact risk for alcohol-related phenotypes in humans. 
Several studies suggest that the serotonin (5-hydroxytryphtophan, 5-HT) system 
might modulate or mediate the effects of diet on behavioral responses to alcohol. In 
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flies, for example, dietary yeast influences brain 5-HT levels147, serotonergic neurons 
regulate feeding148-150, the 5-HT2A receptor impacts dietary protein consumption147, and 
5-HT is implicated in ethanol sedation74. Additionally, there is a large literature linking 5-
HT to alcohol problems in humans (e.g.151-155). Despite the insights of the studies 
summarized here, the possibility that 5-HT signaling underlies diet-induced changes in 
behavioral responses has not been formally addressed. 
In this report, we describe results from our studies on the role of diet in alcohol 
sedation in Drosophila. We chose flies for these studies because of their conserved 
alcohol-related behaviors56, 58-60, 62, 63, 66, 67, 71, 77, 130-138, the powerful tools available for 
performing genetic analyses in this model156, the ability to measure both ethanol 
sedation (see above) and food intake109, the ability to control food composition109, 147, 157, 
and the known genetic connections between fly alcohol behavior and human alcohol 
abuse77-79, 138, 142-144. We report that dietary yeast significantly impacts ethanol sedation 
in flies, possibly by influencing ethanol uptake/elimination. We also report that the effect 
of dietary yeast on ethanol sedation and uptake/elimination depends on serotonergic 
neuron function. Our studies establish flies as a model for exploring diet-induced 
changes in alcohol sedation and suggest that the serotonergic system might be a 
conserved regulator of the underlying processes. 
B. Results 
Drugs, enzyme inhibitors and other molecules can be administered (i.e. fed) to 
flies via a simple paste made of yeast (Saccharomyces cerevisiae) and water (e.g.158-
160). While establishing this drug treatment regimen for investigating alcohol behavior in 
flies, we found that flies exposed to a standard food medium supplemented with a paste 
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made from live yeast and water were substantially resistant to ethanol sedation (Fig. 
3.1A, time-courses; Fig. 3.1B, sedation-time 50 (ST50) values) compared to flies 
provided only a standard medium containing 2% yeast, 10% sucrose and 3.3% 
cornmeal (hereafter 2Y10S3C). The resistance to ethanol sedation was evident by 2 d 
of exposure to yeast paste and persisted during at least 4 d of continuous exposure 
(Fig. 3.1C). 
Yeast produce ethanol via fermentation161-164, including under conditions used to 
rear Drosophila58. To address the possibility that the ethanol resistance in flies fed yeast 
paste reflected tolerance in response to ethanol produced by the supplemented yeast, 
we fed flies paste made of heat-killed yeast (which would be incapable of fermentation) 
and then assessed ethanol sedation. Flies fed heat-killed yeast paste were resistant to 
ethanol sedation compared to flies fed standard food, and ethanol sedation in flies fed 
heat-killed and live yeast paste were indistinguishable (Fig. 3.1A, time-courses; Fig. 
3.1B, ST50 values). Therefore fermentation and ethanol production by supplemented 
yeast is not required for the yeast-induced change in resistance to ethanol sedation. 
Flies were provided with supplemental yeast paste in the studies reported in Fig. 
3.1. To address the possibility that increasing the concentration of yeast incorporated 
into agar-based fly media (versus supplementation with yeast paste) was capable of 
altering ethanol sedation, we assessed ST50 values in flies fed our standard fly medium 
(2% yeast, 2Y10S3C) and in media containing 10% (10Y10S3C), 20% (20Y10S3C) and 
30% (30Y10S3C) yeast. Increasing the yeast concentration increased ST50 values in 
males (Fig. 3.2A) and females (Fig. 3.2B). Flies fed 20% yeast medium had increased 
ST50s after exposure to the diet for 2 or more d, whereas flies fed medium with 30%
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Figure 3.1. Exposure to dietary yeast paste alters ethanol sedation sensitivity. (A) 
w[A] females fed a paste of live or dead yeast (35% w/v) for 2 d took longer to become 
sedated compared to flies fed 2Y10S3C (standard) medium (two-way ANOVA; time, 
p<0.0001; yeast, p<0.0001; interaction, p<0.0001; *Bonferroni’s multiple comparisons 
(BMC) versus 2Y10S3C; p<0.0001; n=7-8 per data point) (Performed by Ian Hines). (B) 
ST50 values derived from panel A. Yeast (Y) paste had a significant overall effect on 
ST50s (one-way ANOVA, p<0.0001, n=7-8). ST50s were greater in flies fed live or dead 
yeast versus 2Y10S3C medium (*BMC, p<0.0001). ST50s were not distinguishable 
between flies fed live or dead yeast paste (BMC, p=0.9682) (Performed by Ian Hines). 
(C) Dietary yeast paste increased ST50 values in r[A] females (two-way ANOVA; yeast, 
p<0.0001; time, p=0.0029; interaction, p=0.3486; *BMC, p=0.0136 to <0.0001; n=8) 
(Performed by Monica Messick). 
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yeast had greater ST50 values after 1 or more d on the diet (Fig. 3.2). Increasing the 
yeast concentration in agar-based medium, like supplemental yeast paste, is therefore 
capable of eliciting resistance to ethanol sedation. Rearing flies on 2Y10S3C and 
30Y10S3C promoted comparable patterns of adult emergence over time (Fig. 3.3A) and 
comparable total numbers of progeny (Fig. 3.3B), suggesting that our standard 
2Y01S3C medium is not nutrient deficient and therefore the yeast-driven changes in 
ST50 (Fig. 3.2) are likely to be related to nutrient supplementation versus restoration of 
sufficient nutrients. The data in Fig. 3.2 also suggest that dietary yeast did not need to 
be alive to elicit resistance to ethanol sedation since the agar-based media were 
generated by boiling. 
It seemed possible that increasing nutrient components other than yeast in 
dietary media might also influence ethanol sedation. We therefore fed flies standard 
agar-based media supplemented with sucrose or cornmeal and then measured their 
ST50s. We found that increasing these other nutrient components of dietary media for 
1-3 d of feeding did not systematically or substantially alter ST50 values in males (Figs. 
3.4A and 3.4C) or females (Figs. 3.4B and 3.4D). Although these experiments do not 
formally rule out a potential role for dietary sucrose or cornmeal in fly ethanol sedation 
resistance, they do indicate that altering these two components of the diet likely has a 
much more modest (if any) effect on ethanol sedation compared to yeast. 
It also seemed possible that omitting other components of the fly media could 
affect ethanol sedation. We therefore measured ST50 values in male and female flies 
fed 2Y10S3C media with (+ATC) or without (-ATC) the antibiotics ampicillin, 
chloramphenicol, and tetracycline (Fig. 3.5A), and with (+TEG) and without (-TEG) the
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Figure 3.2. Supplementation of dietary media with yeast alters ethanol sedation. 
Flies were fed the indicated media for 1-3 d. Concentrations (w/v) of yeast (Y) used are 
underlined. ST50s in r[A] males (A) and females (B) were influenced by supplementing 
the diet with yeast (two-way ANOVA; yeast, p<0.0001; diet exposure time in males, 
p=0.2665; diet exposure time in females, p=0.0852; interaction in males, p=0.0681; 
interaction in females, p=0.2749; n=6). Compared to flies fed 2Y10S3C medium, ST50s 
were increased in flies fed media supplemented with yeast (*BMCs, p=0.068 to 
<0.0001). (Performed by Monica Messick). 
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Figure 3.3. Time to emergence of adult progeny on standard food medium. (A, B) 
Mated adult females were introduced into bottles containing 2Y10S3C or 30Y01S3C 
media and newly emerged adult flies were collected and counted daily. (A) Time course 
of emerging adult flies starting on day 9 and peaking on day 12. (B) Total number of 
adult flies eclosed from day 9 to day 15 (two-tailed t test; p=0.4607; n=4 bottles/media). 
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Figure 3.4. Increasing sugar or cornmeal in dietary media does not substantially 
alter ST50 values. Flies were fed the indicated media for 1-3 days. Supplementation of 
dietary media with sugar (A and B) or cornmeal (C and D) did not robustly alter ST50s. 
Sugar supplementation influenced ST50s in r[A] males (panel A; two-way ANOVA; 
sugar, p<0.0001; diet exposure time, 0.5328; interaction, p=0.5471; *BMC versus 
2Y10S3C, p=0.0047) and females (panel B; two-way ANOVA; sugar, p=0.0103; diet 
exposure time, p=0.3757; interaction, p=0.2862). Overall, there was a significant effect 
of cornmeal supplementation on ST50s in males (panel C; two-way ANOVA; cornmeal, 
p=0.0418; diet exposure time, p=0.0354; interaction, p=0.4242), but not in females 
(panel D; two-way ANOVA; cornmeal, p=0.0670; diet exposure time, p=0.2063; 
interaction, p=0.0833). N=6 in all panels. (Performed by Monica Messick). 
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antifungal Tegosept (Fig. 3.5B). Additionally, to test whether omission of one or more of 
the nutrient components of 2Y10S3C medium could alter ethanol sedation, we 
assessed ST50 values in flies fed media that did not contain yeast, sucrose, orcornmeal 
individually (Fig. 3.6A), lacked combinations of yeast and sucrose, sucrose and 
cornmeal, or yeast and cornmeal (Fig. 3.6B), contained diluted media components 
(0.5X and 0.25X, Fig. 3.6C), or contained no yeast, sucrose or cornmeal (0X, Fig. 3.6C). 
Ethanol sedation was not significantly affected by the omission of antibiotics from the 
media (Fig. 3.5A), consistent with a previous report from our group58, nor by omitting or 
reducing Tegosept (Fig. 3.5B), yeast, sugar, or cornmeal (Figs. 3.6A and 3.6B), or all 
nutrient components (Fig. 3.6C).  
The results in Figs. 3.1-3.6 collectively indicate that increasing dietary yeast is 
capable of increasing resistance to ethanol sedation. To more directly test this 
possibility, we assessed ST50 values in males and females fed our standard 2Y10S3C 
medium, a medium with 2% yeast as the only nutrient (2Y), or a medium with 30% yeast 
as the only nutrient (30Y). ST50 values were indistinguishable in flies fed 2Y10S3C and 
2Y media (Fig. 3.7A; left, males; right, females), consistent with our previous studies 
using media lacking sucrose or cornmeal (Fig. 3.6C). As expected, ST50 values were 
significantly greater in male and female flies fed a 30Y diet compared to both 2Y10S3C 
and 2Y (Fig. 3.7A). These results confirm that manipulating the concentration of dietary 
yeast in the absence of other nutrients is sufficient for altering ethanol sedation.  
The studies reported in all figures discussed thus far used saf-instant bakers (SI 
Bak) yeast. To address whether SI Bak yeast was unique in its ability to elicit resistance
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Figure 3.5. Dietary antimicrobials do not alter ST50 values. Flies were fed the 
indicated media for 2 d. (A) ST50s were indistinguishable in r[A] males and females fed 
media with (+ATC) or without (-ATC) ampicillin, tetracycline and chloramphenicol (two-
way ANOVA; ATC, p=0.2452; sex, p=0.9481; interaction, p=0.6529; n=8). (B) Dietary 
media with (+TEG) or without (-TEG) Tegosept had no effect on ST50s in r[A] males 
and females (two-way ANOVA; TEG, p=0.1523; sex, p=0.4214; interaction, p=0.6527; 
n=8). (Performed by Monica Messick)
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Figure 3.6. Removal or dilution of media nutrients does not impact ST50 values. 
Flies were fed the indicated media for 2 d. (A) Omitting yeast (0Y), sugar (0S), or 
cornmeal (0C) from dietary media did not alter ST50s (one-way ANOVA, p=0.1989, 
n=6). (B) Removing 2 nutrient components from dietary media did not alter ST50s (one-
way ANOVA, p=0.3001, n=6). (C) Dilution of 2Y10S3C medium (0.5X, 0.25X) and 
removal of yeast, sugar and cornmeal from the medium (0X) did not influence ST50s 
(one-way ANOVA, p=0.3364; n=8). (Performed by Monica Messick). 
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Figure 3.7. Effects of multiple types of dietary yeast influences ethanol sedation. 
(A) Flies were fed the indicated media for 2 d. ST50s were greater in r[A] males and 
females fed 30% yeast (30Y) compared to 2Y10S3C or 2% yeast (2Y) media (one-way 
ANOVAs; males, p<0.0001; females, p<0.0001; *BMC versus other groups, p<0.0001; 
n=8). ST50s were increased in male (B) and female (C – performed by Monica Messick) 
flies fed 30Y versus 2Y media for 2 d (individual two-way ANOVAs: males—yeast 
concentration, p<0.0001; yeast source, p=0.2509; interaction, p=0.3232; females—
yeast concentration, p<0.0001; yeast source, p=0.0048; interaction, p=0.1087; *BMC 
versus 2Y, p<0.0001; n=8 for all groups). ST50s in females were lower on 30Y MP 
Brew than in 30Y SI Bak and MP Bak (BMC, p=0.0202 and 0.0012, respectively). 
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to ethanol sedation, we tested whether yeast from other sources could alter ST50 
values (Figs. 3.7B, 3.7C). Males (Fig. 3.7B) and females (Fig. 3.7C) fed media 
containing 30% (30Y) SI Bak, MP bakers (MP Bak) or MP brewers (MP Brew) yeast 
were resistant to ethanol sedation compared to their sex-matched counterparts fed 
media with 2% yeast (2Y) from each source. Media with 30% of all three yeast sources 
had comparable effects on resistance to ethanol sedation in males (Fig. 3.7B), whereas 
30% MP Brew yeast had a smaller effect than the other 2 yeast sources in females (Fig. 
3.7C). The ability to induce resistance to ethanol sedation appears to be a common 
property of yeast. Additionally, our studies suggest that there could be subtle yeast x 
sex effects on ethanol sedation. 
Like mammals, flies develop rapid ethanol tolerance, quantified as the change in 
resistance to ethanol during a second ethanol challenge after recovery from an initial 
exposure to the drug56. To determine whether a high yeast diet altered rapid tolerance 
in flies, we fed flies 2Y or 30Y media, measured their ethanol-naive ST50 values, 
allowed them to recover for 4 h, and then measured their ST50 values during a second 
ethanol exposure. Males (Fig. 3.8A) and females (Fig. 3.8B) fed 2Y and 30Y media 
developed robust rapid tolerance, but the development of rapid tolerance to ethanol was 
not altered by diet in either sex (Figs. 3.8A and 3.8B). This suggests that high 
concentrations of dietary yeast influence initial ethanol sedation, but not the 
development of rapid tolerance.  
Flies from different genetic backgrounds can vary substantially in their feeding109, 
165, alcohol62, 166, and other behaviors167, 168. To determine whether the effect of dietary 
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Figure 3.8. Yeast supplementation does not impact rapid tolerance to ethanol. 
Rapid tolerance was not significantly different in r[A] males (A) or females (B – 
performed by Monica Messick) fed 2Y or 30Y media for 2 d (individual two-tailed t tests; 
males, p=0.9773, n=8; females, p=0.0970; n=8). The ST50s during the second ethanol 
exposure were greater than during the first exposure (paired two-tailed t tests; 2Ymales, 
p=0.0218; 30Y males, p=0.0059; 2Y females, p<0.0001; 30Y females, p=0.0003). 
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yeast supplementation on resistance to ethanol sedation was a common property of 
flies, we measured ST50 values in four additional control strains (w[A], Lausanne-S 
(LS), Oregon-R (OR) and Samarkand (SAM)) after feeding them 2Y or 30Y media for 
two days (Fig. 3.9) or one day (Fig. 3.10). Males and females fed 30Y medium had 
elevated ST50 values compared to flies fed 2Y medium in all cases. The magnitude 
ofthe supplemental yeast effect on ST50 values varied across the additional control 
strains tested (e.g. compare w[A] and SAM in Fig. 3.9A and 3.9D), consistent with 
widely appreciated genetic background effects on behavior. Although the effect of 
dietary yeast on ST50 values varied across the control strains tested, these data 
indicate that the increased resistance to ethanol sedation in response to supplemental 
dietary yeast is a common feature of flies. Additionally, these data confirm that providing 
flies with an elevated yeast diet for 1 or more days is sufficient to increase their 
resistance to ethanol sedation.  
Altering the diet can lead to changes in the body mass of flies169, 170. To 
determine if yeast supplementation altered body mass in our experiments, we 
measured total, dry and water weight in several different control flies fed 2Y and 30Y 
media for 1 d. Compared to flies fed 2Y medium, flies on 30Y had increased total body 
mass in 9 of 10 cases, increased dry mass in 7 of 10 cases, and increased water weight 
in 8 of 10 cases (Table 3.1). To address if body mass might impact ethanol sedation, we 
explored whether total, dry, or water weight correlated with ST50 values in flies on 30Y 
vs 2Y media. Total, dry, and water weight did not correlate with ST50s in males or 
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Figure 3.9. Dietary yeast impacts ethanol sedation in flies from several different 
genetic backgrounds after 2 day media exposure. Compared to flies fed 2Y medium, 
ST50s were increased in male and female w[A] (A), LS (B), OR (C) and Sam (D) after 2 
d of feeding on 30Y medium (individual two-way ANOVAs; w[A]—yeast concentration, 
p<0.0001; sex, p=0.8266; interaction, p=0.1857; LS— yeast concentration, p<0.0001; 
sex, p<0.0001; interaction, p=0.0137; OR— yeast concentration, p<0.0001; sex, 
p=0.1756; interaction, p=0.4990; Sam— yeast concentration, p=0.0002; sex, p=0.2905; 
interaction, p=0.4390; *BMC versus 2Y, p=0.0299 to <0.0001; n=6 for all groups in all 
panels). (Performed by Monica Messick
60 
 
Figure 3.10. Dietary yeast impacts ethanol sedation in 24 hours of media 
exposure in flies from several different genetic backgrounds. Compared to flies fed 
2Y medium, ST50s were increased in male and female w[A] (A), LS (B), OR (C) and 
Sam (D) after 1 d of feeding on 30Y medium (individual two-way ANOVAs; w[A]—yeast 
concentration, p<0.0001; sex, p=0.0012; interaction, p=0.7528; LS— yeast 
concentration, p=0.0002; sex, p<0.1779; interaction, p=0.7468; OR— yeast 
concentration, p<0.0001; sex, p=0.9658; interaction, p=0.8976; Sam— yeast 
concentration, p<0.0001; sex, p=0.7948; interaction, p=0.4659; *BMC versus 2Y, 
p=0.0188 to 0.0003; n=8 for all groups in all panels). (Performed by Monica Messick)
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Table 3.1. Total, dry, and water weight (mg/fly) for multiple control strains and sex fed either 2Y or 30Y media.  
   Total weight   Dry weight   Water weight  
Strain Sex N 2Y 30Y p  2Y 30Y p  2Y 30Y p 
              
              
r[A] males 16 0.749 ± 0.018 0.814 ± 0.019 0.0166  0.151 ± 0.010 0.206 ± 0.010 0.0007  0.598 ± 0.009 0.608 ± 0.012 0.5214 
 females 16 1.016 ± 0.026 1.373 ± 0.018 <0.0001  0.241 ± 0.013 0.355 ± 0.010 <0.0001  0.775 ± 0.022 1.018 ± 0.012 <0.0001 
              
w[A] males 8 0.752 ± 0.009 0.873 ± 0.017 <0.0001  0.188 ± 0.004 0.221 ± 0.013 0.0300  0.577 ± 0.015 0.652 ± 0.010 0.0004 
 females 8 0.990 ± 0.014 1.283 ± 0.017 <0.0001  0.243 ± 0.010 0.344 ± 0.011 <0.0001  0.747 ± 0.011 0.939 ± 0.018 <0.0001 
              
LS males 8 0.681 ± 0.010 0.703 ± 0.022 0.3829  0.199 ± 0.003 0.179 ± 0.013 0.1448  0.482 ± 0.009 0.522 ± 0.016 0.0381 
 females 8 0.991 ± 0.028 1.296 ± 0.015 <0.0001  0.279 ± 0.011 0.373 ± 0.009 <0.0001  0.712 ± 0.020 0.923 ± 0.013 <0.0001 
              
OR males 8 0.841 ± 0.0183 0.893 ± 0.008 0.0162  0.179 ± 0.020 0.216 ± 0.012 0.1287  0.662 ± 0.007 0.677 ± 0.008 0.1805 
 females 8 1.148 ± 0.034 1.608 ± 0.035 <0.0001  0.300 ± 0.024 0.433 ± 0.031 0.0040  0.848 ± 0.023 1.176 ± 0.017 <0.0001 
              
Sam males 8 0.768 ± 0.018 0.851 ± 0.018 0.0036  0.200 ± 0.010 0.222 ± 0.011 0.1402  0.568 ± 0.013 0.630 ± 0.010 0.0013 
 females 8 1.100 ± 0.011 1.432 ± 0.017 <0.0001  0.301 ± 0.011 0.416 ± 0.010 <0.0001  0.798 ± 0.007 1.016 ± 0.013 <0.0001 
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females (Table 3.2). Additionally, feeding 30Y medium for 1 d increased ST50 values in 
males and females of all genotypes tested (Figs. 3.1 and 3.10), even though some 
groups of animals did not have changes in total, dry, or water weight (Table 3.1). Thus, 
flies fed 30Y medium had increased total, dry, and water weight in most cases, but 
these changes were not required for altered ethanol sedation and body mass did not 
predict ST50 values.  
To determine whether the effect of a high yeast diet on resistance to ethanol 
sedation was reversible, we fed flies 30Y medium for two days, switched them to 2Y for 
two days, then assessed their ST50 values. Flies fed 30Y food for two days were 
resistant to ethanol sedation compared to flies fed 2Y for two days as expected (Fig. 
3.11A, males; Fig. 3.11B, females). In contrast, flies fed 30Y medium for two days and 
then switched to 2Y food for two days had ST50 values that were indistinguishable from 
flies fed 2Y medium only (Fig. 3.11A, males; Fig. 3.11B, females). The resistance to 
ethanol sedation driven by supplemental dietary yeast is therefore readily reversible in 
both males and females. 
Flies are well known to adjust the volume of media they consume in response to 
changes in nutrient concentration in their diet109, 165, 171. This compensatory feeding is 
thought to help maintain steady total nutrient intake165, 171, although this phenomenon 
does not always occur109. To address whether flies provided with 30Y medium 
consumed more nutrients than flies fed 2Y medium, we performed consumption-
excretion (Con-Ex) studies using FD&C Blue 1 as a food tracer109. Males and females 
both consumed decreased volumes of 30Y versus 2Y media as anticipated (Fig. 3.12A). 
Given that 30Y medium has 15-fold the yeast concentration of 2Y medium, the level of 
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Table 3.2. ST50 values and weights do not correlate across multiple control 
strains and sex. 
 
 
 
 
 
 
         
      Pearson Correlation, p=0.1485-0.8031; n=10-14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ST50  
 Male  Female  
Total Weight  0.1318 0.4580 
Dry Weight  0.0734 0.3537 
Water Weight  0.1054 0.4921 
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Figure 3.11. Reversible effects of dietary yeast on ethanol sedation. Dietary 
regimen impacted ST50 values in males (A) and females (B – Performed by Ellyn 
Dunbar) (individual one-way ANOVAs for effect of diet; males, p<0.0001; females, 
p<0.0001; n=8). Compared to flies fed only 2Y medium, ST50 values were increased in 
males and females fed 30Y medium for 2 d (*BMC, p<0.0001; n=8), but not in flies fed 
30Y for 2d and then switched to 2Y for an additional 2d (BMC; males, p>0.9999; 
females, p=0.1097). 
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Figure 3.12. Control r[A] flies consume more nutrients from 30Y versus 2Y media. 
(A) Flies consumed-excreted lower volumes (ExVial+INT) of 30Y medium compared to 
2Y medium during 24 h Con-Ex studies (*two-tailed t tests, p<0.0001; males,  n=8; 
females, n=6) (Performed by Brandon Shell). (B) Flies consumed more nutrients 
(relative to 2Y, calculated from panel A) from 30Y medium compared to 2Y (*two-tailed t 
tests; males, p<0.0001, n=8; females, p=0.0016; n=6). (C) Flies fed 30Y medium had 
increased ST50 values compared to flies fed 2Y medium when all media were provided 
in feeder caps (Caps) for 2 d. Including Blue 1 in the media had no effect on ST50 
values (two-way ANOVA; yeast concentration, p<0.0001; Blue 1, p=0.7200; interaction, 
p=0.6652; *BMCs versus 2Y, p<0.0001; n=12). 
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consumption represented in Fig. 3.12A results in 30Y-fed flies ingesting at least 2-fold 
the total nutrients as flies fed 2Y (Fig. 3.12B; males, left; females; right). Importantly, 
consumption of media from the feeder caps in Con-Ex experiments and the presence of 
FD&C Blue 1 in the media did not have discernable effects on yeast-induced resistance 
to ethanol sedation (Fig. 3.12C). These data show that increased yeast nutrient 
consumption accompanies the increase in resistance to ethanol sedation, suggesting 
that they are causally linked. 
Olfactory cues from yeast influence life span in flies172. To determine if olfactory 
cues from supplemental yeast are sufficient to elicit resistance to ethanol sedation, we 
assessed whether mesh barriers that prevented flies from directly contacting the yeast 
paste blocked the change in ST50 values. We used barriers with two different mesh 
sizes to test this possibility because (i) we reasoned that barriers of both sizes would 
eliminate the ability of flies to contact the food surface and (ii) the lager mesh size would 
be more porous to olfactory cues from the yeast paste. Compared to flies fed standard 
medium, flies that physically contacted supplemental yeast paste were resistant to 
ethanol sedation (Fig. 3.13A and 3.13B) as expected (Fig. 3.1). In contrast, ST50 values 
in flies that could not contact the supplemental yeast due to mesh barriers were 
indistinguishable from flies fed a standard diet only (Fig. 3.13A and 3.13B). The yeast-
induced resistance to ethanol sedation therefore requires physical contact with, and 
presumably consumption of, the supplemental yeast to produce resistance to ethanol 
sedation.
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Figure 3.13. Effect of dietary yeast paste on ST50 values requires physical 
contact. Flies had access to the indicated media for 2 d. (A, B) Compared to flies fed 
2Y10S3C medium, ST50 values were increased in flies that had access to yeast paste 
(green bars), but not in flies that were prevented from physically contacting the yeast 
paste by a mesh barrier (green hatched bars). There was an overall effect of treatment 
group in w[A] (panel A) and r[A] (panel B) females (one-way ANOVAs, p<0.0001, n=8 in 
A and B). ST50s were greater in flies with access to yeast paste compared to the other 
groups (*BMC, p=0.0003 to <0.0001). ST50s were indistinguishable in flies fed 
2Y10S3C and in flies prevented from physically contacting the yeast paste (BMC; panel 
A, p=0.8415; panel B, p>0.9999).  
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The mechanism by which dietary yeast influences ethanol sedation in flies is of 
obvious interest. Intriguingly, a high yeast diet increases brain 5-HT levels in flies [147, 
confirmed here (30Y: 439.8 ± 89.0 fmol/brain, n=11; 2Y: 231.7 ± 36.9 fmol/brain, n=14; t 
test, p=0.0282)]. Additionally, serotonergic neuron function is important for regulating 
food consumption in larval and adult flies148-150, the 5-HT2A receptor plays a role in 
preference for dietary protein consumption in flies147, and 5-HT has been implicated in 
fly ethanol sedation74. Furthermore, there is a large literature linking 5-HT to alcohol 
problems in humans (e.g. 151-155). These findings collectively suggested that there could 
be mechanistic connections between serotonergic neurons and the effect of dietary 
yeast on ethanol sedation. To address this possibility, we determined if suppression of 
serotonergic neurons influenced the effect of dietary yeast on ST50 or the consumption 
of high yeast medium.  
Compared to 2Y medium, ST50 values were increased by 30Y diet in control flies 
with the Trh-Gal4.long3 or the Trh-Gal4.long2 driver alone, a UAS-Kir2.1 transgene 
alone, or a UAS-TeTxLC(E2) transgene alone (first four bars, Figs. 3.14A, 3.15A, 3.16A, 
3.17A). These control flies also consumed more nutrients when fed 30Y medium (first 
four bars, Figs. 3.14B, 3.15B, 3.16B, 3.17B). Inhibition of serotonergic neurons by 
expression of UAS-Kir2.1 (which hyperpolarizes neurons173) via Trh-Gal4.long3 (Fig. 
3.14A, hatched bars) or via Trh-Gal4.long2 (Fig. 3.15A, hatched bars) blocked the effect 
of 30Y medium on ST50 values. Similarly, Trh-Gal4-driven expression of tetanus toxin 
light chain (UAS-TeTxLC(E2)), which inhibits vesicle release174) in serotonergic neurons 
blocked the effect of yeast supplementation on ST50 values (Figs. 3.16A, 3.17A, 
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Figure 3.14. Inhibition of serotonergic neurons with Kir2.1 blunts the effect of a 
high yeast diet on ethanol sedation, nutrient consumption and internal ethanol 
levels. Male flies of the indicated genotypes consumed 2Y or 30Y media for 1 d prior to 
determination of ST50s, nutrient consumption, and internal ethanol. (A) There were 
overall effects of yeast concentration and genotype on ST50s, and an interaction 
between the two factors (two-way ANOVA; yeast, p<0.0001; genotype, p<0.0001; 
interaction, p<0.0001; n=8). Compared to flies fed 2Y medium, ST50s were greater in 
control flies (Trh-Gal4.long3/+ and UAS-Kir2.1/+) on 30Y (*BMC, p<0.0001), but not in 
flies with inhibition of serotonergic neurons (Trh-Gal4.long3/+; UAS-Kir2.1/+; hatched 
bars; BMC, p=0.3174). (B) Overall, yeast concentration and genotype influenced 
nutrient consumption and there was an interaction between yeast and genotype (two-
way ANOVA; yeast, p<0.0001; genotype, p<0.0001; interaction, p<0.0001; n=8). All 
genotypes consumed more nutrients from 30Y than 2Y (*BMC, p≤<0.001). (C) Overall, 
the concentration of dietary yeast and genotype influenced internal ethanol levels after 
exposure to vapor from 85% ethanol for 36 minutes (two-way ANOVA; yeast, p<0.0001; 
genotype, p=0.0072; interaction, p=0.0733; n=8). Internal ethanol was decreased in 
control flies (Trh-Gal4.long3/+ and UAS-Kir2.1/+) fed 30Y versus 2Y media (*BMC, 
p≤0.0094), but yeast concentration had no effect on internal ethanol in Trh-
Gal4.long3/+; UAS-Kir2.1/+ flies (hatched bars; BMC, p>0.9999). 
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Figure 3.15 Inhibition of serotonergic neurons with Kir2.1 blunts the effect of a 
high yeast diet on ethanol sedation and nutrient consumption: replication with a 
second Trh-Gal4 driver. Male flies of the indicated genotypes consumed 2Y or 30Y 
media for 1 d prior to determination of ST50s and nutrient consumption. (A) Overall, 
yeast concentration, but not genotype, impacted ST50s and there was an interaction 
between the two factors (two-way ANOVA; yeast, p<0.0001; genotype, p=0.0724; 
interaction, p<0.0001; n=8). ST50s were greater in control flies (Trh-Gal4.long2/+ and 
UAS-Kir2.1/+) on 30Y versus 2Y media (*BMC, p≤0.0005), but yeast concentration did 
not alter ST50s in flies with inhibition of serotonergic neuron function (Trh-Gal4. long2/+; 
UAS-Kir2.1/+; hatched bars; BMC, p>0.9999). (B) Overall, yeast concentration and 
genotype influenced nutrient consumption and there was an interaction between yeast 
and genotype (two-way ANOVA; yeast, p<0.0001; genotype, p<0.0001; interaction, 
p<0.0001; n=8). Control (Trh-Gal4. long2/+ and UAS-Kir2.1/+) flies consumed more 
nutrients from 30Y than 2Y (*BMC p<0.0001), but nutrient consumption from 2Y and 
30Y was indistinguishable in Trh-Gal4. long2/+; UAS-Kir2.1/+ flies (hatched bars; BMC, 
p=0.3767). 
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Figure 3.16. Expression of tetanus toxin in serotonergic neurons dampens the 
effect of dietary yeast on ethanol sedation, nutrient intake and internal ethanol 
levels. Male flies were fed 2Y or 30Y media for 1 d. (A) Overall, yeast concentration, 
but not genotype, influenced ST50s, and there was an interaction between yeast and 
genotype (two-way ANOVA; yeast, p<0.0001; genotype, p=0.3451; interaction, 
p=0.0058; n=8). Compared to flies fed 2Y medium, control Trh-Gal4.long3/+ and UAS-
TeTxLC(E2)/+ flies fed 30Y had greater ST50s (*BMCs, p≤0.0002), but dietary yeast 
had no discernable effect on ST50s in flies expressing Tetanus Toxin Light Chain in 
serotonergic neurons (Trh-Gal4.long3/+; UAS-TeTxLC(E2)/+; hatched bars; BMC, 
p=0.1996). (B) Yeast and genotype had significant overall effects on nutrient 
consumption and there was an interaction between the factors (two-way ANOVA; yeast, 
p<0.0001; genotype, p<0.0001; interaction, p=0.0053; n=6-8). All genotypes consumed 
more nutrients on 30Y versus 2Y (*BMCs, p≤0.0257). (C) Overall, internal ethanol was 
affected by yeast concentration and genotype, but there was no interaction between the 
factors (two-way ANOVA; yeast, p<0.0001; genotype, p=0.0472; interaction, p=0.0524; 
n=8). Compared to flies fed 2Y, internal ethanol was decreased in control Trh-
Gal4.long3/+ and UAS-TeTxLC(E2)/+ flies fed 30Y (*BMCs, p≤0.0045), but not in Trh-
Gal4.long3/+; UAS-TeTxLC(E2)/+ flies (BMC, p=0.0807).  
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Figure 3.17. Expression of tetanus toxin in serotonergic neurons dampens the 
effect of dietary yeast on ethanol sedation and nutrient intake: replication with a 
second Trh-Gal4 driver. Male flies of the indicated genotypes consumed 2Y or 30Y 
media for 1 d prior to determination of ST50s and nutrient consumption. (A) Overall, 
yeast concentration, but not genotype, impacted ST50s and there was an interaction 
between the two factors (two-way ANOVA; diet, p<0.0001; genotype, p=0.3555; 
interaction, p<0.0001; n=8). ST50s were greater in control flies (Trh-Gal4.long2/+ and 
UAS-TeTxLC(E2)/+) on 30Y versus 2Y media (*BMC, p<0.0001), but yeast 
concentration did not alter ST50s in flies with inhibition of serotonergic neuron function 
(Trh-Gal4. long2/+; UAS-TeTxLC(E2)/+; hatched bars; BMC, p=0.3990). (B) There were 
main effects of yeast concentration and genotype on nutrient consumption, but there 
was not an interaction between yeast and genotype (two-way ANOVA; yeast, p<0.0001; 
genotype, p=0.0004; interaction, p=0.0621; n=8). All genotypes consumed more 
nutrients on 30Y versus 2Y media (*BMC; p≤0.0006). 
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hatched bars). The effect of a high yeast diet on ethanol sedation therefore requires 
functional serotonergic neurons. 
Regarding media consumption, flies expressing Kir2.1 via Trh-Gal4.long3 had 
greater intake of nutrients when fed 30Y vs 2Y media (Fig. 3.14B), but not when Kir2.1 
was expressed by Trh-Gal4.long2 (Fig. 3.15B). Flies expressing tetanus toxin via both 
Trh-Gal4 drivers consumed significantly more nutrients from 30Y versus 2Y media 
(Figs. 3.16B, 3.17B). Thus, inhibition of serotonergic neurons did not consistently 
blockthe increase in nutrient intake on 30Y medium, but these flies appeared to 
consume fewer nutrients than control genotypes when on 30Y. 
We postulated that a high yeast diet might impact net uptake/elimination of 
ethanol and, if true, that suppression of serotonergic neurons might influence internal 
ethanol levels in flies on a high yeast diet. We therefore measured internal ethanol in 
control flies and in flies expressing either UAS-Kir2.1 or UAS-TeTxLC(E2) in 
serotonergic neurons when fed 2Y or 30Y media. Internal ethanol concentrations during 
sedation from exogenous ethanol were decreased in control flies on 30Y vs 2Y media 
(Figs. 3.14C, 3.16C, first four bars), indicating that a high yeast diet influences ethanol 
uptake and/or elimination. Interestingly, the effect of 30Y diet on internal ethanol levels 
was blocked by inhibition of serotonergic neurons via expression of UAS-Kir2.1 (Fig. 
3.14C, hatched bars) or UAS-TeTxLC(E2) (Fig. 3.16C, hatched bars).  
The data in Figs. 3.14-3.17 raised the possibility that serotonergic neurons drive 
yeast consumption which in turn drives internal ethanol levels and ethanol sedation. To 
further explore this possibility, we determined whether there were correlations between 
nutrient consumption, internal ethanol levels, and ST50 values using data from Figs. 
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3.14, 3.15, 3.16, and 3.17. We found strong, significant correlations between all pairs of 
measures (Fig. 3.18). ST50 and nutrient intake exhibited a positive correlation (Fig. 
3.18A), while ST50 and internal ethanol (Fig. 3.18B) as well as nutrient intake and 
internal ethanol (Fig. 3.18C) exhibited negative correlations. These results support a 
model in which a high yeast diet leads to serotonergic neuron-dependent increases in 
nutrient intake, and that increased nutrient intake subsequently alters the uptake or 
elimination of ethanol resulting in lower internal ethanol levels, ultimately leading to 
increased ST50 values (Fig. 3.19A). Alternatively, when serotonergic neurons are 
inhibited, flies consume a similar amount of nutrients on 30Y as 2Y, there no changes in 
internal ethanol levels, and subsequently, no changes in ST50s (Fig. 3.19B).
C. Discussion 
Fruit flies are an important genetic model organism for investigating the 
molecular basis of a plethora of physiological outputs including alcohol-related 
behaviors56, 58-60, 62, 63, 66, 67, 71, 77, 130-138, food consumption109, 165, and responses to 
diet157, 169, 175-183. To the best of our knowledge, our studies are the first to integrate 
these three areas of biology in the fly. We find that increasing the concentration of yeast 
in the diet, but not increasing other dietary components or decreasing all components of 
our standard medium, makes flies resistant to ethanol sedation. The resistance to 
ethanol sedation requires physical access to dietary yeast, is a common property of 
yeast, is seen in both males and females of multiple control strains, is reversible, 
appears to be caused by a mechanism independent of rapid tolerance, and is 
associated with increased yeast nutrient consumption as well as decreased internal 
ethanol levels. Importantly, the effect of a  
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Figure 3.18. Correlations between ST50, nutrient intake, and internal ethanol 
levels. Data from figures 8, 9, S7, and S8 were combined to assess correlations 
between ST50, nutrient intake, and internal ethanol levels. (A) There was a positive 
correlation between ST50 and nutrient intake (Pearson r=0.827, p<0.0001, n=24). (B) 
ST50 values inversely correlated with internal ethanol levels (Pearson r=-0.913, 
p<0.0001, n=12). (C) Nutrient intake negatively correlated with internal ethanol levels 
(Pearson r=-0.903, p<0.0001, n=12). Lines are best fit linear regressions. 
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Figure 3.19. Model for effect of dietary yeast on ethanol sedation. (A) As the yeast 
concentration in the diet increases, nutrient intake increases, internal ethanol levels 
decrease, and the time to sedation (ST50) is extended. 5-HT neurons positively 
regulate nutrient intake and thereby influence the effect of dietary yeast on internal 
ethanol and ST50.  (B) Inhibition of serotonergic neuron function prevents the increase 
of nutrient intake when flies are fed high yeast media. This lack of increased intake of 
nutrients leads to there being no changes in internal ethanol, and subsequently, no 
difference in ST50 values when flies are fed high yeast media. 
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high yeast diet on ethanol sedation and internal ethanol levels is blunted by inhibition of 
serotonergic neurons. 
In principle, our data on yeast supplementation and ethanol sedation could be 
interpreted in two ways. One interpretation is that yeast supplementation of a diet 
otherwise capable of supporting growth and normal behavior causes resistance to 
ethanol sedation. A second, alternative interpretation is that decreasing the 
concentration of dietary yeast below that required for normal growth and behavior leads 
to ethanol sedation sensitivity. We favor the former interpretation for several reasons. In 
previous studies, adult flies reared on our standard medium weigh approximately the 
same (e.g. ~1 mg for females59, 62, 132) as flies grown under routine conditions used in 
other labs (e.g. 184). In the studies reported here, flies reared on our standard 2Y10S3C 
and supplemented 30Y10S3C media emerged with similar time-courses and in the 
same numbers. These results suggest that flies grown on 2Y10S3C are not nutrient-
deprived. Additionally, the increased resistance to alcohol sedation in our studies 
requires yeast concentrations in excess of 10%, which is higher than yeast 
concentrations used in routine fly culture. Our interpretation of these observations is that 
yeast supplementation of a diet otherwise sufficient in nutrients is capable of increasing 
resistance to ethanol sedation. It is extremely challenging, however, to formally rule out 
the possibility that flies fed our standard medium are not at least somewhat nutrient-
deprived. Thus, it is a matter of perspective whether our data are interpreted to mean 
that yeast-supplementation increases resistance to ethanol sedation or that yeast-
restriction decreases resistance to ethanol sedation. Importantly, either interpretation 
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wholly supports the hypothesis that the concentration of yeast in the fly diet influences 
ethanol sedation. 
Each Drosophila laboratory can and often does use a unique recipe for fly media. 
Differences in fly media composition could lead to variability in baseline ethanol 
sedation or potentially a lack of reproducibility of results across laboratories. We 
suggest that it become standard practice in the field to report all components and the 
concentrations used for fly media for studies on alcohol sedation as has been 
suggested previously for studies in other areas157. 
The ability to manipulate ethanol sedation by changing the yeast concentration in 
the fly diet expands the utility of the Drosophila model for investigating genes and 
genetic pathways that underlie alcohol-related behaviors. With our data as a backdrop, 
the fly model should be suitable for pursuing at least three major areas of research: 
molecular and cellular mechanisms like serotonergic signaling that drive nutrient 
consumption as it relates to ethanol sedation, nutrient-driven changes in ethanol uptake 
and/or elimination, and pathways downstream of nutrient intake that change behavioral 
responses to alcohol. It is interesting to speculate that at least some genetic 
manipulations known to influence resistance to ethanol sedation in flies or other species 
might relate to one or more of these three areas. 
Dietary yeast influences brain 5-HT content in flies147, 5-HT likely plays a role in 
fly ethanol sedation74, and 5-HT is connected to problematic alcohol consumption in 
humans (e.g. 151-155). Additionally, serotonergic neurons and serotonin signaling are 
important for hunger/satiety and feeding behavior in both larval and adults flies148-150, 185. 
Our studies in flies suggest that serotonergic neurons might influence ethanol sedation 
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via effects on nutrient consumption and ethanol uptake/elimination, raising the 
possibility that there could be a link between 5-HT, diet, and alcohol-related behavior in 
other species. 
The effect of diet on alcohol-related behavior is not unique to flies. In C. elegans, 
mutations that disrupt synthesis of eicosapentaenoic acid (EPA, an omega-3 
polyunsaturated fatty acid) blunt the development of acute functional tolerance to 
alcohol and dietary supplementation with this fatty acid facilitates acute functional 
tolerance87. Reduced caloric intake in rats enhances the alcohol-deprivation effect and 
reinstatement of ethanol-seeking behavior86 and food deprivation decreases alcohol 
drinking in mice145. Furthermore, providing mice with different, but otherwise routinely 
used, laboratory diets influences ethanol drinking, ethanol consumption, and ethanol-
induced locomotion84, and altering EPA in the diet of mice influences both ethanol 
sensitivity and consumption85. These results indicate that diet-induced changes in 
alcohol-related behavior are a common feature of metazoans. Therefore, identification 
of the underlying mechanisms via studies like those described here has the potential to 
be valuable for both prevention and treatment of AUD. 
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Chapter 4: Convergent evidence from humans and Drosophila melanogaster implicates 
the transcription factor MEF2B/Mef2 in alcohol sensitivity 
 
 
 
A. Introduction 
Alcohol consumption is common in the United States and elsewhere, with rates 
in 2014 as high as 87.6% of individuals 18 or older reporting lifetime use and 71.0% 
reporting use within the last year186. Although many individuals use alcohol without 
developing problems, over a quarter of those who abuse alcohol use progress to 
abuse187. The World Health Organization estimates that 283 million people over the age 
of 15 years across the globe have alcohol use disorder (AUD) and that alcohol usage 
contributes to 3 million premature deaths annually126. Problematic alcohol consumption 
also leads to a substantial public health burden in the United States. For example, 
excessive consumption of alcohol cost the United States an estimated $249 billion in 
2010 and caused over 88,000 deaths between 2006 and 2010188, 189. Despite the 
substantial, multi-layered consequences of AUD and other forms of problematic alcohol 
consumption, we currently have a rather incomplete understanding of the mechanisms 
that drive their genesis. 
It is clear, though, that the risk for developing AUD is under genetic influence. 
Twin studies show that AUD is moderately heritable (h2=0.49190) indicating genetic 
factors account for ~50% of the underlying risk. Additionally, outcomes such as 
frequency or quantity of alcohol use191, 192 and intoxication193 exhibit comparable levels 
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of heritability. Genome-wide association studies (GWAS) have been used to identify 
genetic variance that influences problematic alcohol consumption. Such studies have 
implicated several genes in alcohol consumption including AUTS2 and KLB (which 
encode a transcriptional repressor and a receptor for fibroblast growth factor 21 
(FGF21), respectively) as well as genes that encode alcohol- and aldehyde 
dehydrogenases78, 194-196. Other studies have suggested that the gene RYR3 (which 
encodes a ryanodine receptor) and multiple genes that encode proteins in the SWI/SNF 
complex influence the development of alcohol dependence77, 197. Despite these and 
other advances22, 23, 198-200, our understanding of the genetic etiology of alcohol 
outcomes is relatively limited.  
Genetic model organisms, principally Drosophila melanogaster (fruit flies), 
Caenorhabditis elegans (worms), and Mus musculus (mice), have been used 
extensively to identify molecular-genetic mechanisms underlying many different alcohol-
related behaviors. These model organisms have conserved behavioral responses to 
alcohol including (collectively) locomotor activation at low doses, sedation at high 
doses, tolerance during prolonged or after repeated doses of alcohol, and withdrawal 
after discontinuation of the drug56, 201-204. Additionally, flies and mice voluntarily 
consume alcohol and this consumption can escalate with continuing exposure68, 205, 206. 
Given that humans exhibit comparable behavioral responses to alcohol, it is possible 
that many of the molecular targets for alcohol or the signaling pathways required for 
modulating the effects of alcohol on behavior might be conserved across species. There 
are data that support this possibility. For example, AUTS2, KLB, RYR, RSU1, SWI/SNF 
and other genes implicated in various alcohol behaviors in humans also influence 
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behavioral responses to acute alcohol in flies, worms, and mice77-79, 194, 196, 197.These 
findings suggest that the initial response to alcohol rating scale in humans might be 
driven—at least in part—by changes in behavioral responses to initial alcohol exposure 
revealed by studies in genetic model organisms. 
We previously reported a meta-analysis of GWAS on the Self-Rating of the 
Effects of Alcohol (SRE) across two adolescent to young adult samples, Avon 
Longitudinal Study of Parents and Children (ALSPAC) and Spit for Science (S4S)115. 
The SRE 18 captures the number of alcoholic drinks needed for respondents to 
experience intoxication when they first began drinking (i.e., initial sensitivity). Higher 
scores on the SRE have been associated with the development of alcohol use and 
misuse17, 207, suggesting that it has predictive validity for risk of later problematic alcohol 
consumption. The meta-analytic SNP-based heritability estimate (h2SNP) in our previous 
report115 was modest (h2SNP=0.19, SE=0.10) in the combined ALSPAC and S4S 
samples. This modest heritability was driven, however, by the ALSPAC sample, 
(h2SNP=0.36, SE=0.14, p=0.04); the heritability estimate did not differ from 0 in S4S. 
While our previous report focused on primary and secondary analyses of the meta-
analytic results, the moderate h2SNP in ALSPAC suggested that loci implicated in that 
sample might be particularly valuable in follow-up studies. We consequently (i) 
conducted gene-based analyses of SRE in the ALSPAC sample to identify promising 
loci; (ii) identified, among the loci most strongly implicated in ALSPAC, those genes with 
orthologues in Drosophila; and (iii) assessed ethanol sedation sensitivity and tolerance 
in flies expressing RNAi targeting candidate genes. 
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The studies reported here implicated 37 human genes in SRE responses in the 
ALSPAC sample. Of these genes, we focused on 6 (APP, ATG5, GPD2, ISL1, MEF2B, 
and PCDH15) because previous results suggested they might be involved in relevant 
phenotypes in humans, these 6 genes had orthologues in flies, and they were publicly 
available RNAi reagents to manipulate them. We found that neuronal expression of 
RNAi against the fly gene Mef2 decreased ethanol sedation sensitivity. Subsequently, 
we found that flies with loss-of-function mutations in Mef2 also had decreased ethanol 
sedation sensitivity. These alterations in ethanol sedation in flies with decreased Mef2 
expression were not accompanied by changes in internal ethanol levels or rapid 
tolerance to ethanol. Interestingly, another group recently reported that decreased Mef2 
function in flies alters rapid tolerance208, suggesting that the consequences of Mef2 
action in alcohol-related behavior might be context-dependent. Our studies collectively 
implicate human MEF2B in SRE responses and indicate that flies with altered Mef2 
expression have parallel changes in ethanol sedation. Given that MEF2B and Mef2 
encode transcription factors, our data further suggest that proteins with MEF2B/Mef2-
dependent expression might be targets of ethanol or be involved in the modulation of 
behavioral responses to the drug. 
 
B. Results 
Human genetic analyses and identification of loci for potential screening in Drosophila.  
As reported previously115, SRE scores were moderately heritable in the ALSPAC 
sample (h2SNP=0.36, p=0.04). To explore potential genetic contributions to SRE scores, 
we used summary statistics from the SRE GWAS in ALSAPC to conduct gene-based 
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analyses in Functional Mapping and Annotation of Genome-Wide Association Studies 
(FUMA). This yielded results for 18,187 genes, of which 37 had pgene<0.001 for SRE 
(Table 4.1). Of these 37 genes, 29 were orthologous to a total of 52 Drosophila genes 
(defined as having DIOPT score ≥ 2)89 (Table 4.1). Additionally, of the 37 genes with 
pgene<0.001 for SRE, nine had been previously associated with phenotypes (e.g., 
substance use, psychiatric findings, and others) we postulated might be related to 
alcohol use or misuse (Table 4.1). Thus, nine human genes (APP, ATG5, BORCS8, 
BORCS8-MEF2B, GPD2, ISL1, MEF2B, PCDH15 and SFSWAP) had suggestive 
associations with SRE, had previously been connected to potentially relevant 
phenotypes in humans, and were orthologous to at least one gene in flies (Table 4.1).  
The 9 top candidate human genes noted above are orthologous to a total of 12 
Drosophila genes (Table 4.1). We obtained RNAi reagents from public stock centers to 
manipulate expression of 6 of the most highly conserved fly genes (Appl, Atg5, Cad99c, 
Gpo1, Mef2, and tup). We did not explore the 2 remaining fly genes because (i) for 
CG32590 no function has been ascribed to its gene product and (ii) for su(w[a]) only a 
single RNAi reagent was available to manipulate it and it is a rather complex locus with 
several additional genes residing within its transcription unit209, greatly complicating 
genetic analyses. 
 
Initial screening of Drosophila orthologues in ethanol sedation and rapid tolerance 
To explore the role of the 6 Drosophila genes in ethanol-related behavior, we
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Table 4.1. Candidate loci for follow-up in Drosophila.  
Human Gene 
Symbol 
Pgene Previously associated human phenotypes of 
interest1 
Drosophila 
Gene Symbol 
DIOPT 
Score 
MEF2B 
 
0.0007412 
 
Obsessive compulsive disorder 
 
Mef2 
 
4 
 
APP 
 
0.00050488 
 
Cognition, neuropsychological tests, psychiatric 
status rating scales, psychotic disorders, tobacco 
use disorder 
Appl 
 
13 
 
 
ATG5 
 
0.00058657 
 
Drug hypersensitivity, tobacco use disorder 
 
Atg5 
 
14 
 
BORCS82 
 
0.00050716 Tobacco use disorder, obsessive compulsive 
disorder 
CG32590 13 
BORCS8-MEF2B3 0.0007412 Tobacco use disorder Mef2 4 
     
GPD2 
 
0.00028942 Fatty liver Gpo-1 13 
 
ISL1 
 
0.00038948 
 
ADHD 
 
Tup 
 
11 
 
PCDH15 0.00012322 Alcoholism, tobacco use disorder Cad99C 9 
 
SFSWAP 
 
 
0.00038044 
 
 
Tobacco use disorder 
 
 
su(w[a]) 
 
 
13 
ANKRD6 
 
0.00035656 
 
N/A dgo 
 
4 
 
ASPG 
 
0.00081699 
 
N/A CG6428, 
CG8526 
 
13 
 
BHLHE40 
 
0.00074851 
 
N/A Several 
 
2 
 
BIRC6 
 
0.00053743 
 
N/A Bruce 
 
15 
 
C1QTNF5 
 
0.00037187 
 
N/A N/A N/A 
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DEPDC7 
 
9.33E-05 
 
N/A N/A N/A 
 
DSG1 
 
1.27E-05 
 
N/A N/A N/A 
 
EXOC1 
 
2.97E-05 
 
N/A Sec3 
 
14 
 
IKZF1 
 
0.00015571 
 
N/A N/A 
 
N/A 
 
LGSN 
 
0.00034442 
 
N/A Gs1 
 
2 
 
LRRTM1 
 
0.00031065 
 
N/A caps, trn 
 
2 
 
MFRP 
 
0.00037187 
 
N/A CG42255 
 
2 
 
MMP17 
 
0.00013157 
 
N/A Mmp2 
 
7 
 
PPP2R5E 
 
0.00059389 
 
N/A wdb 
 
13 
 
PRAMEF11 
 
0.00044431 
 
N/A N/A 
 
N/A 
 
PRB1 
 
0.00036335 
 
N/A N/A 
 
N/A 
 
PSMD6 
 
0.00062142 
 
N/A Rpn7 
 
15 
 
PXMP2 
 
0.00076238 
 
N/A CG7970 
 
7 
 
SCGN 
 
0.00078013 
 
N/A Cbp53E 
 
8 
 
SCN3B 
 
0.00026792 
 
N/A N/A 
 
N/A 
 
SET 
 
0.00023109 
 
N/A Set 
 
13 
 
STRN3 0.00051438 N/A Cka 15 
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TCP11L1 
 
0.00014072 
 
N/A 
 
CG16721 
 
13 
 
THAP2 
 
0.00030577 
 
N/A 
 
CG14860 
 
2 
 
TMEM185B 
 
0.00083227 
 
N/A 
 
CG14194 
 
12 
 
TMEM53 
 
0.00069173 
 
N/A 
 
CG8245 
 
14 
 
USP2 
 
0.00047617 
 
N/A 
 
Usp2 
 
9 
 
ZBTB44 
 
5.54E-06 
 
N/A 
 
N/A 
 
N/A 
 
     
Listed orthologs have a DIOPT score ≥2. 
1Primary resource was the Public Health Genomics Knowledge Base, supplemented by NCBI literature searches. 
2This locus is also known as MEF2BNB. 
3This locus is also known as MEF2BNB-MEF2B 
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constitutively expressed RNAi targeting each gene (22 RNAi transgenes total) in 
neurons using elav-Gal4 and then assessed ethanol sedation and ethanol rapid 
tolerance in adults. Expression of 3 different RNAi transgenes targeting Mef2, two of 
which have independent target sequences (Figure 4.1), increased ST50 values relative 
to both genetic controls (Table 4.2 and see below). In contrast, expression of Mef2 
RNAi transgenes in neurons did not alter the development of rapid tolerance (Table 
4.2). Thus, we focused our subsequent fly studies on the role of Mef2 in ethanol 
sedation. Expression of RNAi targeting the other 5 Drosophila genes did not 
consistently alter either ethanol sedation or rapid tolerance compared to controls (Table 
4.2). We note, however, that neuronal expression of 2 RNAi transgenes against 
Cad99C with unique target sequences (HMS01451 and JF02660) made flies resistant 
to ethanol sedation (Table 4.2), suggesting that this gene might also warrant further 
study.  
 
Mef2 in Drosophila ethanol sedation 
Human MEF2B is orthologous to Drosophila Mef2 (Table 4.1). Both genes 
encode transcription factors with three domains: MADS (MCM1, agamous, deficiens, 
SRF), MEF2, and transcriptional activation (Fig 4.2)88, 92. Using the longest isoforms for 
both human MEF2B (isoform 1) and fly Mef2 (isoform H), we found that the proteins are 
46% similar/37% identical overall at the amino acid level210. Importantly, the MADS and 
MEF2 domains in the human and Drosophila gene products are 85.5% identical/96.4% 
similar and 82.8% identical/93.1% similar, respectively (Fig 4.2)88, 210. The 
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Figure 4.1. The Mef2 transcriptional region. Image is the Mef2 region from FlyBase 
with additional manual annotations. All Mef2 reagents used in this study are shown 
below the gene span and transcripts. Mef2 RNAi target sequences are boxed in green 
(GD5039 (corresponding to v15550 and v15549) and JF03115). The locations of the 
Mef2 mutations are boxed in blue (Mef230-5, Mef265, and Mef225-34).  
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Table 4.2. Ethanol sedation results from top candidates from human GWAS with Drosophila orthologs.  
Experiment
al set 
Target 
gene Gal4 RNAi 
ST50 
E1 
RapTol 
(E2/E1) n 
Statistic
al test 
ST50 E1 
p 
values 
RapTol 
p 
values 
1 Appl elav JF02878 28.16 ± 1.37 1.92 ± 0.135 8 ANOVA 0.0155 0.0896 
Control -- JF02878 25.26 ± 1.47 2.31 ± 0.14 7 BMC 0.3304 0.1315 
Control elav -- 21.90 ± 1.38* 1.89 ± 0.14 8 BMC 0.0087 > 0.9999 
                    
1 Atg5 elav HMS01244 42.19 ± 1.39 1.27 ± 0.06 8 ANOVA < 0.0001 0.0002 
Control -- HMS01244 29.40 ± 2.74* 2.33 ± 0.24* 8 BMC 0.0001 < 0.0001 
Control elav -- 23.54 ± 0.51* 1.83 ± 0.07* 8 BMC < 0.0001 0.0258  
   
      
2 Atg5 elav JF02661 34.90 ± 1.97 2.11 ± 0.13 8 ANOVA 0.0075 0.8988 
Control -- JF02661 32.63 ± 1.37 2.06 ± 0.11 8 BMC 0.5776 > 0.9999 
Control elav -- 27.69 ± 0.90* 2.14 ± 0.12 8 BMC 0.0048 > 0.9999  
   
      
3 Atg5 elav VSH330300 25.39 ± 1.47 2.00 ± 0.17 8 ANOVA 0.0002 0.0061 
Control -- VSH330300 19.99 ± 0.69* 2.52 ± 0.09* 8 BMC 0.0238 0.0375 
Control elav -- 29.85 ± 1.77 1.80 ± 0.16 8 BMC 0.0670 0.6998  
   
      
4 Atg5 elav KK108904 34.90 ± 3.57 1.36 ± 0.18 8 ANOVA 0.0060 0.0400 
Control -- KK108904 42.28 ± 2.03 1.36 ± 0.09 8 BMC 0.1041 > 0.9999 
Control elav -- 29.31 ± 1.55 1.82 ± 0.12 8 BMC 0.2672 0.0520 
                    
1 Cad99
c elav HMS01451 
46.44 ± 2.39 1.51 ± 0.10 8 ANOVA 
0.0007 0.0804 
Control -- HMS01451 33.24 ± 3.45* 2.41 ± 0.43 8 BMC 0.0044 0.0650 
Control elav -- 30.26 ± 1.96* 1.73 ± 0.18 8 BMC 0.0007 > 0.9999  
   
      
2 Cad99
c elav JF02660 
34.51 ± 2.59 2.02 ± 0.17 8 ANOVA 
0.0007 0.1720 
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Control -- JF02660 24.81 ± 0.88* 2.28 ± 0.14 8 BMC 0.0012 0.3777 
Control elav -- 25.26 ± 1.07* 1.91 ± 0.09 8 BMC 0.0018 > 0.9999  
   
      
3 Cad99
c elav JF02761 
27.53 ± 1.00 2.02 ± 0.11 8 ANOVA 
0.0073 0.0227 
Control -- JF02761 25.84 ± 0.99 2.01 ± 0.11 8 BMC 0.4010 > 0.9999 
Control elav -- 23.05 ± 0.68* 1.67 ± 0.045* 8 BMC 0.0042 0.0293  
   
      
4 Cad99
c elav v27215 
23.74 ± 0.95 1.90 ± 0.10 8 ANOVA 
0.9960 0.0462 
Control -- v27215 23.85 ± 0.70 1.60 ± 0.10 8 BMC > 0.9999 0.1393 
Control elav -- 23.84 ± 1.2 2.00 ± 0.13 8 BMC > 0.9999 > 0.9999  
   
      
5 Cad99
c elav v27216 52.88 ± 1.21 1.48 ± 0.04 
8 ANOVA 
< 0.0001 0.0813 
Control -- v27216 48.45 ± 0.96 1.59 ± 0.05 8 BMC 0.0798 0.7097 
Control elav -- 40.10 ± 1.94* 1.76 ± 0.13 8 BMC < 0.0001 0.0554  
     
    
6 Cad99
c elav v27212 41.54 ± 2.02 1.66 ± 0.07 
8 ANOVA 
0.0170 0.0425 
Control -- v27212 48.96 ± 1.12* 1.39 ± 0.05 8 BMC 0.0172 0.0562 
Control elav -- 42.49 ± 2.12 1.44 ± 0.10 8 BMC > 0.9999 0.1482  
     
    
7 Cad99
c elav v3739 37.50 ± 1.64 1.65 ± 0.11 
8 ANOVA 
0.0812 0.2700 
Control -- v3739 39.30 ± 1.89 1.58 ± 0.10 8 BMC 0.9974 > 0.9999 
Control elav -- 43.56 ± 2.00 1.34 ± 0.15 8 BMC 0.0612 0.2512 
                    
1 Gpo1 elav v19565 36.08 ± 1.08 1.25 ± 0.05 8 ANOVA 0.1106 0.0080 
Control -- v19565 39.86 ± 1.65 1.35 ± 0.06 8 BMC 0.1711 0.5090 
Control elav -- 35.64 ± 1.65 1.55 ± 0.08* 8 BMC > 0.9999 0.0049  
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2 Gpo1 elav KK107425 41.30 ± 1.61 1.36 ± 0.07 8 ANOVA < 0.0001 0.0013 
Control -- KK107425 29.44 ± 1.05* 1.88 ± 0.07* 8 BMC < 0.0001 0.0013 
Control elav -- 30.24 ± 1.20* 1.80 ± 0.12* 8 BMC < 0.0001 0.0054  
     
    
3 Gpo1 elav HMC04006 24.19 ± 0.99 2.32 ± 0.18 8 ANOVA < 0.0001 < 0.0001 
Control -- HMC04006 20.36 ± 0.65* 2.29 ± 0.10 8 BMC 0.0134 > 0.9999 
Control elav -- 39.95 ± 1.01* 1.38 ± 0.047* 8 BMC < 0.0001 < 0.0001 
                    
1 Mef2 elav JF03115 46.90 ± 2.12 1.51 ± 0.07 8 ANOVA < 0.0001 0.2099 
Control -- JF03115 37.89 ± 0.96* 1.63 ± 0.05 8 BMC 0.0006 0.3923 
Control elav -- 33.49 ± 1.09* 1.67 ± 0.07 8 BMC < 0.0001 0.1868  
     
    
2 Mef2 elav v15550 57.25 ± 1.80 1.39 ± 0.05 8 ANOVA < 0.0001 0.6152 
Control -- v15550 44.81 ± 1.31* 1.49 ± 0.09 8 BMC < 0.0001 0.6738 
Control elav -- 39.98 ± 1.71* 1.43 ± 0.06 8 BMC < 0.0001 > 0.9999  
   
    
  
3 Mef2 elav v15549 48.04 ± 2.53 - 8 ANOVA < 0.0001 - 
Control -- v15549 35.26 ± 1.66* - 8 BMC 0.0003 - 
Control elav -- 33.15 ± 1.58* - 8 BMC < 0.0001 - 
                    
1 tup elav HMC03317 47.66 ± 0.96 1.38 ± 0.06 5 ANOVA 0.0002 0.1069 
Control -- HMC03317 44.64 ± 1.76 1.41 ± 0.08 5 BMC 0.3628 > 0.9999 
Control elav -- 34.84 ± 1.66* 1.62 ± 0.09 5 BMC 0.0001 0.1076  
     
    
2 tup elav v45859 38.51 ± 1.54 1.47 ± 0.09 8 ANOVA 0.0414 0.9583 
Control -- v45859 41.13 ± 0.95 1.46 ± 0.03 8 BMC 0.3801 > 0.9999 
Control elav -- 35.86 ± 1.52 1.49 ± 0.08 8 BMC 0.3681 > 0.9999  
     
    
3 tup elav KK101489 40.06 ± 2.11 1.57 ± 0.12 8 ANOVA 0.0009 0.2162 
Control -- KK101489 44.78 ± 2.40 1.47 ± 0.10 8 BMC 0.3577 > 0.9999 
Control elav -- 32.03 ± 1.54* 1.74 ± 0.088 8 BMC 0.0344 0.7602 
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P values from one-way ANOVA tests (to assess overall effects of genotype) and BMCs (for planned comparisons 
between flies expressing RNAi and their respective controls) are shown. *BMC shown in red for significance. 
(Performed by Brandon Shell). 
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Figure 4.2. Human MEF2B and Drosophila Mef2 protein identity/similarity. 
Depiction of the three (MADS, MEF2, and transcriptional activation) domains 
constituting human (A) and Drosophila (B) MEF2B and Mef2 and their corresponding 
amino acid identity and similarity. Transcriptional activation domain amino acid identity 
and similarity is compared up to amino acid 325 for human MEF2B and amino acid 352 
for Drosophila Mef2.
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transcriptional activation domain is not as well conserved as the other two domains88, 210 
(Figure 4.2). The overall conservation in domain structure of the proteins, along with the 
conservation of the primary amino acid sequences of these domains, suggests that 
MEF2B and Mef2 might have conserved functions in humans and Drosophila. We note 
that the MEF2B chromosomal region in humans has two non-overlapping genes 
(MEF2B and BORCS8), each of which produces its own transcript. This region also 
produces a read-through transcript, BORCS8-MEF2B (a.k.a. MEF2BNB-MEF2B). Given 
that BORCS8 has no known function, BORCS8 and BORSCS8-MEF2B were not 
considered further in the current study.  
As noted above, pan-neuronal expression of the Mef2 RNAi v15550 increased 
sedation time 50 (ST50) values compared to controls (Figure 4.3A, ethanol sedation 
time-course; Figure 4.3C, ST50 values). Similarly, pan-neuronal expression of a second 
Mef2 RNAi (v15549) with the same target sequence as v15550 also increased ST50 
values compared to controls (Figure 4.4). More importantly, flies with pan-neuronal 
expression of another RNAi transgene with a distinct target sequence in Mef2 
(JF03115) also had increased ST50 values (Figure 4.3B, ethanol sedation time-course; 
Figure 4.3D, ST50 values). Therefore pan-neuronal expression of Mef2 RNAi lines 
affects ethanol sedation in flies. 
To determine if the altered ethanol sedation in flies expressing Mef2 RNAi could 
be due to a net change in uptake or metabolism of ethanol, we measured internal 
ethanol concentrations in the same genotypes assessed in ethanol sedation. We found 
that expression of Mef2 in neurons had no significant effect on internal ethanol in flies  
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Figure 4.3. Ethanol sedation and internal ethanol levels in flies with pan-neuronal 
expression of Mef2 RNAi. (A and B) Ethanol sedation time courses of flies with pan-
neuronal Mef2 RNAi expression. Expression of Mef2 RNAi transgenes v15550 (A, elav-
Gal4/+;v15550/+) and JF03118 (B, elav-Gal4/+;JF03115/+) in neurons extended 
sedation time-courses compared to controls (elav-Gal4/+, v15550/+, JF03118/+). (C, D) 
ST50 values derived from the data in panels A and B. Pan-neuronal expression of 
v15550 © and JF03115 (D) increased ST50 values compared to controls (individual 
one-way ANOVAs, p<0.0001; *Bonferroni’s multiple comparisons (BMCs), p<0.0001 ©, 
p≤0.006 (D); n=8). (E, F) Internal ethanol levels in flies exposed to 85% ethanol vapor 
for 42 minutes. © In studies with v15550, genotype had a significant overall effect on 
internal ethanol concentrations (one-way ANOVA, p=0.0296, n=8), but internal ethanol 
in flies expressing v15550 was not significantly different than controls (BMCs, p=0.0541-
0.9999). (F) Genotype did not have a significant overall effect on internal ethanol 
concentrations in studies with JF03115 (one-way ANOVA, p=0.0574, n = 8).  
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Figure 4.4. Expression of v15549, an RNAi transgene with the same target 
sequence as v15550, alters ethanol sedation when expressed pan-neuronally. (A) 
Ethanol sedation time courses from control flies (elav-Gal4/+ and v15550/+) and flies 
expressing Mef2 RNAi v15549 in neurons (elav-Gal4/+;v15549/+). (B) ST50 values 
were greater in elav-Gal4/+;v15549/+ flies than in controls (one-way ANOVA, p<0.0001; 
*BMCs vs controls, p≤0.0003; n = 8). 
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(Figures 4.3E and 4.3F). Expression of Mef2 RNAi in neurons therefore affects ethanol 
sedation without having a measurable impact on the overall disposition of ethanol.  
While completing our studies on human MEF2B and fly Mef2, Adhikari and 
colleagues208 reported that ethanol sedation was increased (evidenced by decreased 
ST50 values) in flies with pan-neuronal expression of one of the same Mef2 RNAi 
transgenes used in our studies, although pan-neuronal expression of a Mef2 dominant-
negative protein did not impact ethanol sedation sensitivity in this study208. The ST50 
values from control flies in the experiments conducted by Adhikari et. al were ~15 
minutes, which is shorter than ST50 values from our studies (30-40 minutes when using 
vapor from 85% ethanol). This difference in ST50 values raised the possibility that 
knocking down Mef2 might decrease ST50 values when they are relatively short (as in 
Adhikari et. al), while knocking down Mef2 might increase ST50 values when they are 
relatively long (as in our studies). To explore this possibility, we expressed Mef2 RNAi 
transgenes pan-neuronally in flies and then assessed their sedation in response to 
vapor from 100% ethanol. Exposure of flies to vapor from 100% ethanol appeared to 
decrease overall ST50 values as expected (Figure 4.5). More importantly, though, flies 
with pan-neuronal expression of Mef2 RNAi transgenes v15550 (Figure 4.5A and C) 
and JF03115 (Figure 4.5B and D) continued to have significantly increased ST50 values 
compared to controls even when exposed to vapor from the highest possible 
concentration of ethanol in our behavioral paradigm. Although additional studies would 
be required to fully explore the differences between the phenotypes seen in flies with 
altered Mef2 reported here and by Adhikari and colleagues208, our data suggest that  
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Figure 4.5. Sedation by high dose ethanol in flies expressing Mef2 RNAi. (A and B) 
Sedation time courses in response to vapor from 100% ethanol for flies with pan-
neuronal expression of Mef2 RNAi (A, elav-Gal4/+;v15550/+; B, elav-Gal4/+;JF03115/+) 
and controls (elav-Gal4/+, v15550/+, JF03115/+). (C, D) ST50 values from the data in 
panels A and B, respectively. © Pan-neuronal expression of v15550 © and JF03115 (D) 
increased ST50 values (individual one-way ANOVAs; panel C, p<0.0001; panel D, 
p=0.0012; panel C, *BMCs vs controls, p<0.0001; panel D, BMCs vs controls, 
p=0.0012-0.0049; n=8).  
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these differences are not due to the overall magnitude of ST50 values obtained from the 
behavioral paradigms used in the respective studies. 
Adhikari and colleagues also reported that pan-neuronal expression of Mef2 
RNAi or a Mef2 dominant negative protein decreased the development of rapid 
tolerance to ethanol. We therefore also assessed ethanol rapid tolerance, calculated as 
either the relative (Fig 4.6) or absolute (Fig 4.7) change in ST50 using vapor from 85% 
(Figure 4.6A, 4.6B, 4.7A, 4.7B) or 100% (Figures 4.6C, 4.6D, 4.7C, 4.7D) ethanol. In 
contrast to Adhikari and colleagues, expression of Mef2 RNAi in neurons did not alter 
rapid tolerance under the conditions of our experiments (Figures 4.6 and 4.7). Additional 
studies would again be required to fully explore the differences between our data and 
the data from Adhikari et. al208, but as we found for sedation (see above) these 
differences were not readily resolved by increasing the ethanol concentration used for 
exposure.  
We used immunofluorescence to assess whether pan-neuronal expression of 
v15550 and JF03115 decreased Mef2 levels in whole fly brains (Figure 4.8). We 
focused our histological analyses at the level of the mushroom bodies because neurons 
in these structures are known to express readily detectable levels of Mef2211. Control 
flies harboring the Mef2 RNAi transgenes without a Gal4 driver (Figure 4.8A, v15550/+; 
Figure 4.8B, JF30015/+) had strong expression of Mef2 in the mushroom bodies 
(arrowheads) as expected. Visual inspection of representative images suggested that 
this Mef2 signal was decreased in flies with pan-neuronal expression of Mef2 RNAi 
transgenes (Figure 4.8C: elav-Gal4/+;v15550/+; Figure 4.8D: elav-Gal4/+;JF30115/+). 
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Figure 4.6. Rapid tolerance and pan-neuronal expression of Mef2 RNAi. 
Development of rapid tolerance was not significantly altered by expression of Mef2 
RNAi. (A, B) Rapid tolerance in response to exposure of vapor from 85% ethanol. 
Expression of v15550 (A) or JF03115 (B) in neurons (individual one-way ANOVAs; 
panel A, p=0.6152; panel B, p=0.2099; n=8). (C, D) Rapid tolerance to sedation from 
vapor from 100% ethanol. In experiments with v15550, there was a significant overall 
effect of genotype (one-way ANOVA, p=0.0001, n=8) and elav-Gal4/+;v15550/+ flies 
were different than elav-Gal4/+ controls (BMC, p<0.0001), but not different than 
v15550/+ controls (p=0.0860). (D) In studies with JF03115, genotype had no overall 
effect (one-way ANOVA, p=0.3530, n=8). 
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Figure 4.7. Changes in ST50 values, used as a measure of rapid tolerance, are not 
consistently altered in flies with pan-neuronal expression of Mef2 RNAi. 
Development of rapid tolerance, as measured by the absolute change in ST50 values 
from E1 to E2, was not significantly altered by expression of Mef2 RNAi. (A, B) Rapid 
tolerance in response to exposure of vapor from 85% ethanol. Expression of v15550 (A) 
or JF03115 (B) in neurons (individual one-way ANOVAs; panel A, p=0.3246; panel B, 
p=0.8582; n=8). (C, D) Rapid tolerance to sedation from vapor from 100% ethanol. In 
experiments with v15550, there was a significant overall effect of genotype (one-way 
ANOVA, p=0.0034, n=8) and elav-Gal4/+;v15550/+ flies were different than elav-Gal4/+ 
controls (BMC, p=0.0018), but not different than v15550/+ controls (p=0.2422). (D) In 
studies with JF03115, genotype also had an overall effect (one-way ANOVA, p=0.0499, 
n=8) and elav-Gal4/+;JF03115/+ flies were different than elav-Gal4/+ controls (BMC, 
p=0.0310), but not different than JF03115/+ controls (p=0.3850). 
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Figure 4.8. Whole brain Mef2 expression and validation of Mef2 RNAi transgenes. 
(A-D) representative (10X) confocal images of whole mount brains immunolabeled with 
anti-Mef2. In control flies (A, v15550/+; B, JF03115/+), expression of Mef2 was 
prominent in the calyx of the mushroom bodies (arrowheads) and at lower levels 
throughout the brain. Detection of Mef2 appeared to be reduced in flies pan-neuronally 
expressing Mef2 RNAi transgenes (C, elav-Gal4/+;v15550/+; D, elav-Gal4/+;JF03115/+) 
compared to brains from RNAi transgene control animals (A, B). (E and F) Quantitation 
of Mef2 immunolabeling. Pixel intensity was significantly reduced in flies expressing 
Mef2 RNAi transgenes (E, elav-Gal4/+;v15550/+; F, elav-Gal4/+;JF03115/+) compared 
to their respective RNAi transgene controls (students t-tests; panel E, p=0.0002; panel 
F, p<0.0001, n = 4-5). 
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Quantitation of the Mef2 signal from all optical sections representing whole brains 
confirmed that pan-neuronal expression of Mef2 RNAi transgenes significantly 
decreased Mef2 expression (Figure 4.8E and 4.8F). Both of the Mef2 RNAi transgenes 
used throughout our studies therefore knockdown expression of Mef2 in neurons. 
To further explore the possibility that Mef2 plays a role in ethanol sedation, we 
obtained several previously characterized loss-of-function mutant Mef2 alleles (Mef225-34 
212, Mef230-5 213, 214, and Mef265 215 (Fig 4.1), backcrossed them to a control stock (see 
Methods), and then performed genetic complementation analyses. Flies heterozygous 
for Mef230-5, Mef265, and Mef225-34, had no detectable change in ST50 values (Figure 
4.9). Importantly, Mef230-5/Mef265 (Figure 4.9A, time-courses; Figure 4.9C, ST50 values) 
and Mef225-34/Mef265 (Figure 4.9B, time-courses; Figure 4.9D, ST50 values) 
transheterozygous flies had increased ST50 values compared to all other groups tested. 
These data confirm that flies with reduced Mef2 function have increased ST50 values 
under the conditions used in our experiments. 
To identify whether Mef2 expression in neurons is necessary for normal ethanol 
sedation during adulthood, v15550 (Fig 4.10A and B) or JF03115 (Fig 4.10C and D) 
was expressed by neuronal synaptobrevin GeneSwitch (nsyb-GS). Expression of the 
Mef2 RNAi, v15550, by nsyb-GS had increased ST50s when treated with RU486 
compared to vehicle control (Fig. 4.10A, checkered bars). Importantly, driver and Mef2 
RNAi controls did not have differences in ST50 values when treated with either vehicle 
or RU486 (Fig. 4.10A, first four bars). This result was not able to be reproduced (Fig. 
4.10B). Additionally, two experiments testing flies containing the Mef2 RNAi JF03115 
and nsyb-GS did not have altered ST50s when treated with RU486 or vehicle (Fig. 
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Figure 4.9. Mef2 mutants are resistant to ethanol sedation. (A and B) Ethanol 
sedation time courses of control flies (w[A]) and the indicated Mef2 genotypes. 
Compound heterozygous Mef2 mutants Mef230-5/Mef265 (A) and Mef225-34/Mef265 (B) 
took longer to become sedated than flies heterozygous for these alleles. (C, D) ST50 
values, derived from the data in panels A and B, respectively. There was a significant 
overall effect of Mef2 genotype on ST50 values (individual one-way ANOVAs; panel C, 
p<0.0001; panel D, p<0.0001; n=10). ST50 values were greater in Mef230-5/Mef265 (C) 
and Mef225-34/Mef265 (D) flies than in all other genotypes (*BMCs; panel C, p≤0.0003; 
panel D, p<0.0001)
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Figure 4.10. Mef2 RNAi adulthood expression by neuronal synaptobrevin 
GeneSwitch does not alter ethanol sedation. Female flies were treated with vehicle 
or 100 µM for 6 days. (A) ST50 values of flies with nsyb-GS expression of Mef2 RNAi, 
(nsyb-GS/v15550) specifically during adulthood, had increased values compared to 
vehicle control, whereas controls (nsyb-GS/+ and v15550/+) did not have a difference in 
ST50 when treated with vehicle or RU486 (two-way ANOVA; treatment---genotype, 
p=0.0403; genotype, p<0.0001; *BMC 100 µM versus Vehicle; nsyb-GS/+, p=0.9768; 
v15550/+, p=0.8676; nsyb-GS/v15550, p=0.0344; n=8). (B) Results from panel A did not 
reproduce. ST50 values of flies with nsyb-GS expression of Mef2 RNAi, (nsyb-
GS/v15550) and controls (nsyb-GS/+ and v15550/+) did not have a difference in ST50 
when treated with vehicle or RU486 (two-way ANOVA; genotype, p=0.0009; *BMC 100 
µM versus Vehicle; nsyb-GS/+, p=0.1986; v15550/+, p>0.9999; nsyb-GS/v15550, 
p>0.9999; n=8). (C) ST50 values of flies with nsyb-GS expression of Mef2 RNAi, (nsyb-
GS/JF03115) and controls (nsyb-GS/+ and JF03115/+) did not have a difference in 
ST50 when treated with vehicle or RU486 (two-way ANOVA; n.s.; n=8). (D) Results 
from panel C were reproduced where expression of Mef2 RNAi in neurons during 
adulthood did not alter ethanol sedation. ST50 values of flies with nsyb-GS expression 
of Mef2 RNAi, (nsyb-GS/JF03115) and controls (nsyb-GS/+ and JF03115/+) did not 
have a difference in ST50 when treated with vehicle or RU486 (two-way ANOVA; n.s.; 
n=8) (sedation performed by B.C.S.)
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4.10C and 4.10D, checkered bars). These data suggest that Mef2 expression during 
adulthood is not required for ethanol sedation. 
 
C. Discussion 
The overarching goal of this study was to explore molecular-genetic 
underpinnings of behavioral responses to alcohol by (i) using human genetic analyses 
to identify candidate genes that might influence SRE and then (ii) testing the role of 
Drosophila orthologues of those human candidate genes in fly ethanol sedation and 
rapid tolerance. We chose to focus our studies on human SRE scores and fly ethanol 
sedation/rapid tolerance in part because these measures are well established 
responses to ethanol exposure in the respective species56, 116, 201, 216 and both measures 
have demonstrated value for identifying genes that influence alcohol abuse, 
dependence or other aspects of alcohol abuse17, 77, 78, 116, 216-221. Additionally, both the 
SRE in humans and ethanol sedation/rapid tolerance in flies are behavioral responses 
to acute ethanol exposure, raising the possibility that our approach could uncover 
evolutionarily conserved mechanisms driving the behaviors in humans and flies.  
Our SRE GWAS in the ALSPAC sample found 37 candidate genes with pgene < 
0.001. We prioritized our examination of fly orthologues of these genes based on 3 
criteria: reported roles of the candidate genes in human phenotypes that might predict 
roles in ethanol behavior, presence of obvious orthologous genes in the fly genome, 
and availability of Drosophila RNAi reagents to manipulate gene expression. A total of 6 
human and 6 orthologous fly genes met these criteria: APP/Appl, ATG5/Atg5, 
GPD2/Gpo1, ISL1/tup, MEF2B/Mef2 and PCDH15/Cad99C. We consequently explored 
the role of the fly orthologues in ethanol sedation and rapid tolerance.  
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Flies with constitutive expression of RNAi targeting Mef2 in neurons, as well as 
flies with loss of function mutations in Mef2, were resistant to ethanol sedation in our 
experiments. Decreased function of Mef2 did not impact internal ethanol levels, 
indicating that Mef2 influences the pharmacodynamic response to ethanol. Interestingly, 
decreased function of Mef2 did not alter rapid tolerance to ethanol, suggesting that Mef2 
might influence acute sedation, but not tolerance, under the conditions used in our 
studies. Importantly, our studies on Mef2 used 3 different RNAi transgenes with 2 
different target sequences and 3 independent loss-of-function alleles, all confirmed at 
the protein or DNA level, collectively demonstrating a role for Mef2 in fly ethanol 
sedation. 
Another group also recently reported that Mef2 plays a role in Drosophila alcohol-
related behavior. In contrast to our results, their studies indicate that constitutive 
neuronal expression of RNAi against Mef2 or expression of a Mef2 dominant negative 
alters rapid tolerance to ethanol, but not necessarily ethanol sedation208. We noted that 
the ST50 values were somewhat shorter in the previous report when compared to our 
results, but increasing the ethanol concentration to the maximum possible in our studies 
(thereby shortening the ST50) did not meaningfully alter our conclusions. Additional 
experiments will therefore be required to address whether the differences between the 
previously published and our results might be explained by differences in behavioral 
paradigms, genetic backgrounds, or environmental conditions. Importantly, though, both 
studies demonstrate that Mef2 influences behavioral responses to acute ethanol 
exposure in flies, thereby mutually reinforcing the other. 
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The human MEF2 family of genes has 4 members (MEF2A, MEF2B, MEF2C and 
MEF2D) whereas the fly genome contains only a single orthologue (Mef2). The primary 
amino acid sequence of fly Mef2 protein has similar overall levels of conservation (32 to 
43 percent identical, 43 to 56 percent similar89) relative to all of the human MEF2 
proteins. All gene products are known or predicted to be transcription factors88, 222 and 
are involved in numerous biological processes (e.g., muscle differentiation90, 91, human 
disease/cancer92, 93, neuronal differentiation94-96, and others. Of the MEF2 family 
members within our ALSPAC SRE gene-based analyses, MEF2B was the most robustly 
implicated (pgene=0.0007). Additionally, though, our analyses suggested that MEF2A 
might also be involved (pgene=0.02), whereas MEF2C and MEF2D were not associated 
with SRE scores in our studies (p>0.05). None of the MEF2 family members have, to 
our knowledge, met stringent genome-wide significance criteria for associations with 
alcohol-related outcomes in other human GWAS. Interestingly, though, using the 
recently developed online tool GWAS ATLAS (atlas.ctglab.nl223), which processes 
GWAS results through MAGMA to derive gene-based summary statistics, we identified 
nominal associations (p<0.05) between all four human MEF2 genes and alcohol 
outcomes. Furthermore, MEF2B is associated with alcohol consumption in a GWAS 
study196 and a secondary analysis of GWAS summary statistics using the PheWAS 
option in the online GWAS ATLAS (http://atlas.ctglab.nl/PheWAS) revealed that 
aggregate variation in MEF2B is associated with changes in alcohol use from 10 years 
prior in UK Biobank data. The PheWAS tool and literature searches reveal associations 
between alcohol-related outcomes and other human MEF2 genes as well: MEF2A was 
associated with alcohol intake frequency in UK Biobank, MEF2C was associated with 
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alcohol dependence symptom counts in COGA224, and both MEF2C and MEF2D were 
associated with a range of alcohol-related outcomes in UK Biobank including alcohol 
intake frequency, drinking status, and amount of alcohol consumed on drinking days. 
These diverse associations—in conjunction with the results of the current study—
suggest that multiple or perhaps even all members of the MEF2 family might impact 
variation in alcohol outcomes. Together, our studies in humans and flies, in combination 
with previous studies in humans, suggest that MEF2 family members might impact initial 
sensitivity to ethanol, thereby influencing the risk for abusing the drug. 
As transcription factors, MEF2 family members presumably influence alcohol-
related behaviors principally by regulating expression of other genes. Adhikari and 
colleagues recently reported that Mef2 induces the expression of the immediate early 
gene Hr38, thereby regulating rapid tolerance in flies 208. Additional Mef2 target genes 
might also be important for ethanol behaviors. For example, Sivachenko and colleagues 
identified 342 genes with Mef2-dependent expression in flies225. Fifteen of these 342 
genes (~3.5-fold more than expected by chance, Table 4.3) are known to influence 
behavioral responses to ethanol in Drosophila, suggesting that genes regulated by Mef2 
family members might be enriched for genes that influence alcohol-related behavior. A 
more comprehensive characterization of Mef2-regulated gene expression could 
therefore be a gateway for better understanding mechanisms underlying a variety of 
behaviors in response to alcohol exposure. 
Beyond studies on alcohol, Mef2 genes are important for the effects of cocaine 
on neuronal morphology and behavioral responses. Cocaine increases dendritic spine 
density in the mouse nucleus acumbens via a process that requires reductions in Mef2 
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protein activity, and behavioral sensitization to cocaine requires an increase in Mef2 
protein activity226. Combined with our findings, these results raise the possibility that 
Mef2 proteins and their target genes might have conserved roles in behavioral and 
other types of responses to multiple drugs of abuse. A more comprehensive 
understanding of Mef2 in alcohol behavior could therefore have important implications 
for risk assessment for—and potentially treatment of—substance abuse more broadly.
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Table 4.3. Overlapping genes from previously indicated genes involved in Drosophila alcohol behavior and Mef2 
target genes in adult brains. 
Fly Gene 
Symbol1 
Fly Gene 
Identifier 
Fly 
Annotation 
Symbol 
Orthologous 
Human Gene 
Symbol2 
Human 
Gene ID DIOPT Score 
Weighted 
Score 
dorsal FBgn0260632 CG6667 RELA 9955 9 8.73 
      REL 9954 8 7.7 
      RELB 9956 6 5.93 
DopEcR FBgn0035538 CG18314 GPR52 4508 2 1.93    
GPR21 4476 2 1.88 
Mef2 FBgn0011656 CG1429 MEF2A 6993 12 11.79 
      MEF2C 6996 11 10.89 
      MEF2D 6997 11 10.84 
      BORCS8-MEF2B 39979 4 4.04 
      MEF2B 6995 4 3.93 
Bx FBgn0265598 CG44425 LMO1 6641 9 8.84 
      LMO3 6643 8 7.89 
      LMO2 6642 4 4 
Fas2 FBgn0000635 CG3665 NCAM2 7657 11 10.8 
      NCAM1 7656 10 9.65 
InR FBgn0283499 CG18402 IGF1R 5465 12 11.83 
      INSR 6091 10 9.88 
      INSRR 6093 9 8.85 
mys FBgn0004657 CG1560 ITGB1 6153 13 12.84 
      ITGB2 6155 9 8.85 
      ITGB7 6162 9 8.85 
      ITGB3 6156 8 7.89 
      ITGB5 6160 6 5.84 
      ITGB6 6161 5 4.91 
      ITGB4 6158 5 4.85 
      ITGB8 6163 4 3.94 
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      ITGBL1 6164 2 2 
Pdk1 FBgn0020386 CG1210 PDPK1 8816 11 10.74 
      PDPK2P 49897 5 5.04 
puc FBgn0243512 CG7850 DUSP10 3065 9 8.73 
      DUSP8 3074 4 3.99 
      DUSP16 17909 4 3.99 
      DUSP14 17007 3 3.04 
      DUSP18 18484 3 3.04 
      DUSP28 33237 3 2.97 
      SSH3 30581 3 2.94 
      SSH2 30580 3 2.94 
      DUSP4 3070 3 2.94 
      DUSP1 3064 3 2.94 
      DUSP6 3072 2 2.04 
      DUSP7 3073 2 2.04 
      DUSP21 20476 2 2.01 
      DUSP2 3068 2 1.91 
      DUSP27 25034 2 1.91 
      DUSP26 28161 2 1.91 
      SSH1 30579 2 1.91 
      STYX 11447 2 1.91 
      DUSP22 16077 2 1.91 
      DUSP5 3071 2 1.91 
      DUSP12 3067 2 1.91 
      DUSP3 3069 2 1.91 
      DUSP19 18894 2 1.91 
      DUSP15 16236 2 1.91 
      DUPD1 23481 2 1.91 
      DUSP13 19681 2 1.91 
w FBgn0003996 CG2759 ABCG2 74 6 5.89 
      ABCG4 13884 5 4.84 
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      ABCG1 73 4 3.83 
      ABCG8 13887 4 3.81 
      ABCG5 13886 3 2.91 
aret  FBgn0000114 CG31762 CELF2 2550 11 10.89 
      CELF1 2549 11 10.84 
      CELF6 14059 4 3.94 
      CELF4 14015 3 2.91 
      CELF5 14058 3 2.91 
      CELF3 11967 2 1.9 
bun FBgn0259176 CG42281 TSC22D1 16826 10 9.88 
      TSC22D2 29095 5 4.95 
      TSC22D4 21696 5 4.87 
      TSC22D3 3051 4 3.97 
CG42389 FBgn0259735 CG42389 FNDC3A 20296 12 11.79 
      FNDC3B 24670 10 9.76 
cpo FBgn0263995 CG43738 RBPMS 19097 8 7.75 
      RBPMS2 19098 7 6.8 
dunce FBgn0000479 CG32498 PDE4D 5144 11 10.74 
      PDE4B 5142 11 10.69 
      PDE4A 5141 10 9.72 
      PDE4C 5143 8 7.78 
1 Mef2 target genes were elucidated in the following article: “The transcription factor Mef2 links the Drosophila core clock 
to Fas2, neuronal morphology, and circadian behavior” Sivachenko, et al, 2013. 
2 Human orthologous genes and scores come from DIOPT (https://www.flyrnai.org/cgi-bin/DRSC_orthologs.pl).
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Chapter 5: Nitric oxide synthase, and nitric oxide signaling, in Drosophila ethanol 
sedation 
 
 
 
A. Introduction 
Nitric oxide synthase (Nos) is an enzyme that converts L-Arginine to Citrulline 
and NO. Mammals contain neuronal NOS (nNOS or NOS1), inducible NOS (iNOS or 
NOS2), and endothelial NOS (eNOS or NOS3) and its product, NO, has been 
demonstrated be involved in signaling as a neurotransmitter, regulation of blood 
vessels97, and regulating human disease states98. Signaling of NO to activate soluble 
guanaylyl cyclase (sGC) is the canonical NO signaling pathway. NO is able to readily 
able to diffuse through cell membranes to subsequently activate sGC. Once sGC is 
activated, cyclic GMP (cGMP) is produced, resulting in downstream signaling effects 227, 
228. Other signaling pathways (S-nitrosation) via NO are also important for proper 
regulation of cellular processes and the development of human disease states229.  
A few rodent studies have demonstrated the ability of NOS to influence alcohol-
related behaviors103-105. These studies substantiate the need for further investigation 
into the mechanism NO signaling in alcohol-related behaviors. The long term goal would 
be to use the NO signaling mechanistic aspects as potential new treatment options for 
those who suffer from alcohol use disorder. We therefore used Drosophila 
melanogaster to address multiple questions about Nos, and NO signaling, in fly alcohol-
related behaviors. Drosophila melanogaster has a single ortholog and is most highly 
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conserved with NOS1 but shares similarity to NOS3 and NOS289. Additionally, fly Nos 
has been shown to be involved in numerous processes in the fly, such as imaginal disc 
regeneration100, axon pruning and regrowth101, and immune responses102.  
 We initially set out to determine if Nos plays a role in ethanol-related behaviors, 
address what tissue and timing of interest in which Nos expression is required, and to 
determine the mechanism of action that NO signaling is influencing to regulate ethanol 
sedation. Our preliminary research in flies suggest that knockdown of Nos results in 
increased ethanol sensitivity. RNAi results have not elucidated a tissue of interest, but 
expression of Nos RNAi ubiquitously during adulthood also results in increased ethanol 
sedation. These data suggest a specific role for Nos and NO signaling in ethanol 
sedation and specifically for a role during an adulthood process in flies.  
 
B. Results 
The Drosophila Nos gene is located on chromosome 2L, where there are two 
genes closely flanking the Nos transcriptional region and two genes located within Nos 
(Fig. 5.1). We obtained multiple reagents to assess the effect of the reagents targeting 
Nos on ethanol-related behaviors. Fig. 5.1A highlights the locations of the Nos 
transposon insertions or null lines (blue boxes) that are used in the study, while Fig. 
5.1B highlights the targeted sequences by Nos RNAi lines (purple boxes). Reagents 
used are all listed in Table 5.1. A previous study in our lab generated Nos as a possible 
candidate gene for influencing ethanol sedation when in interaction with another gene of 
interest. Results from this previous study did not suggest that Nos and the gene of 
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Figure 5.1. Nos transcriptional region (FlyBase). Image shows the location of the Nos 
gene and the subsequent transcripts of the gene. The Nos mutants used in this study 
are boxed in blue (A). Locations of Nos RNAi target sequences are boxed in purple (B).
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Table 5.1. Reagents used to investigate Nos in Drosophila ethanol-related behaviors. 
Label 
Stock 
Number 
Chromosome 
Insertion 
Genotype Acquired Notes 
Nos RNAi Stocks      
Nos RNAi #1 v27722 X w[1118] P{GD12013}v27722 VDRC 
Lethal when expressed by 
repo-Gal4 
Nos RNAi #2 v27725 2 w[1118]; P{GD12013}v27725 VDRC 
Lethal when expressed by 
repo, da, & Mef2-Gal4 
Nos RNAi #3 57700 2 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.GLC01867}attP40 
BDSC  
Nos RNAi #4 28792 3 
y[1] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.JF03220}attP2 
BDSC  
Nos RNAi #5 50675 3 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMC03076}attP2 
BDSC  
Nos RNAi #6 v27722[wA] X w[1118] P{GD12013}v27722 Schmitt BX  
Nos RNAi #7 v27725[wA] 2 w[1118]; P{GD12013}v27725 Schmitt BX  
Nos RNAi #8 57700 [1495] 2 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.GLC01867}attP40 
Schmitt BX  
Nos RNAi #9 28792 [1495] 3 
y[1] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.JF03220}attP2 
Schmitt BX  
Nos RNAi #10 50675 [1495] 3 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMC03076}attP2 
Schmitt BX  
Nos RNAi #11 NEW 50675 3 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMC03076}attP2 
BDSC  
Nos Transposon Elements and Null Stocks 
Nose02671 e02671(wA) 2 PBac{RB}Nose02671  EHMS/LL BX  
Nosc01670 c01670(wA) 2 PBac{PB}Nosc01670  EHMS/LL BX  
Nosf02469 f02469(wA) 2 PBac{WH}Nosf02469  EHMS/LL BX  
Nos1 Nos1 (wA) 2 
w[1118]; Nos[1]/CyO, 
P{w[+mC]=ActGFP}JMR1 
BDSC/Schmitt 
BX 
 
UAS-Nos Stocks      
UAS-Nos #1 56829 X P{UAS-Nos.L}1, w*  BDSC  
UAS-Nos #2 56823 2 w1118; P{UAS-Nos.L}2 
BDSC/Schmitt 
BX 
 
UAS-Nos #3 
UAS-
Nos3;UAS-Nos5 
II on 2 & I 
on 3 
 Yakubovich  
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sGC RNAi Stocks  
 
 
 
 
sGC RNAi #1 v107074 2 P{KK102774}VIE-260B VDRC 
Lethal when expressed by 
da, elav, & Mef2-Gal4 
sGC RNAi #2 v100706 2 P{KK108015}VIE-260B VDRC  
sGC RNAi #3 64009 2 
y[1] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMJ30322}attP40 
BDSC  
sGC RNAi #4 60876 2 
y[1] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMJ22589}attP40 
BDSC  
sGC RNAi #5 28748 3 
y[1] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.JF03176}attP2 
BDSC  
sGC RNAi #6 28786 3 
y[1] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.JF03214}attP2 
BDSC  
sGC RNAi #7 36817 3 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.GL01038}attP2 
BDSC  
Miscellaneous Stocks 
 
 
 
E75 RNAi 35780 (1495) 2 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMS01530}attP40 
BDSC  
Fdh RNAi 34937 3 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMS01268}attP2 
BDSC  
UNF RNAi 39032 (1495) 3 
y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRiP.HMS01951}attP2 
BDSC  
y1w1 1495  y[1]w[1] BDSC 
 
 
BX = Backcrossed for 7 generations. LL BX = Lara Lewellyn performed backcross 
 
      
 
129 
 
interest were genetically interacting to influence ethanol sedation. The reagents that 
were obtained and used to investigate Nos caused an increased ethanol sedation, and 
subsequently, became a candidate gene of interest for further investigation. The 
reagents that were originally obtained were three individual Nos piggyBac transposon 
insertions and were assessed for their ability to alter Nos expression and their ability to 
influenced ethanol sedation. Nose02671, females (left panel) and males (right panel), had 
decreased ST50 values, or increased sensitivity to alcohol, compared to their genetic 
background controls (Fig. 5.2A). The two additional transposon insertions, Nosc01670 and 
Nosf02469, also had significantly decreased ST50s compared to control (Fig. 5.2B). 
Additionally, as part of the screen it was determined that the three Nos transposons 
insertions significantly decreased the relative Nos expression as found by qRT-PCR 
results (Fig. 5.2C).To further characterize how the Nos transposon insertions influenced 
ethanol sedation, locomotor behavior was assessed. All three of the Nos transposon 
insertions did not differ in locomotor behavior compared to their genetic background 
control, but all groups were different from the positive locomotor defect control (w[A] 4 
min Vortex) (Fig. 5.2D). Also, it is possible that the Nos transposon insertions alter 
ethanol sedation via changes in ethanol uptake/metabolism, therefore internal ethanol 
was measured in the three Nos transposon insertion lines and control flies. There were 
no consistent changes in internal ethanol levels of the Nos transposon insertions and 
their genetic background control (Fig. 5.2E). These studies suggest that Nos is 
important for normal ethanol sedation in Drosophila melanogaster and that locomotor 
defects or alterations in internal ethanol uptake/metabolism are not the cause for the 
Nos transposon insertions increased ethanol sensitivity phenotype.  
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Figure 5.2. Characterization of Nos p-element insertions. Sedation was performed 
using 70% ethanol. (A) Overall, genotype and gender affected ST50s but not its 
interaction (two-way ANOVA; genotype, p=0.0002; gender, p=0.0016; interaction, 
p=0.5357). Female and male Nose02671 flies had decreased ST50s when compared to 
their corresponding female and male genetic background control, w[A] (*BMC versus 
w[A]; Female, p=0.0035; Male, p=0.0345; n=10).  (B) Genotype caused an overall effect 
on ST50 values determining ethanol sedation with additional Nos mutants (one-way 
ANOVA; p=0.0003). Female Nosc01670 and Nosf02469 had increased ethanol sedation 
compared to controls (*BMC verses w[A]; Nos Mutant #2, p=0.0077; Nos Mutant #3, 
p=0.0001; n=10). (C) Nos transposon insertions did have significantly reduced levels of 
relative Nos expression (*individual two-tailed t tests, different from 1; Nose02671, 
p<0.0001; Nosc01670, p<0.0001; Nosf02469, p=0.0031; n=3-4) (Performed by Lara 
Lewellyn). (D) There was an overall effect of treatment on locomotor behavior (one-way 
ANOVA; p<0.0001). Positive locomotor defect control flies, w[A] 4 min vortex had a 
significant difference in locomotor values to all other groups (*BMC verses w[A] 4 
minute vortex; w[A], p<0.0001; Nose02671, p<0.0001; Female Nosc01670, p<0.0001; 
Nosf02469, p<0.0001; n=8), whereas the Nos transposon insertions are not different from 
the w[A] no treatment group (Performed by Ian Hines). (E) Overall, internal ethanol 
levels were not affected by genotype when comparing Nos transposon insertions to 
control, w[A] (one-way ANOVA; p=0.1182; n=5-15) (Performed by Jena Butler). 
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One particularly challenging aspect of using piggyBac transposon insertions is 
that it has been previously demonstrated that the transposons are able to influence 
genes within a 100 kb range of that insertion230. Therefore the data above make it 
challenging to say that the effects on Nos gene expression is the sole cause of the 
altered ethanol sedation phenotype. To address this, we obtained a Nos null allele 
(Nos1)101. The point mutation changes the control sequence of TGG, encoding 
tryptophan (Fig. 5.3A) to TGA, encoding a premature stop codon (Fig. 5.3B). The 
premature stop codon occurs in the reductase domain NOS, which is required for the 
enzyme to convert L-Arginine to L-Citruline and NO97. Nos1 was backcrossed to 
Nose02671 (which had been backcrossed to w[A]). Using Nose02671, marked with w+ (red 
eyes) allowed for tracking of the Nos1 allele (no marker) via eye color throughout the 
generations. After backcrossing, the ability to maintain the point mutation was confirmed 
via sequencing (Fig. 5.3A and 5.3B). To determine whether the Nos1 influenced ethanol 
sedation, an ethanol dose response was performed. In three of the five concentrations 
of ethanol used (55%, 70%, and 85%), Nos1 homozygous flies had decreased ST50s 
compared to controls (Fig. 5.3C). These results strongly implicate Nos as playing an 
important role in normal ethanol sedation behavior in flies.  
To further characterize Nos1, homozygous Nos1 male and female flies were 
exposed to 55% ethanol vapor and their ethanol sedation determined. Both males and 
females had a decrease in ST50 values compared to controls (Fig. 5.4A, time course 
and Fig 5.4B, ST50s obtained from panel A). To determine whether Nos1 had locomotor 
defects, locomotor behavior was assessed. There were no differences in locomotor 
behavior of the Nos1 flies compared to control flies, but the positive control flies had a 
133 
 
Figure 5.3. Sequencing confirmation of Nos null mutation and its effect on 
ethanol sedation. (A) Control, w[A] (Nos Mutant #4 was backcrossed to Nos1 for 
tracking of eye color; Nos1 was previously backcrossed to w[A]), sequencing of region 
containing location of the Nos null point mutation; TGG > Tryptophan (red box). (B) 
Confirmation of retained Nos null point mutation through 7 generations of backcrossing; 
TGA > Stop (red box). (C) For the dose response of Nos1 and controls, w[A], there was 
a significant overall effect of genotype and ethanol concentration on ST50 values, but 
not for the interaction (two-way ANOVA; genotype, p<0.0001; ethanol concentration, 
p<0.0001; interaction, p=0.2086). There was a significant decrease in ST50 values of 
Nos1 when compared to control, w[A], flies with most ethanol concentrations except 
when 40% and 100% ethanol concentrations were used (*BMC versus w[A]; 40%, 
p>0.9999; 55%, p=0.0004; 70%, p=0.0120; 85%, p=0.0174; 100%, p=0.2137; n=8).  
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Figure 5.4. Ethanol sedation, locomotor, and internal ethanol characterization of 
Nos null. Flies were exposed to 55% ethanol. (A) Time-course of Nos1 male and female 
flies and control, w[A], male and female flies. (B) ST50 values derived from panel A. 
Genotype had an overall effect on ST50 values, but there was no effect of gender or 
interaction (two-way ANOVA; genotype, p<0.0001; gender, p=0.0743; interaction, 
p=0.3369). Nos1 flies, both male and female, had decreased ST50s compared to 
controls, w[A] (*BMC versus w[A]; male, p<0.0001; female, p<0.0001; n=12). (C) An 
overall effect of treatment was seen in flies exposed to locomotor testing (one-way 
ANOVA; p=0.0002). w[A] and Nos1 females are significantly different from the locomotor 
positive control flies, w[A] 4 min vortex, but not each other (*BMC versus w[A] 4 min 
vortex; w[A], p=0.0006; Nos1, p=0.0007; versus w[A]; Nos1, p>0.9999; n=8). (D) The 
water content of Nos1 female flies was not different from control, w[A], female flies (t-
test; p=0.8211; n=8). (E) There is an overall effect of the ethanol exposure length on 
significant locomotor defect compared to control and Nos1 (Fig. 5.4C). Internal ethanol 
was assessed in Nos1 flies at multiple time points of exogenous ethanol exposure (Fig. 
internal ethanol levels, but no effect of genotype or interaction (two-way ANOVA; 
genotype, p=0.1735; ethanol exposure, p<0.0001; interaction, p=0.7537; n=8). There 
were no difference in internal ethanol levels between the Nos1 and control, w[A], female 
flies when measured at multiple ethanol exposure time points. 
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significant locomotor defect compared to control and Nos1 (Fig. 5.4C). Internal ethanol 
was assessed in Nos1 flies at multiple time points of exogenous ethanol exposure (Fig. 
5.4E) and values were corrected for their corresponding water volume (Fig. 54D), Nos1 
flies did not have differences in water volume (Fig. 5.4D) or internal ethanol levels when 
exposed to ethanol for 0, 48, or 96 minutes (Fig. 5.4E). These data suggest that Nos is 
required for normal ethanol sedation and that locomotor defects and ethanol 
uptake/metabolism are most likely not the cause of the increased ethanol sedation.  
Another initial response to alcohol that can be assessed in flies is rapid 
tolerance. Therefore we assessed whether the Nos null fly, Nos1, influenced the 
development of rapid tolerance. Rapid tolerance is determined by exposing flies to 
ethanol during a first exposure, allowing the flies to recover for four hours, and 
reassessing their ethanol sedation during a second ethanol exposure. Nos1 flies were 
sensitive to alcohol in the first exposure (E1, left panel), as expected, but there was no 
difference in ST50s between the Nos null and control flies in the second ethanol 
exposure (E2, right panel) (Fig. 5.5A). Rapid tolerance can be quantified by as the ST50 
from the second ethanol exposure (E2) divided by the first ethanol exposure ST50 (E1). 
Nos1 flies have an increase in the development of rapid tolerance compared to controls 
(Fig. 5.5B). These data suggests that Nos may not only affect initial ethanol sedation, 
but also the development of rapid tolerance.  
The model of how Nos influences ethanol sedation is of important interest, 
different tissues or timing could have very different implications for the role of NO 
signaling. We utilized the UAS-Gal4 system69 to express Nos RNAi lines in different 
tissues. The target locations of the Nos RNAi lines are highlighted in Fig. 5.1B (purple 
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Figure 5.5. Nos null effect on rapid tolerance. For determining ethanol sedation, flies 
were exposed to 55% ethanol vapor. (A) Genotype, ethanol exposure, and subsequent 
interaction between the factors had a significant effect on ST50 values (two-way 
ANOVA; genotype, p<0.0001, ethanol exposure, p<0.0001; interaction, p<0.0001). Nos1 
flies have a decreased ST50 compared to control flies, w[A] during the first ethanol 
exposure (E1), but not the second ethanol exposure (E2) (*BMC versus w[A]; E1, 
p<0.0001; E2, p>0.9999; n=11-12). (B) Rapid tolerance, calculated as ST50 of E2  
ST50 of E1 (data from panel A), is significantly higher in Nos1 compared to control, w[A] 
(t-test; p<0.0001; n=11-12).  
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Figure 5.6. Broad expression of Nos RNAi #6 alters ethanol sedation, but not 
when expressed pan-neuronally or in muscles. Female flies exposed to 70% ethanol 
vapor during sedation. (A) Ethanol sedation time-course of flies containing da-Gal4 and 
Nos RNAi #6 (red triangles) and controls (black circles and gray squares). (B) ST50 
values, from panel A, are significantly affected by genotype (one-way ANOVA; 
p<0.0001). When Nos RNAi #6 is expressed broadly (red bar) there is a decrease in 
ST50s compared to both driver, da-Gal4/+, and RNAi transgene, Nos RNAi #6/+, 
controls (black and gray bars, respectively) (*BMC versus Nos RNAi #6/+;da-Gal4/+; 
da-Gal4/+, p<0.0001; Nos RNAi #6/+, p<0.0001; n=8). (C) ST50 values are not altered 
when Nos RNAi #6 or #7 is expressed pan-neuronally (red bars) compared to both 
driver, elav-Gal4/+, and RNAi transgene, Nos RNAi #6 or #7/+, controls (black and gray 
bars, respectively) (one-way ANOVA; p=0.1584; n=8). (D) There is an overall genotype 
effect on ST50 values (one-way ANOVA; p=0.0274; n=8), but they are not significantly 
altered when Nos RNAi #6 is expressed in muscles (red bar) and compared to both 
driver, Mef2-Gal4/+, and RNAi transgene, Nos RNAi #6/+, controls (black and gray 
bars, respectively).  
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boxes). Expression of Nos RNAi #6 throughout the fly results in a decreased ethanol 
sedation compared to both the driver (da-Gal4/+) and RNAi (Nos RNAi #6) controls (Fig. 
5.6A, time course and 5.6B, ST50s obtained from panel A). Expression of Nos RNAi #6 
and #7 pan-neuronally (Fig. 5.6C), or Nos RNAi #6 in muscles (Fig. 5.6D) did not alter 
ethanol sedation. Furthermore, expression of other Nos RNAi lines in different tissues 
did not affect ethanol sedation or the development of rapid tolerance (Table 5.2).  
To determine whether Nos expression during adulthood is important for ethanol 
sedation, we utilized the GeneSwitch system70. GeneSwitch is a steroid inducible Gal4 
system, which allows for temporal control of expression of a transgene by introducing a 
steroid to flies. We expressed a single copy of Nos RNAi lines, driven by a ubiquitous 
GeneSwitch driver and compared the ST50 values between vehicle treated (no 
expression of transgene) and RU486 (steroid, expression of transgene) for each 
genotype. There were no consistent effects on Nos RNAi expression during adulthood 
on ethanol sedation (Table 5.3). It is possible that expression of a single copy of Nos 
RNAi alone is not sufficient to cause a robust knockdown of Nos. To factor in this 
possible limitation, we created a double transgenic fly that would contain both the 
ubiquitous GeneSwitch Driver and two copies of a Nos RNAi line. When flies expressed 
one copy of the ubiquitous GeneSwitch driver and two copies of Nos RNAi #9, they had 
a decrease in ST50 when treated with RU486 compared to vehicle treated flies (Fig. 
5.7A, checkered bars). Importantly, controls containing the GeneSwitch driver or two 
copies of the Nos RNAi #9 transgene did not have differences in ST50 values when 
treated with either vehicle or RU486 (Fig. 5.7A, first four bars). Additionally, ubiquitous 
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Table 5.2. Expression of multiple Nos RNAi lines do not alter ethanol sedation or rapid tolerance when expressed 
broadly, pan-neuronally, in muscles, or in glial cells. 
Groups Gal4 
Nos RNAi 
Line 
ST50 
E1 
RapTol 
(E2/E1) n 
Statistical 
test 
ST50 E1 
p values 
RapTol 
p 
values 
RNAi da GLC01867 65.33 ± 4.796 1.724 ± 0.1115 8 ANOVA 0.0315 0.0298 
Control -- GLC01867 75.74 ± 4.447 1.532 ± 0.1014 8 BMC 0.1779 0.2897 
Control da -- 81.85 ± 2.886 1.358 ± 0.0363 8 BMC 0.0200* 0.0176* 
RNAi elav GLC01867 70.68 ± 3.806 1.641 ± 0.0611 8 ANOVA 0.2866 0.1257 
Control -- GLC01867 77.91 ± 3.958 1.470 ± 0.0801 8 BMC 0.4043 0.1689 
Control elav -- 78.86 ± 3.895 1.462 ± 0.0570 8 BMC 0.3025 0.1439 
RNAi repo GLC01867 83.26 ± 5.736 1.388 ± 0.0924 8 ANOVA 0.5591 0.3527 
Control -- GLC01867 74.95 ± 6.495 1.484 ± 0.1438 8 BMC 0.6494 >0.9999 
Control repo -- 76.09 ± 5.180 1.243 ± 0.1057 8 BMC 0.7878 0.7758 
                  
RNAi da JF03220 78.80 ± 3.256 1.230 ± 0.0549 8 ANOVA 0.0005 0.1494 
Control -- JF03220 87.64 ± 1.952 1.299 ± 0.0529 8 BMC 0.0428* 0.7259 
Control da -- 70.23 ± 2.159 1.374 ± 0.0530 7 BMC 0.0597 0.1511 
RNAi Mef2 JF03220 78.83 ± 3.929 1.297 ± 0.0456 8 ANOVA 0.1360 0.8995 
Control -- JF03220 95.55 ± 7.820 1.253 ± 0.0870 8 BMC 0.0969 >0.9999 
Control Mef2 -- 
86.73 ± 4.360 1.269 ± 0.0594 
7
-
8 
BMC 
0.6673 >0.9999 
RNAi elav JF03220 79.34 ± 1.632 1.343 ± 0.0291 8 ANOVA 0.0261 0.0564 
Control -- JF03220 78.23 ± 1.540 1.345 ± 0.0394 8 BMC >0.9999 >0.9999 
Control elav -- 70.98 ± 3.025 1.486 ± 0.0613 8 BMC 0.0257* 0.0713 
RNAi repo JF03220 77.84 ± 2.336 1.341 ± 0.0345 8 ANOVA 0.0002 0.8468 
Control -- JF03220 75.51 ± 3.175 1.329 ± 0.0680 8 BMC >0.9999 >0.9999 
Control repo -- 60.51 ± 1.940 1.379 ± 0.0793 8 BMC 0.0002 >0.9999 
   
      
142 
 
Table 5.3. Ubiquitous adulthood expression of one copy of Nos RNAi lines does not consistently alter ethanol 
sedation. 
Groups GS 
Nos RNAi 
Line Vehicle ST50 RU486 ST50 n Statistical test 
Treatmen
t 
RNAi Tub v27722 61.33 ± 2.764 75.41 ± 2.867 8 ANOVA – BMC  <0.0001* 
 RNAi Tub v27722 78.53 ± 4.210 77.27 ± 4.122 3 t-test 0.5367 
        
RNAi Tub GLC01867 32.65 ± 0.814 32.36 ± 1.870 8 ANOVA - BMC >0.9999 
        
RNAi Tub JF03220 54.56 ± 1.197 48.83 ± 1.278 8 ANOVA - BMC 0.1314 
RNAi Tub JF03220 53.31 ± 1.746 48.18 ± 0.641 8 ANOVA - BMC 0.0671 
        
RNAi Tub HMC03067 29.48 ± 1.480 29.89 ± 1.320 8 ANOVA - BMC >0.9999 
RNAi Tub HMC03067 28.81 ± 2.297 31.95 ± 1.085 8 ANOVA - BMC 0.4647 
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5.7. Nos expression during adulthood may be important for normal ethanol 
sedation. Female flies were treated with 1 mM RU486 or vehicle for 6 days before 
determining ethanol sedation with 55% ethanol. (A) Overall, there was an effect of 
genotype, treatment, and an interaction between the factors on ST50 values (two-way 
ANOVA; genotype, p<0.0001; treatment, p=0.0042; interaction, p=0.0391). Flies 
containing one copy of Tub-GS and two copies of Nos RNAi #9, or ubiquitous induced 
expression of Nos RNAi #9, had a significant decrease in ST50 in flies that were treated 
with RU486 compared to vehicle treated, whereas controls (Tub-GS/Tub-GS and Nos 
RNAi #9/Nos RNAi #9) did not have a difference in ST50s compared between RU486 
and vehicle treated flies (*BMC versus vehicle; Tub-GS/Tub-GS, p=0.1977; Nos RNAi 
#9/Nos RNAi #9, p>0.9999; Tub-GS, Nos RNAi #9/Nos RNAi #9, p=0.0035; n=8). (B) 
Genotype significantly altered ST50 values whereas treatment and the factor interaction 
did not (two-way ANOVA; genotype, p<0.0001; treatment, p=0.0993; interaction, 
p=0.1740). There was no difference in ST50 in either controls (Tub-GS/+ and Nos RNAi 
#11/Nos RNAi #11) or flies with induced expression of Nos RNAi #11(Tub-GS, Nos 
RNAi #11/Nos RNAi #11) when comparing RU486 and vehicle treated (BMC versus 
vehicle; Tub-GS/+, p>0.9999; Nos RNAi #11/Nos RNAi #11, p>0.9999; Tub-GS, Nos 
RNAi #11/Nos RNAi #11, p=0.0548; n=8).
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adulthood GeneSwitch expression of two copies of a second Nos RNAi (#11), was 
trending sensitive when treated with RU486 compared to vehicle (Fig. 5.7B, checkered 
bars). Again, there was no difference in ST50s of the driver and Nos RNAi controls 
when treated with either vehicle or RU486 (Fig. 5.7B, first four bars). These data 
suggest that Nos expression, and subsequently NO signaling, specifically during 
adulthood may be important for normal ethanol sedation in the fly.  
As the approach to investigate the tissue of interest was not fruitful when using 
the Nos RNAi lines, we looked determine the answers to these questions by utilizing the 
potential rescue the Nos null, Nos1, phenotype. We obtained three UAS-Nos transgenes 
and determined whether they were able to increase Nos expression. All three lines 
obtained were able to significantly increase relative Nos expression when expressed 
ubiquitously compared to both the driver and their individual UAS-Nos transgene 
controls (data not shown). We moved forward with the UAS-Nos transgene that could 
induce the highest amounts of Nos and the one inducing the lowest amounts of Nos 
(UAS-Nos #1 and UAS-Nos #2, respectively). Next we determined whether expression 
of either of the UAS-Nos transgenes could influence ethanol sedation when expressed 
pan-neuronally. Pan-neuronal expression of UAS-Nos #1 caused a decrease in ST50s 
compared to controls (data not shown), whereas pan-neuronal expression of 
backcrossed UAS-Nos #2 did not cause a consistent difference in ST50s compared to 
controls (Fig. 5.8B). Therefore, backcrossed UAS-Nos #2 was used to determine 
whether the Nos1 ethanol sensitivity phenotype could be rescued. We created a fly 
containing the pan-neuronal Gal4 driver (elav-Gal4) and Nos1 as well as a fly containing 
UAS-Nos #2 and Nos1. Control sedation was determined in flies containing one copy of 
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5.8. Nos overexpression in neurons does not alter ethanol sedation or rescue the 
Nos null ethanol sedation phenotype. Female flies were exposed to 55% ethanol to 
determine ethanol sedation. (A) There was an overall effect of genotype on ST50s but 
not gender or their interaction (two-way ANOVA; genotype, p=0.0259; gender, 
p=0.3319; interaction, p=0.0820). There were no differences in ST50 values in female 
flies (left) pan-neuronally expressing UAS-Nos #2 (red bar) compared to the driver 
control (black bar) or UAS-Nos transgene controls (gray bars). Male flies (right) pan-
neuronally expressing UAS-Nos #2 (red bar) was significantly different from the UAS 
transgene control (gray bar), but not from the driver control (black bar) (*BMC versus 
elav-Gal4/+;UAS-Nos #2/+; elav-Gal4/+, p=0.9141; UAS-Nos #2/+, p=0.0106; n=6). (B) 
Genotype significantly affected ST50s (one-way ANOVA; p=0.0055). Flies containing 
elav-Gal4 and a single Nos1 allele had a significant decrease in ST50 values compared 
to control, w[A], whereas flies containing UAS-Nos #2 and one allele of Nos1 did not 
(*BMC versus w[A]; (4)elav-Gal4/+;Nos1/+, p=0.0090; (4A) UAS-Nos #2, Nos1/+, 
p>0.9999; n=8). (C) Overall, genotype affected ST50 values (one-way ANOVA; 
p<0.0001). Positive control flies ((4)elav-Gal4/+;Nos1/Nos1 and (4A) UAS-Nos #2, 
Nos1/Nos1, gray bars) were sensitive to ethanol compared to control, w[A] (black bar). 
Rescue flies, (4)elav-Gal4/+;(4A)UAS-Nos #2, Nos1/Nos1 (red bar), was also sensitive 
to alcohol compared to control (*BMC versus w[A]; (4)elav-Gal4/+; Nos1/Nos1, 
p<0.0001; (4A) UAS-Nos #2, Nos1/Nos1, p=0.0005; (4)elav-Gal4/+;(4A)UAS-Nos #2, 
Nos1/Nos1, p=0.0001; n=5). 
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the pan-neuronal driver and one copy of Nos1 and of flies containing one copy of UAS-
Nos and one copy of Nos1. In both these control flies, the result anticipated would be no 
differences in ST50s because Nos1 needs to be present in two copies to alter ethanol 
sedation. This was the case for the second control containing the UAS-Nos transgene, 
but not the first control containing the pan-neuronal driver (Fig. 5.8C). The rescue 
experiment was performed, and the two positive control flies (containing two copies of 
the pan-neuronal Gal4 driver and two copies of Nos1 and flies containing one copy of 
UAS-Nos and two copies of Nos1) were significantly sensitive to alcohol compared to 
control as anticipated (Fig. 5.8D, two gray bars versus black bar). The rescue fly, 
containing the pan-neuronal Gal4 driver, UAS-Nos #2, and two-copies of Nos1 had a 
decrease in ST50s compared to control (Fig. 5.8D, red bar versus black bar). These 
data suggest that the reagents used in this study were not capable of answering the 
question at hand, and therefore, the rescue experiment failed.  
To address the mechanism that Nos, and subsequently NO signaling, may be 
influencing ethanol sedation, downstream targets of NO were elucidated via literature 
searches. One of the canonical NO signaling pathways in vertebrates is NO activation 
of soluble guanylyl cyclase (sGC), which has also been demonstrated to occur in 
invertebrates228. We therefore obtained multiple RNAi reagents targeting both the 
guanylyl cyclase α-subunit at 99B and guanylyl cyclase β-subunit at 100B, which are 
specific subunits that make up the conventional sGC in flies231. Broad expression of 
RNAi lines against the subunits of sGC did not alter ethanol sedation (Table 5.4). A 
second set of candidates that could underlie the effect of NO signaling on ethanol 
sedation is E75 and UNF. NO levels mediate the interaction between E75 and UNF to 
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Table 5.4. sGC, a downstream signaling target of NO, does not have consistent evidence for involvement in 
ethanol sedation. 
Groups Gal4 
sGC RNAi 
Line ST50 n 
Statistical 
test P value 
 
RNAi da KK108015 53.80 ± 2.985  ANOVA  <0.0001 
Run with experiment 
HMJ30322 
Control -- KK108015 52.00 ± 1.758  BMC >0.9999 
Control da -- 50.84 ± 3.296  BMC >0.9999 
        
RNAi da HMJ30322 33.53 ± 4.845  ANOVA <0.0001 
Run with experiment 
KK108015 
Control -- HMJ30322 34.10 ± 2.536  BMC >0.9999 
Control da -- 59.00 ± 1.106  BMC 0.0002* 
        
RNAi da JF03176 50.62 ± 3.888 6 ANOVA  0.1085 Run with experiments 
JF03214 & HMC03067 – 
same driver control 
Control -- JF02176 56.98 ± 1.962 6 BMC >0.9999 
Control da -- 57.40 ± 3.948 6 BMC 0.4978 
   
   
  
RNAi da JF03214 50.62 ± 3.888 6 ANOVA 0.1085 Run with experiments 
JF03176 & HMC03067 – 
same driver control 
Control -- JF03214 59.90 ± 1.609 6 BMC >0.9999 
Control da -- 62.65 ± 1.800 6 BMC 0.0192* 
        
RNAi da HMC03067 50.62 ± 3.888 6 ANOVA 0.1085 Run with experiments 
JF03176 & JF03214 – same 
driver control 
Control -- HMC03067 59.08 ± 1.859 6 BMC >0.9999 
Control da -- 58.38 ± 2.591 6 BMC 0.2915 
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switch between axon pruning and regrowth101. Flies broadly expressing a UNF RNAi 
had decreased ST50s compared to the driver and RNAi transgene controls, whereas an 
E75 RNAi had no effect (Fig. 5.9A). When RNAi targeting E75 or UNF was expressed in 
muscles or glia, there was no effect on ethanol sedation in either cases (Fig. 5.9B and 
5.9E). Significantly, pan-neuronal expression of UNF RNAi had decreased ST50s 
compared to controls, but the RNAi targeting E75 did not (Fig. 5.9C). Ethanol sensitivity 
in flies with UNF RNAi expression pan-neuronally was able to be reproduced (Fig. 
5.9D). This data suggests that UNF may be important for ethanol sedation and would be 
a good candidate to study further in regards to being a mechanism underlying NO 
signaling influences on ethanol sedation.  
An additional mechanism of NO signaling is called S-nitrosation. NO has a very 
short half-life of a few seconds232, therefore additional mechanisms are needed to allow 
for NO to be stable for longer periods of time. S-nitrosation is the process of adding NO 
to cysteine thiols of proteins to result in post translation modifications and occurs in both 
vertebrates233 and flies234. This process is highly regulated via S-nitrosoglutathione 
reductase (GSNOR)233 in vertebrates or by the fly ortholog, fdh234. When an Fdh RNAi 
is expressed broadly or pan-neuronally, there is a trend of increased ST50s of the pan-
neuronal expressed Fdh RNAi compared to controls whereas that was not the case for 
the broad expression of the Fdh RNAi (Fig. 5.10A). In a separate experiment, pan-
neuronal expression of the Fdh RNAi had increased ST50s compared to both controls 
(Fig. 5.10B). These results suggest that Fdh, and subsequently S-nitrosation, may be 
important for ethanol sedation and could be a good  
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5.9. Potential candidate mechanisms underlying NO signaling effects on ethanol 
sedation. Female flies were exposed to 55% ethanol in panels A-C and 85% ethanol in 
panels D-E. (A) Genotype played a role in ST50 values (one-way ANOVA; p<0.0001). 
Flies broadly expressing UNF RNAi (da-Gal4/UNF RNAi, red bar) had reduced ST50s 
compared to driver (da-Gal4/+, black bar) and UNF RNAi control (UNF RNAi/+, gray 
bar) (*BMC versus da-Gal4/UNF RNAi; da-Gal4/+, p=0.0039; UNF RNAi/+, p=0.0008). 
Flies broadly expressing E75 RNAi (E75 RNAi/+;da-Gal4/+, red bar) was only different 
from the driver (da-Gal4/+, black bar) control but not its RNAi control (E75 RNAi, gray 
bar) (*BMC versus E75 RNAi/+;da-Gal4/+; da-Gal4/+, p=0.0029; E75 RNAi/+, 
p>0.9999; n=7-8). (B) Genotype played an overall role in ST50 values (one-way 
ANOVA; p<0.0001). Flies expressing UNF RNAi (Mef2-Gal4/UNF RNAi, red bar) in 
muscle had no differences in ST50 when compared to driver (Mef2-Gal4/+, black bar) 
and UNF RNAi control (UNF RNAi/+, gray bar). Flies expressing E75 RNAi (E75 
RNAi/+;Mef2-Gal4/+, red bar) in muscle had a decrease in ST50 compared to the driver 
(Mef2-Gal4/+, black bar) control but an increased ST50 compared to its RNAi control 
(E75 RNAi, gray bar) (*BMC versus E75 RNAi/+;Mef2-Gal4/+; Mef2-Gal4/+, p=0.0069; 
E75 RNAi/+, p=0.0012; n=8). (C) Genotype significantly influenced ST50s (one-way 
ANOVA; p<0.0001). Pan-neuronal expression of UNF RNAi (elav-Gal4/+;UNF RNAi/+, 
red bar) had reduced ST50s compared to driver (elav-Gal4/+, black bar) and UNF RNAi 
control (UNF RNAi/+, gray bar) (*BMC versus elav-Gal4/+;UNF RNAi/+; elav-Gal4/+, 
p<0.0001; UNF RNAi/+, p<0.0001). Flies pan-neuronally expressing E75 RNAi (elav-
Gal4/+;E75 RNAi/+, red bar) had a decreased ST50 value compared to the driver (elav-
Gal4/+, black bar) control, but not its RNAi control (E75 RNAi, gray bar) (*BMC versus 
elav-Gal4/+;E75 RNAi/+; elav-Gal4/+, p<0.0001; E75 RNAi/+, p>0.9999; n=8). (D) 
Reproduction of UNF RNAi expression pan-neuronally, genotype still affected ST50 
values (one-way ANOVA; p=0.0004). UNF RNAi expressed pan-neuronally (elav-
Gal4/+;UNF RNAi/+, red bar) had reduced ST50s compared to driver (elav-Gal4/+, 
black bar) and UNF RNAi control (UNF RNAi/+, gray bar) (*BMC versus elav-
Gal4/+;UNF RNAi/+; elav-Gal4/+, p=0.0033; UNF RNAi/+, p=0.0003; n=8). (E) 
Genotype significantly affected ST50 values (one-way ANOVA; p<0.0001). Flies 
expressing UNF RNAi (repo-Gal4/UNF RNAi, red bar) in all glial cells had no 
differences in ST50 when compared to driver (repo-Gal4/+, black bar) and UNF RNAi 
control (UNF RNAi/+, gray bar). Flies expressing E75 RNAi (E75 RNAi/+;repo-Gal4/+, 
red bar) throughout glia had a decrease in ST50 compared to the driver (repo-Gal4/+, 
black bar) control but no difference when compared to its RNAi control (E75 RNAi, gray 
bar) (*BMC versus E75 RNAi/+;repo-Gal4/+; repo-Gal4/+, p=0.0001; E75 RNAi/+, 
p=0.7590; n=8). 
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Figure 5.10. Second possible mechanism of how NO signaling may influence 
ethanol sedation, via the post-translational modification of S-nitrosation. Female 
flies were exposed to 85% ethanol. (A) Genotype had an overall effect on ST50 values 
(one-way ANOVA; p<0.0001). In both cases, flies expressing Fdh RNAi in either a 
broad manner (da-Gal4/Fdh RNAi, first red bar) or pan-neuronally (elav-Gal4/+;Fdh 
RNAi/+, second red bar) were significantly different from their corresponding driver 
controls (da-Gal4/+ or elav-Gal4, black bars), but not the Fdh RNAi control (Fdh RNAi/+, 
gray bar) (*BMC versus da-Gal4/Fdh RNAi; Fdh RNAi/+, p>0.9999; da-Gal4/+, 
p=0.0018; versus elav-Gal4/+;Fdh RNAi/+; Fdh RNAi/+, p=0.0622; elav-Gal4/+, 
p=0.0040; n=8). (B) Repeat sedation of Fdh RNAi being expressed pan-neuronally, 
genotype had an overall effect on ST50 (one-way ANOVA; p=0.0005). Flies expressing 
Fdh RNAi pan-neuronally (elav-Gal4/+;Fdh RNAi/+, red bar) had an increase in ST50s 
compared to both the driver (elav-Gal4/+, black bar) and the RNAi transgene control 
(Fdh RNAi/+, gray bar) (*BMC versus elav-Gal4/+;Fdh RNAi/+; elav-Gal4/+, p=0.0003; 
Fdh RNAi/+, p=0.0291; n=8). 
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candidate for investigation as to the mechanism of action for NO signaling in ethanol 
sedation.  
 
C. Discussion 
NO is an important molecule with wide-ranging effects on human disease 
states229. Importantly, Nos has been shown to be important in some rodent alcohol-
related behaviors. Specifically, one study found that treatment of rats with NOS 
inhibitors resulted in an increase in the anxiolytic effects of alcohol as demonstrated by 
increased time spent in the open arms of the elevated plus maze103. A second study 
found that treatment of rats with sodium nitroprusside (SNP), a NO donor, caused an 
increase in the development of tolerance during a second day of ethanol exposure104. 
Additionally, in a third investigation, it was found that neuronal Nos (nNos) null mice 
consumed larger amounts of increased concentrations of alcohol and were able to 
recover from doses of alcohol more quickly than their control counterparts by recovering 
faster from the loss of righting105.  
Our studies here demonstrate that Nos may play a role in ethanol sedation in 
flies. Multiple transposon insertion flies were consistent in having an increase in ethanol 
sedation compared to controls. One important note is that the piggyBac transposon 
insertion flies (Nose02671, Nosc01670, and Nosf02469) not only significantly alter Nos gene 
expression, but all significantly influence numerous others genes expression that are 
located near Nos (data not shown). This suggests that the increased ethanol sedation 
seen in these three mutants may not be specific to Nos and could be due to the 
alteration of one of the other genes, or even a combined effect of multiple genes being 
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altered at once. Notably, the results obtained from using the Nos null fly (Nos1), 
demonstrates the role for Nos in ethanol sedation and supports that the results seen in 
the Nos transposon insertion flies is due to Nos expression changes.  
Results using Nos1 suggest Nos may play a role in the development of rapid 
tolerance, but there is a second way of interpreting the data. Nos1 flies are sensitive in 
E1, but have no difference in ST50 during E2. It is possible that whatever effect the null 
mutation in the Nos null caused is specific to the first ethanol exposure, and the effect is 
able to be either ineffective or recovered by the second ethanol sedation. This would 
suggest that the appearance of increased rapid tolerance in Nos1 flies is actually not an 
increase in rapid tolerance, rather the Nos null flies regaining control levels of response 
to alcohol.   
Overall, the use of Nos RNAi lines to investigate the tissue of importance of Nos 
expression was inconclusive. It is possible that there is a specific threshold that Nos has 
to be knocked down to have effects on ethanol sedation and the RNAi lines may not be 
capable of robustly knocking down Nos to these levels. Although Nos RNAi #6, when 
expressed broadly, appears to influence ethanol sedation, it has an off-target prediction. 
It is possible that the effect seen by this RNAi is really due to the alteration of the off-
target gene and not the effect on Nos. Additionally, the RNAi data suggesting Nos may 
not be important for ethanol sedation is because it is plausible we have not targeted the 
correct tissue of importance. The Gal4 driver with broad expression may not have a 
strong enough expression pattern in the tissue of importance for a phenotype to be 
seen.  
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On the other hand, expressing two copies of Nos RNAi lines ubiquitously during 
adulthood did cause a change in ethanol sedation. Not only does this data suggest that 
Nos is important for ethanol sedation, and specifically during adulthood, but gives 
substance to the idea that one copy of an RNAi alone is not causing a robust enough 
knockdown to produce a phenotypic effect. Future experiments would be useful for 
creating double transgenic lines containing more than one copy of an RNAi, more than 
one copy of a Gal4 driver, or further combinations of more copies of RNAi and Gal4 
driver, to potentially increase the Nos knockdown.  
The Nos null rescue experiments did not produce results that are able to be 
interpreted for or against a role of Nos in ethanol sedation. Flies containing the pan-
neuronal driver and only one copy of Nos1 were sensitive to alcohol, suggesting that the 
reagents used were not adequate for the rescue experiment. A fly containing only one 
copy of Nos1 should not have ST50s different from controls (data not shown) because 
two copies of Nos1 is needed to produce changes in ethanol sedation. With this fly 
having an increase in ethanol sedation, the rescue fly containing the pan-neuronal Gal4 
driver, UAS-Nos, and two copies of Nos1 cannot readily be assessed for its ability to 
rescue the null phenotype. Further investigation and production of sufficient Nos 
reagents is needed to address whether Nos1 can be rescued in either a tissue/timing 
specific manner by UAS-Nos.    
The mechanism that NO signaling is influencing to alter ethanol sedation is of 
significance to understand the role of NO in this phenotype. In our studies, the canonical 
signaling pathway, activation of sGC, by NO does not have any support for being 
involved in regulating ethanol sedation responses. This is not to say that sGC is not 
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involved, we just do not have data to support that it does. Two other candidate 
mechanisms, the process of switching between axon pruning and regrowth101 and that 
of posttranslational modifications via S-nitrosation234, could be used for further 
investigation. In both these instances, RNAi expression against key players in the 
pathways resulted in an ethanol sedation effect that would be consistent with the 
ethanol sedation sensitivity seen in Nos Mutant flies. Moreover, additional RNAi lines or 
mutants would be needed to confirm the candidate genes as having a role in ethanol 
sedation. Further investigation, via genetic interaction studies would be important to 
identify whether these candidate mechanisms are indeed regulated by NO to influence 
ethanol sedation.  
These studies suggest that Nos, and NO signaling, play a role in the 
development of normal ethanol sedation in flies. More work is needed to elucidate 
mechanism of action, but it appears that Nos expression during adulthood is important 
for ethanol sedation and would make a good starting point for future investigations. 
157 
 
 
 
 
 
 
6. Discussion 
 
 
 
A. Diet, serotonin, and alcohol-related behaviors in mammals and flies 
Some evidence suggests that serotonin and food consumption are connected 
and that serotonin and alcohol behaviors are connected. To my knowledge, the 
experiments performed in our laboratory are some of the first to address the connection 
between serotonin, food consumption, and alcohol-related behaviors.  
Previous studies have shown that there is an inverse relationship between the 
levels of brain serotonin and food intake in humans235, as well as in Drosophila 
melanogaster. One study found that activation of specific subsets of serotonergic 
neurons in flies resulted in increased food seeking behavior even when fully fed. 
Conversely, when serotonergic neurons were inhibited, flies that were starved did not 
increase their food seeking behavior as would be expected149. Additionally, the authors  
found that different serotonin receptors on different subsets of dopaminergic neurons 
regulate the response of hunger or satiety149. A second group demonstrated that 
activation of a subset of serotonergic neurons in adult flies caused an increase in food 
consumption even when fed150. Furthermore, a third study addressing food consumption 
in larvae, found that the drug Metitepine causes decreased feeding by specifically 
blocking the serotonin 2A receptor148. These studies suggests that there is an effect of 
serotonergic neuron signaling in regulating consumption of food in flies and that the 
different effects and cellular targets may be diverse. Therefore, further investigation is 
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needed to fully understand the role of serotonergic neuron function, and presumably 
serotonin signaling, in fly feeding behaviors.   
The relationship between serotonin and alcohol behaviors has been investigated 
in a few human and rodent studies. In one study, the authors found that a binge drinker 
on a tryptophan low diet undergoes a stress condition (public speaking), they 
experience an increased desire to drink alcohol49. Oppositely, when non-binge drinkers 
intake a tryptophan high diet were exposed to a stressful event, they had an increased 
desire for consumption of alcohol49. Additionally, alcohol dependent rats were treated 
with an inhibitor of the serotonin transporter, fluoxetine or other anti-depressants, and 
the treatment caused a significant decrease in the amount of withdrawal symptoms 
exhibited once the alcohol was removed236. Short term fluoxetine treatment allows for 
an increase in serotonin signaling in the synaptic cleft due to the inhibition of the 
serotonin reuptake transporter located on the presynaptic membrane. Therefore this last 
result suggests that increased serotonin signaling may be able to dampen the effects of 
alcohol withdrawal. In a second rodent study, alcohol dependent rats were treated with 
either Phentermine (a dopamine agonist) or 5-HTP (serotonin precursor) and, when 
given separately, there were no effects on the amount of alcohol withdrawal seizures237. 
When Phentermine and 5-HTP were give together, there was a drastic decrease in the 
amount of rats that had withdrawal seizures and they observed a decrease in these rats 
alcohol consumption237. The authors found that serotonin levels increased with 5-HTP 
and Phentermine + 5-HTP in rat striatal and cortical tissues, dopamine levels did not 
change, but the dopamine metabolite increased suggesting (at least in part) that 
serotonin levels are involved in the decrease in withdrawal seizures and alcohol 
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intake237. In combination, these previous studies in rodents and humans demonstrate 
that there may be a connection between tryptophan levels, serotonin signaling, and 
alcohol dependence/consumption.  
Our results demonstrate recapitulated findings of aspects seen in previous 
literature. We demonstrate that flies consume less volume, but intake more nutrients, 
when on a high yeast media compared to a low yeast media. This increase in nutrients 
is followed by decreased internal ethanol levels and subsequent increases in ST50 
values. When serotonergic neurons are inhibited, by expression of the human Kir2.1 
channel specifically driven by a serotonergic neuron Gal4 driver, there is a blunting of 
the increased nutrient intake effect on flies on a high yeast diet. With the previous 
literature, it is possible serotonin signaling to dopaminergic neurons is part of the 
mechanism for how nutrient intake influences internal ethanol levels and ST50 values. 
Inhibition of dopaminergic neurons in flies would be a beginning place to start 
addressing if they play a role in diet induced ethanol resistance. Secondly, as serotonin 
and dopamine have been implicated in influencing alcohol withdrawal seizures, it 
increases dopaminergic neuron function as a candidate, for being involved downstream 
of serotonin, in our model of diet induced ethanol resistance. 
A second hypothesis that could be used to explain the connection between all of 
these key players (food consumption, serotonin signaling, and alcohol-related 
behaviors) is the role of ADH and ALDH in serotonin metabolism in humans. In humans, 
serotonin is metabolized into 5-hydroxyindole-3-acetaldehyde (5-HIAL) by monoamine 
oxidase (MAO), and under normal conditions, is further broken down into a primary 
metabolite (5-HIAA by ALDH) and secondary metabolite (5-HTOL by ADH)238. When 
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alcohol is consumed, the ratio of serotonin metabolites changes where there is an 
increase in 5-HTOL and a decrease in 5-HIAA levels238. It would be interesting to 
determine whether this switching of the primary serotonin metabolite in the presence of 
alcohol may have to do with the compensatory effects of ALDH and ADH activity 
needed to accommodate alcohol metabolism. The first step of alcohol metabolism is an 
oxidizing reaction while 5-HIAL metabolism is a reduction reaction. This could allow for 
the perfect set of conditions (circular loop of cofactors needed for each reaction) to 
allow for increased enzyme activity of ADH239. The second step of alcohol metabolism, 
via ALDH, and the other half of 5-HIAL metabolism are both oxidative reactions. In this 
case both reactions are requiring NAD+, which may become the limiting reagent and 
could explain why ALDH metabolism of 5-HIAL does not produce the primary metabolite 
when alcohol is consumed239. Subsequently, if this hypothesis were correct, it could 
explain the increase in negative alcohol side effects when 5-HTOL is made the primary 
metabolite238. ALDH would be competing between alcohol and 5-HIAL metabolism, 
potentially making the levels of the intermediate ethanol metabolite (acetaldehyde) to 
increase, thereby increasing negative alcohol side effects. This evidence that serotonin 
levels, either by metabolism as just described or by serotonin reuptake (5-HTTP), in 
combination with the genetic association data could suggest that the composition of diet 
is important for alcohol-related responses in humans. Specifically with serotonin as a 
diet component, leads to a very possible factor for influencing the effects of alcohol and 
subsequently a potential risk factor/mechanism for AUD that could be exploited.  
Flies have many of the key components that would be needed to address this 
hypothesis of alcohol and serotonin metabolism being able to influence alcohol-related 
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responses. The limiting step with using flies is that they, to data, do not have an 
orthologous gene for MAO or a known gene to breakdown serotonin. Figuring out how 
serotonin is broken down, if it is, would need to be elucidated. Recently, a fly gene has 
been discovered that is involved in the degradation of tyramine240, another monoamine. 
Therefore it is possible that flies contain a way to metabolize serotonin. Our results from 
studies in flies (serotonergic neurons being important for consumption of nutrients and 
subsequently altering internal ethanol levels and ST50s) are consistent with this 
hypothesis in humans.  
 
B. Mef2 and its influence in ethanol-related behaviors in flies and humans 
The overarching goal of performing GWAS and taking candidate genes and 
altering them in Drosophila was to explore the possible molecular-genetic underpinnings 
of behavioral responses to alcohol in humans. The ALSPAC sample contained 
phenotypic data, in the form of SRE scores, and genotyping data. We used this 
information to determine whether any genes were associated with SRE scores. Briefly, 
of the candidate genes found from the GWAS, knockdown of Mef2 appeared to be the 
genetic manipulation that most consistently altered ethanol sedation in the same 
direction, but not rapid tolerance, in flies.  
Mammals have 4 members (MEF2A, MEF2B, MEF2C and MEF2D) and are all 
predicted to be transcription factors88, 222 and are involved in numerous biological 
processes (e.g., muscle differentiation90, 91, human disease/cancer92, 93, neuronal 
differentiation94-96, and others). In the ALSPAC SRE gene-based analyses, MEF2B was 
nominally associated (pgene=0.0007), but in another online tool GWAS ATLAS 
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(atlas.ctglab.nl223), there was a small association (p<0.05) between MEF2A, MEF2B, 
MEF2C, and MEF2D and alcohol outcomes. This suggests that MEF2, as a family of 
transcription factors, may play important roles in alcohol behaviors in humans.  
To address the possible downstream mechanism of Mef2 influencing alcohol 
sedation in flies, we utilized a previous study that performed a fly brain Mef2 chromatin 
immunoprecipitation followed by microarray to identify Mef2 targets. The authors 
identified 342 genes with Mef2-dependent expression in flies225. Impressively, fifteen of 
these 342 genes (~3.5-fold more than expected by chance, Table 4.3) were found to  
influence behavioral responses to ethanol in Drosophila. These overlapping genes 
would be a great start for looking at the downstream mechanism of action of Mef2. All 
fly genes listed have multiple reagents available through the Bloomington Drosophila 
Stock Center and/or the Vienna Drosophila Resource Center. It would be an important 
step to first determine the candidate genes ability to alter ethanol sedation using either 
mutants or RNAi lines, determine which genes may fit the hypothesis of being a 
downstream target of Mef2, and then further validation of the reagents. Once this initial 
screen is performed, genetic interaction studies would be needed to confirm their role in 
the Mef2 mechanism responsible for altering ethanol sedation in flies. Furthermore, an 
additional study of interest would be to look into more GeneSwitch reagents to identify a 
neuronal driver that is able to significantly induce transgene expression when treated 
with RU486. This would allow for determining whether Mef2 expression during 
development or adulthood is important for normal ethanol seadation and would help to 
elucidate the downstream mechanism. 
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C. Nitric oxide synthase and nitric oxide signaling in alcohol related behaviors 
NO is small molecule that is able to diffuse across cell membranes, has a short 
half-life, and is implicated in numerous human disease229. There are some rodent 
studies  with evidence suggesting a role for Nos in alcohol-related behaviors in 
mammals103-105. Briefly, our studies in Drosophila support the role for Nos in ethanol 
sedation. Multiple Nos transposon insertion flies and a Nos null fly had increased 
ethanol sensitivity and preliminary adulthood expression of two copies of a Nos RNAi 
line implicate a role of Nos during adulthood to influence this behavior. 
 As specific adulthood expression of Nos appears to be important, of the 
candidate mechanisms we found to influence ethanol sedation, it would be more likely 
that NO signaling is acting via the S-nitrosation pathway and not the E75/UNF axon 
pruning and regrowth developmental pathway. As the E75/UNF axon pathway is a 
developmental process, my data would support the role for a separate mechanism of 
which NO signaling is acting. This is not to say that Nos expression during development 
isn’t important for ethanol sedation, or that the mechanism of NO cannot be via 
E75/UNF signaling. Further studies would need to be performed to rule in or out these 
possibilities. Importantly, S-nitrosation is important for protein function and cell 
signaling229, making this pathway a very attractive target for further investigation. 
 
D. Summary 
 Alcohol abuse is a disastrous disease that affects a significant portion of people 
around the world. Understanding the genetic and environmental factors that influence 
the risk are important for treatment, and prevention of, alcohol dependence, abuse, or 
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alcohol use disorder. Using Drosophila melanogaster as a model, we have found that 
media with increased yeast concentrations cause decreased internal ethanol levels and, 
subsequently, result in ethanol resistance. Our data also suggest a role for serotonergic 
neuron function in regulating nutrient intake on high yeast media, and when inhibited, 
there is a blunting of the yeast-induced ethanol resistant phenotype. Additionally, we 
have demonstrated evidence for both the transcription factor, Mef2, and the gene, Nos, 
as playing roles in ethanol sedation. Further elucidation of their mechanisms, and more 
information on serotonergic neuron function and nutrient intake, would allow for 
potential development of new therapies where both diet and drug treatments could be 
used. This would potentially allow for enhanced recovery for people suffering from 
alcohol abuse. 
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A. Abstract 
 
 
 
Although the Drosophila melanogaster (fly) model is a popular platform for 
investigating diet-related phenomena, it can be challenging to measure the volume of 
agar-based food media flies consume. We addressed this challenge by developing a 
dye-based method called Consumption-Excretion (Con-Ex). In Con-Ex studies, flies 
consume solid food labeled with dye, and the volume of food consumed is reflected by 
the sum of the dye inside of and excreted by flies. Flies consumed-excreted measurable 
amounts of FD&C Blue No. 1 (Blue 1) and other dyes in Con-Ex studies, but only Blue 1 
was readily detectable at concentrations that had no discernable effect on consumption-
excretion. In studies with Blue 1, consumption-excretion (i) increased linearly with 
feeding duration out to 24 h at two different laboratory sites, (ii) was sensitive to 
starvation, mating status and strain, and (iii) changed in response to alteration of media 
composition as expected. Additionally, the volume of liquid Blue 1 consumed from 
capillary tubes was indistinguishable from the volume of Blue 1 excreted by flies, 
indicating that excreted Blue 1 reflects consumed Blue 1. Our results demonstrate that 
Con-Ex with Blue 1 as a food tracer is a useful method for assessing ingestion of agar-
based food media in adult flies.   
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B. Introduction 
 
The fruit fly (Drosophila melanogaster) has emerged as a powerful model for 
investigating the effects of diet on both physiological and disease-like states. Studies in 
flies have revealed that diet has substantial effects on lifespan 177, 182, 241-243, egg-laying 
157, metabolism 184, fat deposition 183, perceived nutritional value of food 147, food choice 
244, sleep 175 and a host of other phenotypes 169, 170, 176-182, 245-255. Flies are housed on 
solid, agar-based media for days at a time in most laboratory studies. Unfortunately, it 
can be challenging to determine the volume of media flies consume under routine 
housing conditions 256. This lack of clarity greatly undermines the causal connections 
that can be drawn between diet, dietary intake and physiological measures in the fly 
model. 
Approaches for measuring solid food consumption in flies have been described. 
Methods that rely solely on the accumulation of internal dye consumed from fly food can 
be highly problematic because the internal dye signal quickly plateaus with time 165. 
Other previously described approaches record the proportion of flies extending the 
proboscis (mouth parts) into the food 257 or the proportion of flies feeding on food 258. A 
limitation of these two other approaches is that it is unclear if proboscis extension into 
food media or the proportion of flies feeding on food media equates with the volume of 
media consumed. Another method called FlyPAD determines feeding behavior in 
individual flies based on their interaction with solid food medium 259. This highly 
sophisticated method quantifies a number of key parameters associated with feeding in 
flies, but was not designed to measure consumption of solid food media under routine 
laboratory conditions. 
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 Arguably the most promising approach for measuring solid food intake in flies 
under typical housing conditions described to date quantitates the consumption of 
dietary media labeled with a radioactive tracer. Studies using this approach revealed 
that mated females consume more media than virgin females 260, demonstrated 171 or 
confirmed 165 that flies adjust their intake of solid media to compensate for changes in 
nutrient concentrations, and that RU486 (the steroid inducer in a frequently used 
conditional expression strategy in flies 70, 261) reduces food consumption 252. 
Unfortunately, the prospect of radioactive flies being inadvertently released from a 
laboratory makes this approach impractical for some users. Additionally, the radioactive 
chemicals (e.g. leucine, ATP, CTP, etc.165, 171, 260) used in this approach must be 
metabolized and then incorporated into long-lived molecules within the fly to be 
detected. The requirement for metabolism and macromolecular incorporation, two 
processes that might change in response to altered dietary composition, is a potential 
confound for using radioactive tracers to measure ingestion of food media.  
Here, we report the development of a dye-based method called Consumption-
Excretion (Con-Ex) for assessing solid food intake in flies. Flies in Con-Ex studies 
consume solid media labeled with FD&C Blue No. 1 for hours to days at a time. The 
amount of food media consumed is reflected by the sum of the dye inside flies and the 
dye excreted from flies. Our studies show that Con-Ex is suitable for detecting the 
effects of starvation, fly strain, mating status and changes in the composition of the diet 
on media intake. Additionally, our studies show that Con-Ex has utility in multiple 
laboratory environments. Con-Ex is technically straightforward, inexpensive, and 
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requires equipment found in virtually any laboratory. The Con-Ex method should be 
suitable for assessing consumption of solid food media in flies in a wide range of 
laboratories, especially those in which the use of radioactive food labels might be 
challenging. 
 
C. Results 
The goal of these studies was to develop and validate a simple, reliable, 
inexpensive method for measuring consumption of solid food medium in Drosophila. 
Several related ideas influenced the method we developed: (1) many inexpensive food 
dyes are commercially available; (2) when flies consume food medium labeled with dye, 
accumulation of dye inside flies plateaus over time because dye intake is quickly 
balanced by excretion of the dye as waste 165; (3) dye in excreted waste should 
accumulate over time within vials in which flies are housed; and (4) at the conclusion of 
a feeding experiment, the sum of the dye found inside flies and the dye excreted from 
flies should reflect food intake. Considering these ideas, we developed the 
Consumption-Excretion (Con-Ex) method. Major experimental steps in Con-Ex studies 
include (i) placing adult flies in empty food vials containing a single removable feeder 
cap that contains solidified food medium labeled with dye (Figs. 7.1A, 7.1B); allowing 
flies to consume food from the feeder caps and excrete waste in the vials for prescribed 
periods of time (Fig. 7.1C); (iii) at the conclusion of food exposure, extracting the dye 
inside flies (Internal dye, INT) and the excreted dye (ExVial, ExMedium) (Fig. 7.1D); (iv) 
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Figure 7.1. Con-Ex experimental process. Agar-based food medium containing dye 
(dissolved in media prior to solidifying) was poured into plastic feeder caps (Fig.  1A) 
and allowed to cool at room temperature to solidify, placed in a humidified plastic box, 
and stored at 4 °C overnight. The following day, feeder caps containing media were 
warmed to room temperature for 1 h, inverted and placed in the open end of vials 
containing adult flies (Fig. 1B). The feeder caps used in these studies hold ~4.5 mL of 
medium (many-fold more than flies consume), have flanges that prevent them from 
falling into the vials and fit in the vials used so that condensation does not build-up, 
yet flies cannot escape. Adult flies (typically 15/vial, but see Fig. 6) in the vials 
consumed medium from the feeder caps (the only food source) and then excreted 
waste over time (Fig. 1C). A single feeder cap was used in each vial over the duration 
of each experiment. Feeder caps were discarded at the conclusion of feeding 
(Fig. 1D). The dye inside the flies (internal dye, INT) was collected via 
homogenization of animals in 1.5 ml of water followed by centrifugation to pellet 
debris. The dye excreted by flies on the walls of the vials (excreted vial dye, ExVial) 
was collected by addition of 3 ml of water to vials followed by vortexing (Fig.  1D). 
Absorbance of the INT and ExVial dye in water extracts was determined in a 
spectrophotometer (Fig. 1E) at wavelengths appropriate for each dye. Absorbance 
values were converted to volumes of medium consumed by interpolation from 
standard curves of pure dyes (Fig. 1F). Extracts of flies fed medium without dye 
controlled for background absorbance.  
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quantitating the dye in these extracts via spectrophotometry (Fig. 7.1E); (v) converting 
the dye absorbance to volume via interpolation from standard curves of pure dye (Fig. 
7.1F); and calculating the consumed-excreted volume of media (Fig. 7.1G). See Table 
7.1 for definitions of all measures. 
We initiated our Con-Ex studies by identifying a suitable dye (and its 
concentration) and then validated the method in a number of ways including (i) 
determining whether it could detect the effects of feeding duration, genetic background, 
starvation and media composition on food intake, (ii) exploring whether the method 
works in multiple laboratories, and (iii) determining whether consumed dye equated with 
excreted dye.  
 
Identification of dyes and appropriate fly density for Con-Ex 
To identify dyes suitable for Con-Ex studies, we provided flies (r[A], a standard 
control strain in the Grotewiel laboratory) with food containing 1% w/v of several 
different dyes for 24 h and then assessed the signal to noise (i.e. absorbance of 
ExVial+INT dye divided by the background absorbance). The dyes FD&C Blue No. 1, 
xylene cyanol and FD&C Red 40 (Fig. 7.2A), as well as the dyes FD&C Blue No. 2, 
FD&C Red 4 and FD&C Yellow 5 (Fig. 7.2B) all had significantly greater signal than 
noise. Based on their large signal to noise ratios and the absolute magnitudes of their 
signals, we chose to further explore the utility of FD&C Blue No. 1 (Blue 1), xylene 
cyanol (XC) and FD&C Blue No. 2 (Blue 2) in Con-Ex studies. The other dyes tested 
(Red 40, Green 5, Red 4, Red 6 and Yellow 5) might have had smaller signals in Con- 
199 
 
 
  
200 
 
 
Figure 7.2. Signal-to-noise for candidate food dyes in Con-Ex. Data are the 
summed absorbance values of INT + ExVial. Dye (simple filled bars): absorbance 
values from flies fed media containing 1% of the indicated dyes (signal). No Dye 
(hatched bars): absorbance values from flies fed media without dye (noise). Control 
r[A] female flies (20/vial) consumed media and excreted waste products in vials for 
24 h. Numbers in brackets indicate signal-to-noise ratios. Signal (Dye) was greater 
than noise (No dye) in experiments with (panel A) Blue 1, xylene cyanol (XC) and 
Red 40, and (panel B) Blue 2, Red 4 and Yellow 5 (*individual two-tailed t tests, 
p = 0.007 to <0.0001, n = 5–6). 
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Ex studies because they are aversive tastants, are metabolized after being consumed, 
have pharmacological properties that suppress medium consumption or excretion, or 
other reasons and were not considered further. 
Ideally, the food tracers used in a feeding method should not significantly 
influence consumption of the media being consumed. To determine if Blue 1, XC or 
Blue 2 satisfied this criterion, we fed flies increasing concentrations of the dyes in either 
our standard fly medium (2% yeast, 10% sucrose, 3.3% cornmeal, 1% agar and 
antimicrobials (hereafter 2Y10S3C), Figs. 7.3A, 7.3C, 7.3E) or in a medium containing 
1% agar only (Figs. 7.3B, 7.3D, 7.3F). We reasoned that using two different media 
might reveal food × dye interactions (i.e. food-dependent effects of dye). Note that 
unless indicated otherwise we hereafter report the volume of dyed media consumed 
determined from interpolation of standard curves of pure dye. 
The concentration of Blue 1 (0.25-2% w/v) in either 2Y10S3C (Fig. 7.3A) or agar-
only media (Fig. 7.3B) had no effect on the sum of INT and ExVial dye, consistent with a 
previous report showing that Blue 1 does not impact consumption 165. The dose-effects 
of the other dyes were more complex. Consumption-excretion of 2Y10S3C was not 
affected by 0.25-2.0% XC (Fig. 7.3C), but this dye dose-dependently decreased 
consumption-excretion of media made with agar only (Fig. 7.3D). In contrast, increasing 
concentrations of Blue 2 increased consumption-excretion of both 2Y10S3C (Fig. 7.3E) 
and agar-only media (Fig. 7.3F). Since changes in consumption-excretion driven by  
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Figure 7.3. Effect of dye concentration on Con-Ex. Control r[A] females consumed 
2Y10S3C (A,C,E) or media containing only 1% agar (B,D,F) with the indicated 
concentrations of Blue 1 (A,B), xylene cyanol (XC, panels C,D), or Blue 2 (E,F). Flies 
consumed media and excreted waste in the vials for 24 h. ExVial + INT dye was not 
affected by the concentration of Blue 1 in 2Y10S3C (A) or agar-only media (B) 
(individual one-way ANOVAs; 2Y10S3C, p = 0.2255; agar-only medium, p = 0.1533; 
n = 8–20 in panel A and 8 in panel B). ExVial + INT dye was not affected by the 
concentration of xylene cyanol in 2Y10S3C (C, one-way ANOVA, p = 0.0839, n = 16), 
but increasing concentrations of xylene cyanol in agar-only media decreased 
ExVial + INT dye (D; one-way ANOVA, p < 0.0001, n = 8). The concentration of Blue 2 
in 2Y10S3C (E, one-way ANOVA, p < 0.0001, n = 16) and agar-only media (F, one-
way ANOVA, p < 0.0001, n = 16) significantly increased ExVial + INT dye. Asterisks 
indicate significantly different pair-wise groups in D,E and F (*Bonferroni’s multiple 
comparisons, p = 0.0493 to <0.0001). 
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food tracers such as XC and Blue 2 could be a significant experimental confound, we 
focused all subsequent studies on Blue 1. 
To identify the appropriate density of animals to use in Con-Ex studies, we varied 
the number of flies/vial during 24 h feeding experiments. ExVial+INT measured with 
Blue 1 was comparable when 10-20 flies per vial were used, but it decreased 
significantly with 30 flies per vial (Fig. 7.4). Although we do not understand why 
consumption-excretion per fly decreased as the density of animals increased, these 
results indicate that using a consistent number of flies, and 20 or fewer flies, is an 
important practical consideration in Con-Ex studies with Blue 1 as a tracer under the 
conditions used in these experiments. 
 
Con-Ex time-course studies under different laboratory conditions 
The data in Figs. 2, 3 and S1 are from experiments in which flies consumed-
excreted media for 24 h. To address how the duration of Con-Ex studies influenced the 
results, we performed time-course experiments with Blue 1 as a food label using r[A] 
(Fig. 7.5A) and Canton-S (Fig. 7.5B) females. Importantly, the data in Figs. 7.5A and 
7.5B were generated in the Grotewiel and Pletcher laboratories, respectively. In both 
studies, the amount of INT Blue 1 plateaued or peaked by 4 (Fig. 7.5A) or 12 (Fig. 7.5B) 
hours after the initiation of feeding. There was an initial lag in appearance of ExVial Blue 
1 (Fig. 7.6A and 7.6B), but thereafter the amount of ExVial dye accumulated with time 
(Fig. 7.5). ExVial and ExVial+INT dye accumulation approximated linear functions in 
both r[A] and Canton-S females (linear regression; R2 = 0.8330 to 0.9387; p<0.0001 in 
all cases). The quantitative differences between the results in Figs. 7.5A and 7.5B are   
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Figure 7.4.Fly density in Con-Ex. Control r[A] females at the indicated number/vial 
consumed 2Y10S3C with 1% Blue 1 for 24 h while excreting waste. The density of flies 
significantly influenced ExVial+INT (one-way ANOVA, p<0.0001, n=16). ExVial+INT 
was lower in flies housed in groups of 30/vial than other groups (*Bonferroni’s multiple 
comparison test, p=0.0010 to <0.0001), but was not different in groups of 10 and 20 
flies (Bonferroni’s multiple comparison, p=0.9255).  
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Figure 7.5. Con-Ex time-courses. Control r[A] (A) and Canton-S (B) females 
consumed medium labeled with 1% Blue 1 and excreted waste for the indicated times 
(X-axes). Data are INT, ExVial and ExVial + INT from the Grotewiel (A) and Pletcher 
(B) laboratories. Time influenced INT and ExVial (one-way ANOVAs; panel A, 
p < 0.0001; panel B, p < 0.0001; n = 8 at each time-point). 
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Figure 7.6. Early time-points of INT and ExVial. Detailed view of early time-points 
from the data in Fig. 7.5. 
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presumably driven by differences in environment including food media, strain and age of 
the animals (see Methods). Our results with different strains and ages of flies reared 
under different conditions suggest that accumulation of consumed-excreted Blue 1 can 
be measured out to 24 or possibly 48 h without major concerns regarding ceiling effects, 
that consumption of Blue 1 precedes its excretion, and that the Con-Ex method works 
well in different laboratories. 
 
Detecting strain, starvation, mating status and media composition effects 
To address the ability of the Con-Ex method to detect differences across fly 
strains, we assessed 24 h consumption-excretion in control r[A] and control Lausanne-S 
(LS) females fed 2Y10S3C medium. ExVial+INT in LS flies was ~twice that of r[A] (Fig. 
7.7A), indicating that the Con-Ex method can readily detect the effects of strain (genetic 
background in this case) on consumption of food media. There was no difference in 
total body weight of r[A] and LS females (0.939±0.004 and 0.991±0.026 mg, 
respectively; t test, p=0.076; n=8) and therefore the differences in Con-Ex between 
these two strains in unrelated to body size. Although the effects of genetic background 
on Drosophila feeding behavior are widely appreciated (e.g. 165), the difference in Con-
Ex between the r[A] and LS strains we report is novel. 
A period of starvation in flies increases their consumption of liquid food media 175, 
244, 262, 263. To determine whether starvation increases consumption of solid media, we 
compared 4 h consumption-excretion in fully fed and starved flies. We assessed   
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Figure 7.7. Genetic background, starvation and mating influence Con-Ex. 
Control females were fed 2Y10S3C containing 1% Blue 1 for 24 h (A,C) or refed this 
medium for 4 h (B). ExVial + INT was significantly greater in LS compared to r[A] (A; 
*two-tailed t test, p < 0.0001, n = 8), was greater in starved compared to fully fed r [A] 
females (B; *two-tailed t test, p < 0.0001, n = 8), and was greater in mated compared 
to virgin r[A] females (C; *two-tailed t test, p < 0.0001, n = 10). 
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consumption-excretion at 4 h (as opposed to a more typical 24 h) in these studies 
because the effects of starvation might wane once flies return to a fully fed state. Prior 
starvation substantially increased consumption-excretion of media labeled with Blue 1 in 
r[A] females (Fig. 7.7B). Con-Ex studies are therefore capable of detecting the 
consequences of short-term starvation on refeeding in flies. 
Mated females consume more solid food media than virgin females when 
consumption is measured by a radioactive tracer 165. To assess the utility of Con-Ex for 
detecting the effect of mating status on medium consumption, we compared 24 h 
consumption-excretion in mated and virgin females. Mated females consumed-excreted 
more medium than virgin females (Fig. 7.7C) in Con-Ex as expected 165. 
Flies exhibit compensatory feeding (i.e. an increase in the volume medium 
consumed as the concentration of nutrients is decreased 165, 171). As expected, 
decreasing the concentration of all components of 2Y10S3C (1.0X) medium to 0.25X 
led to an increase in ExVial+INT (Fig. 7.8A). Furthermore, increasing the concentration 
of yeast from 2% to 30% or increasing the sucrose concentration from 10% to 30% 
significantly reduced ExVial+INT (Figs. 7.8B and 7.8C, respectively). Increasing the 
concentration of corn meal from our standard 3.3% to 10% (the practical maximum), 
however, did not significantly alter ExVial+INT (Fig. 7.8D). Taken together, the data in 
Fig. 7.8 indicate that Con-Ex studies with Blue 1 can detect the expected changes in 
feeding behavior in response to alteration of food media composition. Our results also 
suggest that flies  
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Figure 7.8. Composition of food media influences Con-Ex. Control r[A] females 
consumed the indicated media labeled with 1% Blue 1 and excreted waste for 24 h. 
ExVial + INT was greater in flies that consumed 0.25X medium than in flies fed 
1.0 × 2Y10S3C medium (panel A, *two-tailed t test, p < 0.0001, n = 16), in flies fed 
medium containing 2% yeast (2Y10S3C) compared to 30% yeast (30Y10S3C) (panel 
B, *two-tailed t test, p < 0.0001, n = 8) and in flies fed medium containing 10% 
sucrose (2Y10S3C) compared to 30% sucrose (2Y30S3C) (panel C, *two-tailed t test, 
p = 0.0003, n = 8). (D) ExVial + INT was indistinguishable in flies fed medium 
containing 3% cornmeal (2Y10S3C) and 10% cornmeal (2Y10S10C) (two-tailed t test, 
p = 0.2532, n = 8).position of food media influences Con-Ex. Control r[A] females 
consumed the indicated media labeled with 1% Blue 1 and excreted waste for 24 h. 
ExVial + INT was greater in flies that consumed 0.25X medium than in flies fed 
1.0 × 2Y10S3C medium (panel A, *two-tailed t test, p < 0.0001, n = 16), in flies fed 
medium containing 2% yeast (2Y10S3C) compared to 30% yeast (30Y10S3C) (panel 
B, *two-tailed t test, p < 0.0001, n = 8) and in flies fed medium containing 10% 
sucrose (2Y10S3C) compared to 30% sucrose (2Y30S3C) (panel C, *two-tailed t test, 
p = 0.0003, n = 8). (D) ExVial + INT was indistinguishable in flies fed medium 
containing 3% cornmeal (2Y10S3C) and 10% cornmeal (2Y10S10C) (two-tailed t test, 
p = 0.2532, n = 8). 
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might alter their dietary consumption in response to changes in some (yeast and 
sucrose), but not all (cornmeal), food components. 
 
Coupling of CAFE and Con-Ex to assess Blue 1 as a tracer for consumption 
The capillary feeding (CAFE) assay has been used extensively to measure 
consumption of liquid diets in flies 67, 165, 175, 244, 262. We coupled CAFE and Con-Ex 
methods in a single experimental design to address whether the volume of Blue 1 
excreted might reflect the amount of Blue 1 consumed. In pilot studies, we found that 
flies consuming liquid media (labeled with Blue 1) from capillary tubes excreted on both 
the vial wall and the foam plug holding the capillary tubes (not shown, but see below). 
Importantly, Blue 1 applied directly to foam plugs can be collected and quantitated (Fig. 
7.9A), thereby allowing it to be measured as part of the excreted dye signal. 
Additionally, while flies fed medium containing Blue 1 have readily detectable INT dye 
after 24 h of access to the medium, flies contain no detectable INT dye 24 h after being 
switched to medium without dye (Fig. 7.9B). We therefore performed CAFE-excretion 
studies in which flies were provided access to liquid 5% sucrose media containing Blue 
1 in capillary tubes for 8 h (to measure the amount of labeled media they consumed and 
also allow excreted dye to begin accumulating) and then were switched to capillary 
tubes containing liquid medium without dye for 24 h (to allow INT dye from prior 
consumption to be excreted). We used both fed and starved flies to generate a range of 
liquid medium consumption and excretion in these experiments in anticipation of 
correlation analyses (Fig. 7.10B). 
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Figure. 7.9. Methodological background for measuring excretion on foam plugs 
and food medium. (A) The amount of Blue 1 recovered from foam plugs were 
indistinguishable from the volume added (individual one sample t tests, p=0.2829 to 
0.9999, n=3). (B) INT in r[A] females that had consumed dyed food for 24 h (24 h dye) 
was significantly greater than in flies after subsequently consuming media without dye 
for an additional 24 h (24 h dye -> 24 h no dye) (*two-tailed t test, p 24 h no dye flies 
was not distinguishable from zero (one sample two-tailed t test, p=0.2518). (C) The 
volume of Blue 1 extracted from the food medium in feeder caps was indistinguishable 
from the volumes added to the surface of the medium (individual one sample t tests, 
p=0.2607 to 0.4577, n=4).  
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Figure 7.10. CAFE consumption of Blue 1 equates with excretion of Blue 1.  (A) 
In control r[A] females, the volume of liquid medium consumed from capillary feeders 
(CAFE) and excreted (ExVial + ExPlug) was significantly increased by starvation, but 
the two measures were statistically indistinguishable (two-way ANOVA; starvation, 
p < 0.0001; measure, p = 0.5302, interaction, p = 0.3537; n = 18–24 per group). (B) 
Additional analysis of the data in panel A. The volume of liquid medium consumed 
from capillary feeders (CAFE) correlated with ExVial, ExPlug and ExVial + ExPlug 
(Pearson correlations: R2 = 0.6573, R2 = 0.8165, R2 = 0.9539, p < 0.0001 for all, 
n = 42). Lines are best-fit linear regressions. 
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Previously fed flies consumed little liquid medium from capillary tubes while 
starved flies consumed considerably more as expected given the relatively short feeding 
period employed (Fig. 7.10A). Flies excreted a substantial amount of dye on the vial 
walls (ExVial) and on the foam plugs (ExPlug) (Fig. 7.10A). The amount of Blue 1-
labeled liquid medium consumed by flies (CAFE) was indistinguishable from the amount 
of Blue 1 excreted (ExVial+ExPlug) in both fed and starved flies (Fig. 7.10A). 
Additionally, the amount of liquid Blue 1 consumed from capillary tubes (CAFE) 
correlated with (i) ExVial+ExPlug, (ii) ExVial and (iii) ExPlug (Fig. 7.10B). The volume of 
Blue 1 excreted therefore reflects, and is potentially equivalent to, the volume of Blue 1 
consumed by flies under the conditions used in these studies. 
 
Con-Ex in males 
The results reported in Figs. 7.2-7.10 are from studies using females. We 
therefore performed an additional set of experiments to address whether Con-Ex is 
similarly suitable for studies in males. INT dye plateaued quickly and ExVial as well as 
ExVial+INT accumulated in a largely linear fashion out to ~48 h in both in r[A] and 
Canton-S males (Fig. 7.11A, Grotewiel lab; Fig. 7.11B, Pletcher lab). Additionally, 
ExVial+INT was greater in LS compared to r[A] males (Fig. 7.11C) and starvation 
increased ExVial+INT in r[A] males (Fig. 7.11D). The results from males and females 
are qualitatively similar overall, indicating that Con-Ex is suitable for studies in both 
sexes.  
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Figure 7.11. Targeted Con-Ex studies in males. (A and B) Time-dependent 
accumulation of INT, ExVial and ExVial+INT in r[A] (A, Grotewiel laboratory) and 
Canton-S (B, Pletcher 2 laboratory). ExVial and ExVial+INT increased in a linear fashion 
with time (p<0.0001, R2 =0.8450-0.9108, n=7-8 per time-point). (C) ExVial+INT was 
greater in LS compared to r[A] males (two-tailed t test, p<0.0001, n=8). (D) Starvation 
increased ExVial+INT in r[A] males (two-tailed t test, p<0.0001, n=8). 
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Excretion of dye on the food medium 
In addition to INT and ExVial dye, we anticipated that flies in Con-Ex studies 
would excrete dye on the food medium (excreted on medium, ExMedium). To address 
this possibility, we fed control flies 2Y10S3C food labeled with Blue 1 for 4 h (vial 1) and 
transferred the dye-fed flies to new vials containing feeder caps with medium without 
dye (vial 2). Flies then excreted the previously consumed dyed media for 24 h in vial 2 
and we collected the resulting ExVial and ExMedium dye. Importantly, flies excreted the 
vast majority (if not all) of the Blue 1-labeled contents of their gastrointestinal tract in 24 
h (Fig. 7.9B) and Blue 1 added to the surface of the food medium in feeder caps was 
readily recovered by water extraction (Fig. 7.9C). 
When provided with 2Y10S3C medium, control r[A] and LS females excreted 
comparable percentages of waste dye on the food medium (ExMedium %, Fig. 7.12A). 
Interestingly, whereas diluting 2Y10S3C medium to 0.25X had no effect on ExMedium 
%, increasing the yeast concentration to 30% led to an increase in ExMedium % (Fig. 
7.12B). Additionally, increasing the sucrose concentration to 30% and increasing the 
cornmeal concentration to 10% both decreased ExMedium % (Figs. 7.12B and 7.12C). 
The simplest interpretation of these data is that ExMedium % might not vary 
substantially across control strains fed the same diet, but it is influenced by media 
composition. 
The most comprehensive approach when using Con-Ex would in principle be to 
measure INT, ExVial and ExMedium simultaneously. This is unfortunately impossible 
when using a single food tracer because the medium must be labeled to track it, the   
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Figure 7.12. Excretion on the food medium in Con-Ex. Data are percentage of excreted 
dye found on the food medium. (A) The percentage of dye on 2Y10S3C medium (ExMedium 
%) was indistinguishable in r[A] and LS females (two-tailed t test, p = 0.5738, n = 8). (B) Food 
medium composition influenced ExMedium % (one-way ANOVA, p < 0.0001, n = 6–10). 
Compared to 2Y10S3C, ExMedium % was significantly greater on 30Y10S3C (*Bonferroni’s 
multiple comparison, p = 0.0366) and lower on 2Y30S3C (*Bonferroni’s multiple comparison, 
p = 0.0009. (C) ExMedium % was lower on 2Y10S10C than on 2Y10S3C (*two-tailed t test, 
p < 0.0001, n = 8).  
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flies must have physical access to the medium to consume it and access to the medium 
allows flies to deposit waste products on the already labeled medium. Given this 
experimental limitation, we explored whether including ExMedium measurements was 
necessary to detect changes in consumption-excretion by reanalyzing the data in Figs. 
7.3A, 7.4, 7.5A, 7.7A, and 7.8A-D (data from experiments in which the relevant 
measurements were made). In these analyses, we calculated the adjusted volume 
excreted in the vial (ExAdj) as ExVial x [1/(1-fraction ExMedium)] (the final bracketed 
term accounts for the fraction of dye on feeder caps). In addition to ExMedium, we also 
explored whether including INT had a substantial impact on Con-Ex data interpretation. 
Using the results of 8 independent studies shown in Figs. 7.3A, 7.4, 7.5A, 7.7A, 
and 7.8A-D, we performed a total of 19 statistical tests on the four different measures: 
ExVial alone, ExAdj alone, ExVial+INT and ExAdj+INT (Table 7.3). Note that due to low 
dye signal from groups with low dye concentrations (Fig. 7.3A), lower number of flies 
(Fig. 7.4) and after shorter periods of feeding (Fig. 7.5A), determining ExMedium in 
these studies was not possible and consequently we assumed that ExMedium (and 
therefore the calculation of ExAdj) was not affected by dye concentration, the number of 
flies per vial or time on the medium. In 17 of 19 tests, the statistical outcomes were 
indistinguishable across all four measures (Table 7.3). Of the two cases in which the 
statistical tests were not consistent across the four measures, one involved the percent 
change at early time-point in time-course studies during which INT is a substantial 
fraction of the total dye measured (Table 7.3, Fig. 7.5A, Bonferroni’s: 1-4 h) and the 
other involved a food medium with the highest practical concentration of cornmeal which  
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influences ExMedium and therefore ExAdj (Table 7.3, Fig. 7.8D, two-tailed t test). 
Importantly, the percent changes in ExVial, ExAdj, ExVial+INT and ExAdj+INT were 
highly correlated, comparable in size, and in the same direction in virtually all cases 
(Table 7.3). Our reanalysis suggests that INT and ExMedium do not contribute 
significantly to interpretations in many cases and therefore that measuring ExVial alone 
might be sufficient to detect major changes in Con-Ex in most studies. 
 
Con-Ex power analyses  
An important consideration regarding the utility of any experimental method is the 
number of replicates that must be performed to detect differences of varying magnitude 
(i.e. power). Using the average standard deviations for ExVial, ExAdj, ExVial+INT and 
ExAdj+INT derived from 23 experiments with control r[A] females, we found that all four 
measures had similar power to detect differences between groups (Fig. 7.13), 
consistent with the statistical reanalysis of these four measures (Table 7.3). Additionally, 
we found that 30%, 20% and 10% differences between two mean values can be 
detected at 80% power in Con-Ex studies with 4-6, 8-11 and 30-50 replicates, 
respectively (Fig. 7.13). Detection of differences of 20% or greater in Con-Ex studies 
therefore requires a reasonable number of replicates to be performed. The number of 
replicates required to detect differences in Con-Ex appears comparable to CAFE, but 
greater than when using radioactive methods 165. 
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Figure 7.13. Power analysis of Con-Ex data. Data are the N required (number of 
replicates in each of two groups; X-axis) to detect the indicated % changes between the 
means of the two groups (Y-axis) using an unpaired two-tailed t test with 80% power 
when measuring ExVial, ExAdj, ExVial+INT and ExAdj+INT based on average standard 
deviations for the four measures of 0.058, 0.076, 0.057 and 0.081 μl/fly/d, respectively. 
The number of replicates required to detect 30%, 20% and 10% differences between 
means are indicated by arrows. 
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D. Discussion 
Despite the growing interest in studies on diet in flies, it is often very challenging 
to determine the amount of dietary media consumed when flies are housed on solid, 
agar-based food 256. We developed Con-Ex as a dye-based method for determining 
intake of solid media in Drosophila. Flies are provided continuous access to agar-based 
media for hours to days at a time in Con-Ex studies, mimicking routine fly housing 
conditions. Flies in Con-Ex studies consume food media labeled with dye and then 
excrete dyed waste throughout their environment within the vial for the duration of the 
experiment. Of the dyes that we tested in Con-Ex experiments, FD&C Blue No. 1 is the 
only dye that has a strong absorbance signal, has reasonably low background noise, 
and does not influence media consumption. Con-Ex studies with Blue 1 detect the 
predicted influences of feeding duration, strain, starvation, mating status and food 
composition on media ingestion. Additionally, the volume of Blue 1 consumed in liquid 
medium is comparable to, if not identical to, the volume of excreted Blue 1.  
Furthermore, Con-Ex data generated in the Grotewiel and Pletcher laboratories 
were qualitatively similar. Our studies indicate that Con-Ex with Blue 1 as a food tracer 
is useful for assessing solid media consumption in adult flies. Identifying additional food 
dyes, particularly dyes that have distinct detection requirements (i.e. dyes with 
absorbances that do not interfere with the detection of Blue 1) would be valuable, for 
example, in studies aimed at measuring concurrent consumption-excretion of different 
media, experiments that require a specific absorbance spectrum due to interference by 
a transgenic marker, etc. Labeling food with fluorescent tracers like rhodamine B or 
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fluorescein 136, 262 might increase the sensitivity of or otherwise further broaden the utility 
of the Con-Ex method. 
The accumulation of ExVial or ExVial+INT dye rises in a largely linear fashion out 
to ~24 h in Con-Ex studies, but thereafter it appears to begin to plateau as described 
previously in studies using a radioactive tracer 165. Since flies are exposed to and 
consume the same food medium over several days in Con-Ex and radioactive labeling 
studies (as well as under standard housing conditions), non-linear food intake after 
~24h on the medium might be the norm with routine fly husbandry. Additional studies 
are needed to determine whether the non-linear consumption at later feeding time-
points is related to time-dependent loss of water from the medium, accumulation of 
waste on the medium, or other changes. 
The dye used to label food media in Con-Ex studies as described here can be 
detected in 3 samples: INT, ExVial, and ExMedium. In studies that included all relevant 
measures, we calculated the total amount of excreted dye (ExAdj) by adjusting ExVial to 
account for the volume excreted on the food medium. Although ExAdj+INT is arguably 
the most comprehensive value to assess in Con-Ex studies because it likely reflects the 
total volume of media consumed, we found that assessing ExVial alone was typically 
sufficient. In the majority of studies, statistical analyses with or without ExMedium or INT 
led to the same interpretations and the magnitudes as well as the directions of change 
in the volumes consumed-excreted were comparable whether ExMedium or INT were 
considered. Thus, manipulations that cause large effects could likely be identified—at 
least in a preliminary fashion—by measuring ExVial alone. 
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Flies stand on or walk across the surface of the food medium in Con-Ex studies. 
This physical interaction with the food medium, which is required for consumption, 
raised the possibility that some of the dye we measured as excreted might instead have 
been transferred onto the vial wall by the flies’ appendages, thereby potentially 
confounding the use of Con-Ex to measure consumption per se. Several observations 
lead us to believe that the vast majority of dye that is deposited in the vial during Con-
Ex studies is from consumption and subsequent excretion of the food medium. In our 
time-course studies with Blue 1, we detect greater amounts of INT dye than ExVial dye 
at early time-points and there is a lag of at least 1 h before ExVial dye can be detected. 
This strongly suggests that flies can interact with the medium to consume it without 
transferring detectable amounts of dye from the food to the vial on their appendages 
and is wholly consistent with dye consumption preceding dye excretion. Additionally, in 
Con-Ex studies dye is clearly visible inside of flies and in excretion products on the walls 
of vials, and the total volume of media consumed is comparable to previously reported 
volumes determined using radioactive food labels 165. The most parsimonious 
interpretation of our data is that the vast majority of the detectable dye in Con-Ex 
experiments is derived from consumed food media. 
One of the most widely used approaches for measuring solid media consumption 
in flies is based on the internal accumulation of a radioactive tracer 165, 171, 260. 
Consumption of media labeled with some radioactive tracers leads to the progressive 
accumulation of the tracer within flies for up to 3 days 165. Although the utility of this 
method is well established, the possibility of inadvertently releasing radioactive flies in a 
laboratory could make this approach challenging to implement in some settings. 
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Additionally, the radioactive chemicals (leucine, ATP, CTP, etc. 165, 171, 260) in this 
approach must be metabolized and then incorporated into long-lived molecules within 
the fly to be detected. This requirement for macromolecular incorporation is a potential 
confound for using accumulation of radioactive tracers given that changes in absorption 
of nutrients from the gut or metabolism of the tracers could occur in response to dietary 
manipulations. 
FlyPAD is another method for assessing feeding behavior in Drosophila fed solid 
food media 259. FlyPAD is a highly sophisticated approach that measures the 
interactions of individual flies with solid food medium over relatively short time periods of 
up to ~1 h. Major strengths of the FlyPAD method include that it assesses behavior in 
individual flies, it captures very detailed information regarding feeding behavior, and the 
number and duration of fly interactions with the food medium correlate with estimates of 
medium consumption 259. In contrast to FlyPAD, Con-Ex requires equipment found in 
virtually any modern laboratory, was developed primarily to estimate consumption of 
solid medium, and assesses consumption of medium under routine housing conditions 
in groups of animals on media for hours to days. Although both FlyPAD and Con-Ex 
could certainly be adapted for uses beyond those described here, the two methods are 
quite different technically and are suitable for addressing distinct questions related to 
the biology of feeding in flies. 
Of the previously described methods, Con-Ex is most similar to those based on 
the accumulation of radioactive isotopes. Both Con-Ex and the radioactivity 
accumulation methods label food with a tracer that does not impact consumption, report 
essentially linear rises in the volume of media consumed out to 24 h or more, can be 
229 
 
used for feeding durations lasting hours to days under conditions mimicking routine 
housing conditions, detect the effects of genetic background, starvation and mating 
status on consumption, and are able to measure the consequences of changing the 
nutritional composition of fly media 165. Advantages of the radioactivity-based methods 
are that they are operationally straightforward and sensitive. Advantages of the Con-Ex 
method are that it uses a readily available dye tracer, does not rely on radioactivity, is 
inexpensive and circumvents potential confounds associated with metabolism of the 
food label. Our results using Con-Ex with Blue 1 indicate that it is a suitable, non-
radioactive method for determining consumption of solid media in Drosophila. 
The Con-Ex approach described here was designed to assess the effects of 
discrete treatments on feeding (e.g. starved versus fully fed flies). Since the amount of 
excreted Blue 1 corresponds to the amount of consumed Blue 1, it should be possible to 
use Con-Ex to estimate the total volume of medium flies consume when INT, ExVial and 
ExMedium are all determined. Importantly, though, Con-Ex has utility even when ExVial 
alone is determined. The utility and ease of assessing ExVial alone raises the possibility 
that the method could be adapted for larger scale approaches aimed at identifying 
genes, genetic pathways and neural circuits that regulate feeding behavior. The 
possibility that Con-Ex can be used as a large scale screening platform is a significant 
potential advantage not shared by other current methods for assessing consumption of 
solid food media in Drosophila.  
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7.2 – Protocols 
 
P.1 - Basic Fly Handling and Husbandry 
 
 
 
A. Standard Fly Lab Lingo: 
1. Stock or strain: a culture of flies with a particular genotype. Balanced stocks 
have a special chromosome called a balancer that is marked with a dominant 
phenotype and suppresses recombination on the corresponding sister chromosome. 
Balanced stocks are often weak (i.e. grow poorly). 
2. Seeding: putting adult flies into a new bottle or vial. Also called ‘setting-up’. 
3. Transfer: moving flies without anesthesia from one vial or bottle to another. 
One-to-one transfer means moving flies from one bottle/vial to one new bottle/vial. Two-
to-one transfer means moving flies from 2 vials/bottles to 1 new vial/bottle. Also called 
‘flipping’. 
4. Clearing: removing all of the adults from a bottle or vial. Can be done with or 
without anesthesia. 
5. Anesthesia: CO2 used to temporarily immobilize flies. 
6. Brood: refers to the number of times a set of adults has been used to seed 
bottles. Using flies for 2 broods is common, with 3 broods being possible in some cases. 
7. white plus (w+): indicates eye color. white minus (w-) flies have white eyes. w+ 
flies have eyes that can vary from light peach to deep red. 
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8. Food: All of our fly food currently has antibiotics on it (ampicillin, tetracycline 
and chloramphenicol, ATC). Yeasted (Y) food vials and bottles have live yeast on 
added. Yeasted food should be used for seeding new vials and bottles for growing flies. 
Nonyeasted (NY) food has no yeast on it and should be used to house flies prior to 
behavioral studies and for storing virgin females and males prior to setting-up crosses. 
 
B. Standard Fly Husbandry 
1. Remove necessary number of yeasted bottles or vials from the cold room. Use 
bottles to grow lots of flies for behavioral, stress or other large experiments. Use vials 
for smaller numbers of flies in limited scale crosses or other small scale experiments. 
2. Before putting in new flies, bottles and vials must be dried 2 hours to overnight 
in the environmental chamber so that all condensation on the walls evaporates. The 
food will pull away from the wall of the bottle or vial if they are over-dried. It is poor 
practice to use over-dried food. 
3. Turn on the CO2. Clean microscope, CO2 pad and counter with ethanol. Clean 
before starting, between each genotype and after you are finished. Be sure the CO2 is 
on before putting ethanol on the pad. 
4. Open CO2 to pipette, invert bottle or vial, insert pipette along cotton plug and 
tap bottle/vial gently. Flies will become anesthetized quickly and should fall onto the 
plug and/or the neck of the bottle/vial. 
5. Clic off CO2 to pipette, remove CO2 pipette from vial/bottle. Hold inverted 
bottle/vial over CO2 pad. Remove plug and gently shake/tap flies onto pad into a pile. 
Return plug to bottle/vial and set aside. 
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6. Place anesthetized flies in a row and sort flies according to needs. Short CO2 
times are important. For collecting flies that will be used in behavioral studies, goals are 
(1) all genotypes experience the same CO2 exposure and (2) all flies are anesthetized 
for less than 5 minutes. 
7. Set-up new bottles/vials by putting sorted flies from step 6 into dried 
bottles/vials. Anesthetized flies should be kept on the wall of the bottle/vial. If they fall 
into the food, many of them will stick there and die. Robust strains such as w[A], CS, 
etc. will do well with 10 females (♀, see below) per bottle or 3 females per vial. It is good 
practice to include a comparable number of males (♂, see below). Weaker stocks will 
need more females, up to as many as 50 per bottle and 15 per vial. When working with 
a stock that is new to you it is good practice to seed bottles or vials with a range of 
females (10-25/bottle for example) and then use an optimum number thereafter based 
on how the various bottles/vials grow. 
8. Insert cotton plug, invert new bottle/vial and tap anesthetized flies onto the 
plug. Lay the bottle/vial on its side, label with genotype and date. First broods (i.e. 
bottles or vials in which the flies are new parents) are marked with a single slash. 
9. Wait for flies to regain locomotor activity. Turn bottles/vials upright and place in 
environmental chamber to grow. 
10. Beginning at around 4 days after seeding, check bottles/vials daily for larval 
activity. When larval activity is obvious, transfer adults to new bottles/vials (dried 
appropriately). Label second brood with genotype, date and two slashes. 
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11. Beginning at around 4 days after seeding the second brood, check 
bottles/vials daily for larval activity. Discard adults when larval activity is obvious. If 
necessary, a third brood is possible in some cases. 
12. You should expect to see obvious larval activity 4 to 7 days after seeding and 
obvious pupae 5-10 days after seeding. New adults should begin emerging ~10 days 
after seeding. Some strains, especially balanced strains, can take up to 4 additional 
days to emerge. Perfectly seeded bottle/vials will have robust larval activity followed by 
large numbers of pupae that populate the bottom three-fourths of the wall. Pupae will 
not typically be in the food or on the plug in these bottles. Large numbers of healthy 
adults suitable for experiments will emerge from perfectly seeded bottles/vials. 
13. Common Problems: If your bottles/vials are too dry or wet (as described 
below), the resulting adults should not be used for behavioral, stress or gene expression 
studies. The resulting adults are fine genotype-wise and reproduction-wise, though, and 
can be used to set-up new bottles/vials as necessary. 
 a. Food too dry after 4-7 days of new adults in bottle/vial: The food should not be 
so dry that it detaches from the wall of the bottle of vial and the pupae are in the food. In 
cases like this, the food was either over-dried, there were not enough females placed in 
the bottle/vial, or possibly both. If this occurs across several strains that have grown well 
in the past, it is likely due to over-drying. If it occurs with a subset of strains, it is more 
likely due to insufficient numbers of females being used for those specific strains. The 
appropriate fixes are to decrease drying time, add more females, or both.  
When you transfer flies from the first to second brood or when clearing the second 
brood, note the quality of the culture and food. If the food in some bottle/vials is 
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detached from the wall after 7 days, go ahead and transfer/clear the adults and then 
add ddH2O (NOT ETHANOL!) to the bottle/vial until the gap between the food and the 
wall is filled. In many cases this will help the larvae quite a lot and you still might get a 
decent yield of adults, although they might be delayed a few days due to lack of water. 
 b. Food too wet after 4-7 days of new adults in bottle/vial: The food should not be 
so wet that it runs down the wall of the bottle/vial when it is inverted and the pupae are 
on the plug. If this happens, the food was not dried sufficiently before adults were 
added, too many adults were added, or possibly both. If this occurs across several 
strains that have not had this problem in the past, it is likely due to under-drying the 
food. If it occurs with only a subset of strains, it is more likely due to too many females 
being added in those specific strains. The fixes are to increase the drying time for 
bottles/vials, decrease the number of females used, or both. 
 If you notice that your bottles are too wet when transferring from the first to 
second brood or when clearing the second brood, you can put a folded Kim wipe in the 
bottle/vial so that it touches both the food and the plug. This will not result in a 
miraculous drying of the bottle/vial, but it can convert a bottle/vial that is far too wet into 
one that can be managed with some care. 
 
C. The Basics of Setting-Up Crosses 
1. You will need males (♂, mated or unmated) and females (♀ with a ‘v’ on top, 
unmated or virgin) for your crosses. Grow bottles or vials as above for strains required 
to generate males and virgin females. For planning purposes, you can comfortably 
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collect 100 males and/or 50 virgin females from a robust bottle. Likewise, you can 
probably count on collecting 20 males and 10 virgin females from each well-seeded vial. 
2. Around day 10 after seeding, begin to collect virgin females, identified by their 
light body pigmentation and female genitalia (see below). Typically, one would collect 
virgin females first thing in the morning, again around noon, and again last thing before 
leaving for the day. 
3. Keep virgin females in nonyeasted vials with no more than 25 females/vial. 
Label each vial with genotype, date and number collected. Keep collected females in 
environmental chamber until ready to use. One will often collect virgin females over 
several days or until a sufficient number of virgin females has been collected. Also, it is 
convenient to store virgin females in upside-down vials. 
4. When sufficient numbers of virgin females have been collected (~10% more 
than you plan to use) or when it is obvious that you will be able to collect all the virgin 
females you will need, collect all males into nonyeasted vials needed for your crosses. 
Males are identified by their male genitalia (see below). 
5. Set-out yeasted bottles or vials to warm and dry as described above. On the 
day of the cross, check all virgin female vials for larvae using the microscope. Any vials 
with larvae MUST be discarded because at least one of the females has mated. Use 
only virgin females from vials with no larvae. 
6. To set-up a cross, anesthetize the males and check them, anesthetize the 
virgin females on the same plate and check them, and put appropriate numbers of 
males and females into yeasted bottles/vials as described in steps B7-B9 above. 
Handle them thereafter as described in B10-B12 above. 
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7. Make sure that you know what progeny to expect from your crosses before 
you set them up. 
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P.2 - Quarantine of New Fly Stocks 
 
 
 
The following is an outline of steps which should be followed when new stocks are 
brought into the lab. It is important that stocks go through the entire quarantine 
procedure to prevent a mite infestation. All new stocks should be handled as if there are 
mites present. Quarantine stocks must be kept isolated from all other stocks. 
1.New stocks must be brought directly to an isolated spot. Do not bring them near any 
current lab stock.  
2.Transfer the adults to a fresh vial (P0) and keep the original vial for ~one week. Place 
vials in a water moat. Each stock needs its own individual moat. 
3.When the P0 vial contains adequate larvae, second brood the adults to a backup vial. 
Save all vials for monitoring of mites later.  
4.Shortly after the adults eclose from the P0 vial, transfer them to a fresh vial (F1) for 
~one week and repeat step #3.  
5.Keep the stock isolated for two more generations (F2 and F3). 
6.When the adults eclose from the F3 vial, put them in a fresh vial and check vials from 
all previous generations for mites. 
7.If ALL vials are clear of mites, the stock may be taken out of quarantine.  
8.If mites are found at any time or suspected of being in a stock, restart the quarantine 
process until no mites are found.  
Adapted from the recommendations of the  
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The Curator of Drosophila Stocks 
Dept. of Biology 
Jordan Hall A503 
Indiana University 
Bloomington, IN 47405 
(812) 855-5783 
(812) 855-2577 (FAX) 
Kathy Matthew, Curator (812) 855-5782 
 
Mid-America Drosophila Stock Center 
Dept. of Biological Sciences 
Bowling Green State University 
Bowling Green, OH 43403 
(419) 372-2631 
 
original text by Todd Laverty 
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P.3 - Ethanol Sedation Assay 
 
 
  
A. Day before assay 
1. Collect flies (reared for behavioral assays) in groups of 11 (single sex) under brief 
CO2 (~5 minutes) following standard procedures for behavioral assays. Collect only 
those flies that look healthy, are relatively the same size, have normal wings, and 
appear dry. Flies should be transferred from the CO2 plate into an Eppendorf tube using 
a funnel and then dumped from the Eppendorf tube into a non-yeasted vial. 
2. Allow flies to recover overnight in upside-down non-yeasted food vials in the 
environmental chamber. It is possible to test a maximum of 24 vials of flies in a single 
experiment. 
3. Dilute ethanol solution as necessary (85% is our standard concentration). ~250 ml of 
ethanol solution can be stored in a sealed 500ml bottle or other sealed container for a 
week without a problem. Make ethanol fresh weekly. Diluted ethanol is exothermic and 
should be stored overnight at room temperature before use. 
 
B. Day of assay  
1. For each vial of flies to be tested, you will need (a) a clean, empty food vial; i.e. 
testing vial, (b) a new Flug, (c) a silicone #4 plug and (d) 1.0 ml of ethanol solution (85% 
ethanol is our standard concentration). 
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2. Turn on humidifier and allow relative humidity in testing room to rise to 55-65%. 
Temperature should be 20-23°C. Record humidity and temperature on test log. 
3. Have someone else in the lab assign a unique code to each group of vials for each 
genotype and—IMPORTANTLY—record the code for later. Place coded vials with flies 
in testing room to acclimate. 
4. Label empty testing vials to match codes on fly vials from B.3. 
5. Construct a testing log by entering the code for each vial into the Test Log E or Test 
Log EE sheet within the Excel Sedation file SA E EE 6 min SIGMOIDAL 2015.10.05. 
Use a random or cycling order. Add other pertinent information (% ethanol, sex, etc.) to 
the Test Log worksheet and print for use during testing. 
6. Using the Test Log as a guide, arrange coded food vials with flies and empty testing 
vials into matching arrays with 4 vials in each row. The maximum possible number of 
vials that can be tested in a single experiment is 24 vials (i.e. 6 rows of 4 vials each). 
7. Transfer flies from food vials into matched/labeled testing vials one at a time and 
immediately insert Flugs into testing vials until Flugs are a uniform distance below the 
vial tops. Use the Fluginator to push Flugs down into vials. 
8. Time 0 assessment: Grasp each vial individually with thumb and forefinger, tap gently 
on the table three times to knock flies to the bottom of the vial, wait 30 seconds and 
then count the number of flies that are immobile. Typically, this is 0 or 1 at time 0. 
Record the number of immobile flies for each vial at time 0 in the printed Testing Log. 
9. Hereafter, each row of four vials will be handled as a set at staggered one-minute 
intervals.  
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Start timer counting up at time 0 and immediately begin adding 1 ml of ethanol to the 
Flug in the vials for the first row/set of 4 vials. Add ethanol to the vials at 5 second 
intervals in the order they will be tested. Add ethanol to the Flugs in a circular motion so 
that all ethanol is absorbed as uniformly as possible. When ethanol has been added to 
all four testing vials in the set, insert a silicone #4 plug in each vial to seal it. 
At times 1, 2, 3, 4 and 5 minutes on the timer, add 1 ml of ethanol to the second, third, 
fourth and fifth sets of 4 vials, respectively. Continue inserting #4 plugs after adding 
ethanol to each set of 4 vials. 
10. At time 6 minutes, test the first set of 4 vials by grasping the first vial with thumb and 
forefinger and then tapping gently on the table three times to knock flies to the bottom of 
the vial. Tap the other 3 vials in the set the same way at 5 second intervals. 30 seconds 
after tapping the first vial, count and record the total number of flies that are sedated. 
Count and record the number of sedated flies in the other 3 vials at 5 second intervals. 
Flies are scored as sedated if they do not appear to have productive locomotion. 
The specific schedule is: 
Vial Tap Assess 
1 6 min 0 s 6 min 30 s 
2 6 min 5 s 6 min 35 s 
3 6 min 10 s 6 min 40 s 
4 6 min 15 s 6 min 45 s 
 
At times 7, 8, 9, 10 and 11 minutes, test the second, third, fourth, fifth and sixth sets of 
vials, respectively, as done for the first set. 
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11. At time 12 minutes, test the first set of 4 vials again as described in B10 and 
continue testing the second, third, fourth, fifth and sixth sets of vials at 13, 14, 15, 16 
and 17 minutes, respectively.  
Continue testing flies as described in B10 and B11 until all flies are sedated (typically 
60-90 min). 
12. Record the total number of flies in each vial. 
13. Clean-up is (a) turn off humidifier, (b) remove #4 plugs for washing and reuse, (c) 
discard Flugs/vials/flies, (d) remove any trash from and straighten up testing room and 
(e) turn off light in testing room. 
14. Enter the total number of flies in each vial and the number of flies sedated at each 
time point in the Test Log within the Excel worksheet. Percent Active flies will be 
automatically calculated and graphed below the Test Log. Press ‘Ctrl + s’ to calculate 
ST50s for each vial and sort the data by group in the Sorted Data worksheet. 
15. Note any flagged data in Sorted Data worksheet. Consider excluding data that looks 
qualitatively poor. 
 
M Grotewiel, R Schmitt, K Lee: 7/2014, 3/2015, 7/2016 
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P.4 - Simple Locomotor Assay 
 
A. Day before assay 
1. Collect experimental flies (reared for behavioral assays) in groups of 11 (single sex) 
under brief CO2 following standard procedures for behavioral assays.  A maximum of 24 
vials, 6 groups of 4, can be tested during the assay. You will need to collect 4 additional 
vials of controls flies to be the vortexed group. 
2. Allow flies to recover overnight in non-yeasted food vials in the environmental 
chamber.   
B. Day of assay – Flugged Vial Experiment 
1. Turn on humidifier(s) and allow relative humidity in testing room to become/remain 
between 55-65%.  
2. Prior to the experiment, print the locomotor test log sheet. For each vial of flies to be 
tested, you will need: a clean, empty testing vial and a new Flug 
3. Transfer flies from all food vials into matched testing vials one at a time and 
immediately insert Flugs into testing vials until the bottom of the Flugs are just below the 
vial tops. For vials used for vortexing, use “The Fluginator” to force Flugs further down 
into vials until the tape is in contact with the vial. 
4. Vortex the control vials for 4 minutes. Up to four vials will be vortexed at once. In 
order to prevent vial destruction during the vortex, use a couple of rubber bands on 
each vial and a few rubber bands to hold all four vials together. (See Below)  
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5. Have someone else in the lab assign a unique code to each vial for each genotype 
and—IMPORTANTLY—record the code for later*. Place coded vials with flies in testing 
room to acclimate. 
6. Label empty testing vials to match codes on fly vials from B5 
7. Using the Test Log as a guide, arrange coded food vials with flies and empty testing 
vials into matching arrays in the testing room. It is possible to test 6 sets of 4 vials 
simultaneously, so arrange 24 vials (maximum) in 6 sets or rows containing 4 vials 
each.  Then transfer flies from food vials to the matching testing vials. 
8. Time 0 assessment (# dead): For each vial individually: grasp with thumb and 
forefinger, tap the vial on the table three times to knock flies to the bottom of the vial, 
wait 30 seconds and then count the number of flies that are dead (no movement 
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whatsoever). Record this number of flies for each vial at time 0 in the printed Testing 
Log. 
9. Hereafter, each row of four vials will be handled as a set at staggered one-minute 
intervals.  
Start timer counting up at time 0 upon completion of recording the number of dead flies. 
10. At time 6 minutes, test the first set of 4 vials by grasping each vial individually with 
thumb and forefinger, tapping on the table three times to knock flies to the bottom of the 
vial. Then wait 30 seconds to count and record the total number of flies that are on the 
bottom.  
The specific schedule is: 
Vial Tap Assess 
1 6 min 0 s 6 min 35 s 
2 6 min 5 s 6 min 40 s 
3 6 min 10 s 6 min 45 s 
4 6 min 15 s 6 min 50 s 
 
At times 7, 8, 9, 10 and 11 minutes, test the second, third, fourth, fifth and sixth sets of 
vials, respectively, as done for the first set. 
11. At time 12 minutes, test the first set of 4 vials again as described in B10 and 
continue testing the second, third, fourth, fifth and sixth sets of vials at 13, 14, 15, 16 
and 17 minutes, respectively.  
Continue testing flies as described in B10 and B11 for 60 minutes. 
12. Record the total number of flies in each vial on the locomotor assay sheet. 
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13. Fill out the locomotor assay file. Percent Active flies will be automatically calculated. 
Compile the data as directed on the sheet to calculate aggregate percent active and 
fraction alive for each vial and sort the data by group in the Sorted Data worksheet. 
Clean-up is (a) turn off humidifier, (b) discard vials containing flies, (c) remove any trash 
from and straighten up testing room, and (d) turn off light in testing room. 
 
I. Hines, 2015.10 
M. Grotewiel, 2016.07  
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P.5 - Micro-Batch Food Protocol 
 
1. Add 750mL distilled water to a large beaker and bring to boil on hot plate (turn it 
all the way up.) Use a large stir bar and the stir function around 4-5. 
2. For complete food, measure out ingredients as follows: 
 
 
Comple
te 
20% 
Sugar 
30% 
Sug
ar 
40% 
Sug
ar 
10% 
Yeas
t 
20% 
Yeas
t 
30% 
Yeast 
10% 
Cornmeal 
Comp
lete 
(no 
sugar 
Or 
cornm
eal) 
30% 
Yeast 
(no 
sugar Or 
cornmea
l) 
Sugar 100 g 200 g 
300 
g 
400 
g 
100 
g 
100 
g 
100 g 100 g 0 g 0 g 
Agar 10 g 10 g 10 g 10 g 10 g 10 g 10 g 10 g 10 g 10 g 
Yeast 20 g 20 g 20 g 20 g 
100 
g 
200 
g 
300 g 20 g 20 g 300 g 
Cornm
eal 
33 g 33 g 33 g 33 g 33 g 33 g 33 g 100 g 0 g 0 g 
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3. Alter any ingredients as needed. 
4. Mix together the dry ingredients for each batch. 
5. Once the water is boiling, turn it down to about 5 and VERY slowly sprinkle in the 
solid ingredients. If you go too fast, it will boil over. Consider wearing an autoclave glove 
for steam protection. 
6. Bring volume up to 1 L with hot water. (Microwave water in beaker until boiling) 
7. Cook on low boil for 20 minutes. 
8. Turn off heat and periodically check the temperature of the food (roughly 15-20 
mins) 
9. When the food temperature is 70°C, add Tegosept solution: 
8.6 mL EtOH 
1.67 g Tegosept 
10. Let the food cool to at least 65°C (not lower than 55°C), then pour using the vial 
despenser. 
11. Let the food solidify/cool for an hour or more, then add antibiotic solution (100 μL 
per vial): 
12 mL total (1 tray): 
6 mL H2O 
0.12 g Ampicillin 
0.024 g Tetracyline 
5.7 mL EtOH + 0.3 mL H2O 
0.15 g Chloramphenicol 
Brandon Shell 8/2016 
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P.6 - Standard Feeding Assay 
 
Making the food (make the day before you begin the assay) 
1. Determine number of Mocaps needed for feeding assay. 
2. Each Mocap holds about 5 mL of food. Calculate amount of water needed to 
make food. 
a. Example: 32 Mocaps x 5 mL = 160 mL batch (up batch to 200 mL) 
b. It’s easiest to make one big batch of food and then split it in two so there is 
one with dye and one without dye. *Note: Only split the batch if you have a 
way to keep both batches above 65°C. (2nd hot plate or water bath) 
3. Measure out food ingredients. (Measurements in Table on back page) 
4. Mix together dry ingredients for each batch. 
5. Fill a flask with the appropriate amount of DI water. (Measurements in Table on 
back page) 
6. Place flask on hot plate, add stir bar, and turn on stir function. 
7. Turn the heat all the way up until the water begins to boil (roughly 10 minutes). 
8. Once the water is boiling, turn the temperature down to about 100°C and VERY 
slowly sprinkle in the solid ingredients. If food is poured too fast, it will boil over. Wear 
autoclave gloves for steam and heat protection. 
9. Cook food on low boil for 20 minutes. 
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10. While the food is cooking, make antibiotic solutions. (Measurements in Table on 
back) 
11. Turn the heat completely off to let the food cool down (roughly 10 minutes) and 
periodically check the temperature with a thermometer. 
12. When the food temperature is 70°C, pour the antibiotic solutions directly into the 
food. 
13. After the antibiotic solutions are mixed in, split the food into two batches, one that 
will have no dye and one that will have dye added to it. 
a. Example: Split a 200 mL batch into two 100 mL batches. Then add 1 g of 
Blue 1 dye to one of the 100 mL batches. 
14. Add 1% Blue #1 to one of the batches. (Measurements in Table) 
15. Let the food cool to at least 65°C (not lower than 55°C), then pour into Mocaps 
using a small beaker for easier pouring. 
16. Let the food solidify (about 10 minutes), then place inside a lidded container and 
keep at 4°C overnight. 
 
Seeding Flies (day after making food) 
17. Set food out and allow to return to room temperature. 
18. Collect 15 flies/vial and place Mocap on top of vial. 
19. Allow flies to consume food for 24 hours at 25°C and 65% relative humidity. 
 
Next Day (day 2) 
Preparing Samples 
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20. After 24 hours of feeding, record the number of dead flies. 
21. Fill an ice bucket with ice. 
22. Transfer flies from vials to 1.7 mL microcentrifuge tubes. Place each tube on ice 
after transfer. Do NOT discard vials. 
23. When all flies have been transferred to tubes, put tubes in -20°C to euthanize. 
 
Measuring Vial Excretion 
24. Add 3 mL of sterile water to each vial. 
25. Cover vial with parafilm. Make sure the parafilm is tight enough to be able to turn 
the vial upside down without any water escaping. 
26. Vortex the vial for 15 seconds upright and 15 seconds upside-down. Check to 
make sure all the dye excreted on the sides of the vial has been absorbed into the 
water. If not, continue to vortex. 
27. Pipette 1 mL of each sample into disposable cuvettes. 
28. Spec at 630λ (for Blue 1 dye) and record each sample using sterile water as a 
blank. 
 
Measuring Internal Fly Dye 
29. Retrieve flies from -20°C and let cool back to room temperature. 
30. Add 500µL of sterile water to each microcentrifuge tube. 
31. Homogenize flies using drill and pestle for 30 seconds. 
32. Add 1 mL of sterile water into each micrcentrifuge tube (for a total of 1.5 mL). 
33. Vortex each tube for 15 seconds. 
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34. Spin all tubes in centrifuge for 10 minutes. 
35. Pipette 1 mL of each sample into disposable cuvette 
36. Spec at 630λ (for Blue 1 dye) and record each sample using sterile water as a 
blank. 
 
Tegosept and Chloramphenicol Solvent = Ethanol (add both to the same ethanol) 
Tetracycline and Ampicillin Solvent = Water (add both to the same water) 
 
Example: 
For a 100 mL batch, measure out 1 mL of Ethanol and add 0.200 g Tegosept and 
0.0125 g Chloramphenicol to it. Then measure out 1 mL of Water and add 0.002 g 
Tetracycline and 0.010 g Ampicillin to it. 
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P.7 - Single Fly Genomic DNA Preparation 
 
1) The squishing buffer (SB) is 10 mM Tris-Cl pH 8.2, 1mM EDTA, 25 mM NaCl, and 
200 ug/ml Proteinase K (diluted 1:100 in SB) from a frozen 20 mg/ml stock each 
day. 
2) Place one fly, alive, in a 0.5 ml tube and freeze tube at -80 or -20C for a few 
minutes to days to kill them. 
3) Mash the fly for 5-10 seconds with a pipette tip containing 50 µl of SB without 
expelling any liquid (sufficient liquid escapes from the tip during mashing).  Then 
expel any remaining SB from the tip. 
4) Incubate at 25-37C (room temp.) for 20-30 minutes. 
5) Inactivate the Proteinase K by heating to 95C for 1-2 minutes. 
6) Spin down crud in centrifuge and store at 4C for up to several months. 
7) Use 3-5 µl of the DNA prep (supernatant) in a 50 µl PCR reaction. 
 
 
adapted from Gloor et al. 1993 
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P.8 - Basic Polymerase Chain Reaction (PCR) Protocol 
  
1.  Dilute primers to 10 pmol/μl.  The primers in the Primer Boxes in the -20°C freezer 
are at 1 nmol/μl (1000 pmol/μl), so those need to be diluted 1:100 in dd H2O. 
2.  Thaw in hand and/or store on ice: 
primers 
Taq Buffer (in Taq box; includes MgCl2) 
2.5 mM dNTPs 
dd H2O 
3.  Each PCR sample or tube should contain: 
1-5 µl template (e.g. 200 ng purified gDNA or 5 μl of squish prep) 
5 µl forward primer  
 5 µl reverse primer  
5 µl Taq  Buffer 
5 μl 2.5 mM dNTPs 
0.3 µl Taq polymerase 
X µl dd H2O to 50 μl total 
Making each individual sample separately is cumbersome, so make a Master Mix for 
n+1 samples according to the PCR Worksheet MASTER.  The master mix contains all 
components that will be used in multiple samples.  For example, if amplifying several 
different gDNA samples with the same primer pairs, the Master Mix should contain 
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everything except the gDNA templates.  When making the Master mix, add all 
components except for Taq polymerase, vortex to mix, add the Taq polymerase, then 
vortex to mix. 
4.  Aliquot the Master Mix into labeled 0.5 ml thin-walled PCR tubes and add remaining 
component(s). 
5.  Close lids and pulse vortex.  If necessary, gently tap tubes to bring liquid to bottom. 
6.  Place tubes in thermocycler, adjust thumb-wheel on lid until you start to feel a 
SMALL amount of pressure, set program to MSG1 (or other as appropriate), enable 
heated lid, press Proceed.  A run takes ~3 hours, but can vary depending on cycling 
parameters. 
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P.9 - Fly Head/Body Prep 
 
1. Bring the following equipment to the cold room: large plastic box, styrofoam box with 
sieve and tube holder in it, large metal forceps, a vortexer, and enough funnels, large 
orange-capped conical tubes, and labeled 1.7 snap-cap tubes for the number of preps 
you are doing. 
2. Obtain liquid N2 (in dewar) and dry ice (in styrofoam container) from 6th floor supply 
center. 3/4th full liquid N2 and 1/2 full dry ice is sufficient for ~12 preps. 
3. Store samples on dry ice before and after prep. 
4. Fill conical tube 3/4 full (in styrofoam container) with liquid N2. 
5. Add flies to tube, screw on cap WITH HOLES (or it will violently explode), and vortex 
(stopping as little as possible) until the liquid N2 is almost gone (~1 min). 
6. Repeat—filling tube with flies 1/2 full and vortexing again. 
7. Pour N2 into sieve so it is sufficiently cold (otherwise the flies will stick and you’ll get 
nothing). Dump flies into sieve and beat laterally with heavy forceps for several minutes. 
8. Collect heads (middle layer) or bodies (top layer) using funnel and labeled 1.7 snap-
cap tube. 
9. Store at -80°C until use. 
Notes: 
1. Wear safety glasses, lab coat, 2 pairs of latex gloves and cryo gloves. 
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2. Between genotypes: take a break to clean and completely dry sieve (or it will freeze 
together and form an ice layer over the holes). Get a new funnel and conical tubes 
J. Butler 4/2015 
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P.10 - RNA and cDNA Prep 
Part A: Fly collection 
 
Whole body fly collection 
1. Collect 25 flies of desired age, genotype and gender in a 1.5mL snap cap tube. 1 
tube = 1 n. Place tubes on ice immediately after flies enter tube.  
2. Once done collecting, place flies in -80. Once flies are frozen and dead, you can 
proceed to Part B 
 
Head Preps 
1. Collect whole body flies of desired age, genotype and gender in a conical tube. 1 
tube = 1 n. For head preps, about 250 flies should be in each tube (absolute 
minimum = 150 flies, but this is not recommended). Store flies on ice at all times. 
After each collection, place flies immediately back in the -80 freezer.  
2. Once collected, bring the following equipment to the cold room 
 large plastic box 
 styrofoam box with sieve and tube holder in it 
 large metal forceps 
 a vortex 
 funnel(s) 
 large orange-capped conical tubes  ONLY USE CAPS WITH HOLES 
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 labeled 1.7 snap-cap tubes for the number of preps you are doing 
 Cryogloves  WEAR AT ALL TIMES 
 
3. Obtain liquid N2 (in dewar) and dry ice (in styrofoam container) from 6th floor supply 
center. 3/4th full liquid N2 and 1/2 full dry ice is sufficient for ~12 preps. 
4. Store samples on dry ice before and after prep. 
5. Fill conical tube 3/4 full (in styrofoam container) with liquid N2. 
6. Add flies to tube, screw on cap WITH HOLES (or it will violently explode), and vortex 
(stopping as little as possible) until the liquid N2 is almost gone (~1 min). 
7. Repeat—filling tube with flies 1/2 full with N2 and vortexing again. 
8. Pour N2 into sieve so it is sufficiently cold (otherwise the flies will stick and you’ll get 
nothing). Dump flies into sieve and beat laterally with heavy forceps for several min. 
9. Using funnel, quickly collect heads (middle layer) or bodies (top layer) using funnel 
and labeled 1.7 snap-cap tube. 
9. Between genotypes: take a break to clean and completely dry sieve (or it will freeze 
together and form an ice layer over the holes). Get a new funnel and conical tube. 
10. Store at -80°C until use. 
**Wear safety glasses, lab coat, 2 pairs of latex gloves and cryo gloves (plus warm 
clothes and long pants). 
 
Part B: RNA extraction 
** All water used is DEPC water 
** Samples must be kept on ice at all times, unless otherwise stated 
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1. Wipe down bench and all pipettes, pipette boxes, ect with 100% ETOH. Place clean 
plastic pestles in 50mL conical tube, cover pestles with chloroform, and let them 
soak for 20 minutes. Transfer pestles to new clean empty 50mL conical tube, and 
allow to air dry for 20 minutes.  
** all chloroform is stored under the hood, and any procedures involving chloroform 
should always be done under the hood 
2. While under the fume hood, add 250µL Trizol (pink, stored in fridge) to each tube of 
flies. Homogenize for 1 minute with drill and pestle 
3. Add 100µL of chloroform to each tube. Vortex for 15 seconds. Incubate for 3 minutes 
at room temperature 
4. Centrifuge samples at maximum speed (14,000 x g)  for 15 minutes in the cold room  
5. Label new 1.5mL tubes appropriately. Remove roughly 200µL of the upper aqueous 
phase and place in new tube. If you accidently pipette any fly parts or other liquid, 
centrifuge that sample again (i.e. repeat step 4) and then attempt this step. Discard 
tubes with fly parts and the pink liquid.  
6. Add 250µL isopropanol (labeled ISO in RNA reagents station) to each tube 
containing the upper aqueous sample. Invert the tube 10 times. Incubate samples 
for 10 minutes at room temperature. After, centrifuge samples at maximum speed 
(14,000 x g) for 10 minutes in cold room 
7. A white pellet on the bottom of each tube should be visible. Remover liquid from the 
tube with a 200µL pipette. Add 500µL of 75% ETOH to each tube. Invert 10 times to 
wash. After, centrifuge samples at maximum speed (14,000 x g) for 5 minutes in the 
cold room 
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** 75% ETOH should be made with DEPC water. Large amounts are typically pre-made 
and stored at the RNA reagents station 
8. While samples are in the centrifuge, re clean bench with ETOH. Clean a piece of 
glass plate (stored at RNA reagents station) with ETOH and then chloroform. Place 
the clean glass on a cleaned section of your lab bench.  
9. Using 200µL and 20µL pipettes, remove as much liquid as possible surrounding the 
pellet. Dispose of all liquid.  
10. Lay tubes with the lids open on the glass plate. Allow tubes to air dry until i) no liquid 
droplets remain and the pellet is clear or ii) 60 minutes has passed 
11. Add 50µL of DEPC water to each pellet. Allow samples to sit at room temperature 
for 60 minutes. After, place samples in 4°C incubator overnight.   
Part C: cDNA conversion 
DNAse treatment (all reagents kept in DNAse treatment box in -20 freezer) 
1. Re-suspend the pellet by pipetting up and down. Once re-suspended, vortex the 
sample 
2. Measure RNA concentration. The reference is 100µL DEPC water. Samples are 
98µL DEPC water, 2µL of the RNA sample. Absorbance is read at 260nm. Record 
absorbance’s for each sample 
** RNA can be stored in -80 until ready to proceed 
3. Set heat blocks to 37°C (smaller holes) and 65°C (larger holes) 
4. Using the RNA absorbance excel spreadsheet, calculate how much DEPC water 
and RNA sample is needed. For each sample, 6µg of RNA is added to a 0.5mL snap 
cap tube. The total volume is brought to 17µL by DEPC water. Vortex samples 
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5. Add 2µL DNAse buffer (10X DNAse 1 – buffer) and 1µL DNAse enzyme (R DNAse 
1). Incubate samples at 37°C for 25 minutes 
6. After incubation, switch heat block to 42°C (larger holes) 
7. Pulse centrifuge samples. Add 2µL DNAse inactivation reagent. Incubate samples at 
room temperature for 2 minutes. While incubating, flick tube gentle to resuspend the 
inactivation reagent. Sample should be a cloudy white.  
8. Centrifuge samples at 10,000 x g for 1.5 minutes 
9. Use pipette to transfer 11µL of the clear upper phase to new 1.5mL snap cap tubes 
Reverse transcription (all reagents kept in reverse transcription box in -20 freezer) 
10. Add 1µL of oligo-dT to each sample of DNAse treated RNA 
11. Incubate at 65°C for 15 minutes. While incubating, thaw 1st strand buffer, DTT and 
10mM dNTP on ice 
12. After incubation, put tubes on ice for 1 minute. Pulse centrifuge.  
13. Keep all samples on ice throughout. Add the following to each tube: 
 4µL of 5 X 1st strand buffer (5 X FS buffer) 
 2µL of 0.1M DTT 
 1µL of 10mM dNTP 
 1µL of Superscript 2 enzyme (SSll) **must always stay on ice** 
14. Incubate samples at 42°C for 50 minutes 
15. Store cDNA samples at -20°C  
Notes: 
o When reagents are low, tell someone immediately! 
o Use RNAse free reagents only 
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o  All DNAse treatment reagents from Applied Biosystems (AM1906) 
o Reverse transcriptase and buffers are from Invitrogen (18064014)  
o Oligo-dT from Invitrogen (18418-012) 
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P.11 - Real-Time PCR: Primer Check 
 
**Reserve your PCR machine time slot ahead of time 
Note:  RT-PCR is highly sensitive.  Knobs on pipettes MUST be taped at all possible 
steps when pipetting replicate samples.  Change tips after each volume is dispensed. 
1. Dilute a single control cDNA to these four dilutions: 1:8, 1:16, 1:32, 1:64 
cDNA 
dilution 
µL 
water 
µL cDNA 
1:8 168 24 (from sample) 
1:16 100 100 (from 1:8 dilution) 
1:32 100 100 (from 1:16 
dilution) 
1:64 100 100 (from 1:32 
dilution) 
 
2. Dilute all primers to 3 pmol/µL (actin primers and primers for genes of interest (GOI)) 
 All primers are stored at 1000 pmol/µL in the battle ship boxes in -20°C 
 Make the following dilutions: 
a. 5 µL of the 1000 pmol/µL primer + 45 µL water = 100 pmol/µL dilution 
b. 30 µL of the 100 pmol/µL primer + 270 µL water = 10 pmol/µL dilution 
c. 15 µL of the 10 pmol/µL primer + 35 µL water = 3 pmol/µL dilution 
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3. For each dilution of cDNA (four total from Step 1) make a master mix containing: 
 
  
1 
primer 
pair 
2 
primer 
pairs 
3 
primer 
pairs 
4 
primer 
pairs 
5 
primer 
pairs 
6 
primer 
pairs 
7 
primer 
pairs 
8 
primer 
pairs 
water 18 µL 36 µL 54 µL 72 µL 90 µL 108 µL 126 µL 144 µL 
SYBR 30 µL 60 µL 90 µL 120 µL 150 µL 180 µL 210 µL 240 µL 
cDNA 4 µL 8 µL 12 µL 16 µL 20 µL 24 µL 28 µL 32 µL 
 
4. For each master mix, label a tube for each primer pair that will be run. Pipet 49.4 µL 
of the master mix into each tube. E.g. 4 dilutions of 1 cDNA with 2 primer pairs. 
 
 
 
 
 
 
 
 
 
 
 
 
master mix  
(1:16 cDNA) 
master mix  
(1:8 cDNA) 
Actin 
1:8 
GOI 
1:8 
Actin 
1:32 
GOI 
1:32 
Actin 
1:16 
GOI 
1:16 
Actin 
1:64 
GOI 
1:64 
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5. Make a primer mix for each primer pair: 20 μL forward primer + 20 μL reverse primer 
6. Pipet 7.6 µL of the primer mix (step 5) into the corresponding tubes containing the 
master mix (step 4) for each cDNA dilution 
 
 
  
 
 
 
 
7. Vortex and spin down samples. Pipette 15 µL of each sample in triplicate into a 96 
well real time plate. Which samples go into each well on the plate should be pre-
determined ahead of time. 
8. Put clear adhesive cover over the plate. Use the rubber tool to press the cover 
down. Be very careful to void bubbles and smudges. Use the razor blade to cut off 
the excess edges of the cover, and use the rubber tool again to make sure the 
edges are sealed to the plate.  
9. Spin plate at 1000 rpm for 2 minutes using the centrifuge in Rita’s lab 
10. Run plate in real-time machine as described at end of protocol. 
 
master mix  
(1:64 cDNA) 
master mix  
(1:32 cDNA) 
Actin 
primer mix 
Actin 1:64 
Actin 1:32 
Actin 1:16 
Actin 1:8 
GOI 
primer mix 
GOI 1:64 
GOI 1:32 
GOI 1:16 
GOI 1:8 
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P. 12 – Real-Time PCR: Gene Expression 
 
**Reserve your PCR machine time slot ahead of time 
Note:  RT-PCR is highly sensitive.  Knobs on pipettes MUST be taped at all possible 
steps when pipetting replicate samples.  Change tips after each volume is dispensed. 
1. Dilute primers (e.g. Actin and gene of interest (GOI) primers) to 3 pmol/µL 
 All primers are stored at 1000 pmol/µL in the battle ship boxes in -20°C 
 Make the following dilutions: 
a. 5 µL of the 1000 pmol/µL primer + 45 µL water = 100 pmol/µL dilution 
b. 30 µL of the 100 pmol/µL primer + 270 µL water = 10 pmol/µL dilution 
c. 15uL of the 10 pmol/µL primer + 35µL water = 3 pmol/µL dilution 
2. Dilute cDNA samples to a 1:10 dilution (or another dilution previously determined) 
3. Make a master mix for each diluted cDNA sample using the table below. Pulse 
vortex and pulse centrifuge. 
  
1 
primer 
pair 
2 
primer 
pairs 
3 
primer 
pairs 
4 
primer 
pairs 
5 
primer 
pairs 
6 
primer 
pairs 
7 
primer 
pairs 
8 
primer 
pairs 
water 18 µL 36 µL 54 µL 72 µL 90 µL 108 µL 126 µL 144 µL 
SYBR 30 µL 60 µL 90 µL 120 µL 150 µL 180 µL 210 µL 240 µL 
cDNA 4 µL 8 µL 12 µL 16 µL 20 µL 24 µL 28 µL 32 µL 
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4. For each master mix, label one tube for each primer pair. Into each tube, pipet 49.4 
µL of the appropriate master mix. E.g. 2 cDNA sample and 2 primer pairs (Actin and 
GOI). 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Make a primer mix for each primer pair: 50% forward primer, 50% reverse primer 
Number of cDNA 
samples 
uL of forward 
primer 
uL of reverse 
primer 
2 12 12 
3 16 16 
4 20 20 
5 24 24 
cDNA sample 
1 master mix  
cDNA sample 1: Actin 
cDNA sample 1: GOI 
cDNA sample 
2 master mix  
cDNA sample 2: Actin 
cDNA sample 2: GOI 
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6. Pipet 7.6 µL of the primer mix into the corresponding tubes containing the master 
mix for each cDNA sample from step 4. E.g. 2 primers (Actin and GOI) and 2 
different cDNA samples. 
 
 
 
 
 
 
 
 
 
 
 
7. Pulse vortex and pulse centrifuge samples 
8. Aliquot 15µL of each sample in triplicate into a 96 well real time plate. Which 
samples go into each well on the plate should be pre-determined ahead of time. 
6 28 28 
7 32 32 
8 36 36 
9 40 40 
10 44 44 
Actin 
primer mix 
cDNA sample 1: Actin 
cDNA sample 2: Actin 
 
GOI 
primer mix 
cDNA sample 1: GOI 
cDNA sample 2: GOI 
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9. Put clear adhesive cover over the plate. Use the rubber tool to press the cover 
down. Be very careful to void bubbles and smudges. Use the razor blade to cut off 
the excess edges of the cover, and use the rubber tool again to make sure the 
edges are sealed to the plate 
10. Spin plate at 1000 rpm for 2 minutes using the centrifuge in Rita’s lab. 
11. Run plate in real-time machine as described in final protocol. 
REAL-TIME PCR:  USING THE PCR MACHINE 
**Report any issues with the real time PCR machine to Dr. Grotewiel** 
1. Open the StepOne software 
2. Use your name as the username 
3. Select Advance Set Up 
4. Experiment properties tab: 
 Enter experiment name 
 Select 96 wells 
 Select quantification comparative cT 
 Select SYBR green and check box to include melt curve 
 Select standard 2 hour run time 
5. Plate set up tab: 
 Target = primers used 
 Samples = cDNA (include dilutions or sample number, as appropriate) 
 Click assign targets and samples 
o Assign wells but selecting with primer and cDNA sample are in each well 
 Select rox as the dye to use 
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 Select actin as the endogenous control 
6. Run method tap: 
 Enter 15 as the reaction volume per each well 
 Use all other default settings on this page! 
7. Click RUN 
8. Click START RUN 
9. Save file in the Grotewiel folder 
10. Analyze data per standard lab protocols. 
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P.13 - Quantitative Measurement of β-Gal Activity in Flies 
 
1) Homogenize (with drill/pestle in 1.5 ml snap-cap tubes) 10 lacZ-expressing flies 
of desired age and gender in 250 µl of extraction buffer (1X PBS with 1X 
protease inhibitor cocktail) for 25 seconds. 
 if using rotating spec, can only test 6 samples at a time  
(1 every 10 seconds for a minute) 
2) Add 500 µl extraction buffer to each tube from step 1, mix by vortexing for 30 sec 
3) Centrifuge extracts for 5 min at 14,000 rpm at room temperature 
4) Transfer supernatants from step 3 into new labeled 1.5 ml snap-cap tubes 
5) Set spectrophotometer at 562 nm. 
6) Add 900 µL of 1 mM CPRG to 100 µl of water to a plastic cuvette for the blank. 
Set spec reference with the blank (water sample + CPRG). 
7) Transfer 100 µl of each fly extract to an individual plastic cuvette. Add 900 µL of 
1 mM CPRG to each of the fly extracts. Stagger the addition of CPRG to coincide 
with the order and timing of absorbance measurements. 
8) Record absorbance of each cuvette every minute for 6 mins 
CPRG 
*CPRG is more sensitive than X-GAL and product measurement at 562 not interfered 
with by fly pigment 
*CPRG solution is only good for 24 hours 
275 
 
 
Final volume 
of 1mM 
CPRG (mL) 
CPRG 
added 
(g) 
10 0.005 
15 0.008 
35 0.0205 
 
Protease inhibitor cocktail 
Stored in the -20 
Sigma (P8340) 
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